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SUMMARY
This thesis describes studies on the pathogenesis of heartwater by investigating
the effects of cytokines and nitric oxide (NO) in experimental Cowdria ruminantium
infections in in vitro and in vivo models. The latter were carried out in sheep and mice.
In sheep infections, there was increased levels of antioxidation enzymes,
glutathione peroxidase and superoxide dismutase with the highest levels coinciding with
the period of the clinical disease. C. ruminantium was also found to induce increased
levels of nitrite, indicative ofNO, in plasma where the nitrite levels were found to have
an earlier and higher increase in sheep with prior exposure to C. ruminantium antigens
as compared to naive sheep infections. Mean interferon gamma (IFN-y) levels in
plasma were found to be increased after infection, just prior to or at time of the febrile
reaction, with higher levels being recorded in the sheep with prior exposure to C.
ruminantium antigens than in the naive animals. There was a gradual increase in mean
interleukin 8 (IL-8) and tumor necrosis factor alpha (TNF-a) levels after infection and
the highest levels coincided with the febrile reaction. Higher levels of IL-8 were
recorded in the primary infections than in the sheep with prior exposure to C.
ruminantium antigens.
To determine the source of the NO detected in in vivo studies, in vitro studies
of C. ruminantium infections of bovine pulmonary endothelial cells (BPEC) were
conducted and NO was found to be induced by C. ruminantium infections. The NO
production was found to be enhanced by bovine recombinant IFN-y and was inhibited
by nitric oxide inducible synthase inhibitor, LNMMA. Induction of apoptotic cell death
was seen in IFN- y treated cells with the infected cells showing higher apoptotic cell
death than the uninfected cells. Treatment of elementary bodies with NO was found to
reduce both infectivity and viability of C. ruminantium. This indicates that NO is
released during endothelial infection and has an elfect upon infectivity and viability of
the organism.
The importance of interferons in the control of C. ruminantium infections was
further investigated in an in vivo model using mice deficient in IFN- y and IFN-a/b
receptors. Infection of these mice resulted in a more severe disease characterised by a
shorter incubation period, higher morbidity and mortality rates in relation to time, with
more pronounced pathology characterised by increased amount of oedema fluid,
infiltration of inflammatory cells and higher lung and brain infection rate as compared to
control mice. Electron micrographs from infected mice 7 days post-infection indicated
that organisms had developed to later developmental stages in the mice deficient in
IFN- y receptors, where as earlier developmental forms were seen in controls, with
mixed stages being seen in the IFN-a/p receptor deficient mice.
Studies then looked at the time course of cytokine production in relation to C.
ruminantium infection in mice. Infection of mice with C. ruminantium induced
transient productions of IFN-y and the biologically active 70 kDa heterodimeric form
of IL-12, (IL-12p70) and a corresponding initial reduction in IL-4 and IL-10 levels. IL-
12p70 levels were highest on days 2-4 while IFN-y levels were highest on day 6, just
prior to disease onset followed by a dramatic reduction which also coincided with the
clinical onset on day 8. Levels of IL-4 and IL-10 were reduced immediately after C.
ruminantium infection with the lowest levels coinciding with the highest IFN-y levels
on day 6 post-infection. This study showed induction of a transient Th 1 immune
response which was not sustained, possibly resulting in the fatal outcome of infection of
mice.
In contrast, inoculations of mice with murine recombinant interleukin 12 (MrlL-
12) were found to have immunomodulatory effects on C. ruminantium infections in
mice and to protect a significant number of mice. The highest protection was afforded
by mice inoculated with MrIL-12 from beginning of infection with booster doses every
2 days; 20% of these did not show any clinical signs and were immune to challenge
infection with an overall recovery rate of 45% as compared to the control. There was
reduction of mortality and morbidity rates in mice inoculated with MrIL-12 before or at
time of infection but giving IL-12 after disease onset was found not to offer any
protection to the animals against C. ruminantium infection. The increased resistance or
reduced severity of infection coincided with sustained increase in IFN- y, nitrite levels
and in IgG2a immunoglobulins and a reduction in IL-4 and IL-10.
This study showed that the course taken by C. ruminantium infection in both
in vivo and in vitro models is dependent on the cytokine and antibody milieu in
plasma and possibly tissues prior to or during infection. Involvement of NO in C.
ruminantium infections was suggested in this study. Infection in mice was
characterised by a transient high IFN-y response at about day 6 which was not
sustained. It is likely that this response controls C. ruminantium to some extent
because mice deficient in IFN-y receptors died earlier in the disease with higher
infection levels as compared to the control. Sustained release of IFN-y occurred in
mice treated with MrIL-12 and provided protection in a significant proportion. The
failure to sustain IFN-y in mice may be related to a lack of sustainable IL-12
production.
The importance of a Th 1 type immune response was, therefore, underlined and
the possible roles for IL-12 and IFN- y with involvement of nitric oxide in the killing of
the infectious agent suggested. The study showed for the first time the possible roles of
nitric oxide in the killing immune response and pathology of the disease and the
importance of availability of IL-12 early in infection in the development of protective
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INTRODUCTION
Heartwater is an infectious, often fatal, non-contagious, tick-borne disease of
wild and domestic ruminants. The disease is caused by a rickettsial organism, Cowdria
ruminantium (Cowdry, 1925) and transmitted by ticks of the genus Amblyomma
(Walker and Olwage, 1987). The distribution of the disease follows that of the vector
tick (Camus and Barre, 1982). Heartwater has been diagnosed in Sub-Saharan Africa
(Provost and Bezuidenhout, 1987) and the surrounding islands (Uilenberg, 1983).
Although heartwater is considered to be primarily an African disease, it has also been
diagnosed in the West Indies and it seems possible that the disease may spread to the
American continent (Camus and Barre, 1987).
Until the sixties, most work on heartwater was done in South Africa, but this
has changed in recent years with the increase in awareness of the importance of the
disease, due to the increase in importation of exotic breeds of livestock (Camus et al.,
1996). The disease has been described as second in importance only to East Coast
Fever and trypanosomiasis in the African continent (Uilenberg, 1983), hence, it is
especially of significant economic importance in areas where improved breeds and
managemental practices are being tried; it is a major hindrance to the development of
improved livestock production systems (Ilemobade, 1976; Uilenberg, 1981).
Both domestic and wild ruminants are susceptible to heartwater but only the
former manifest clinical disease in field cases while the latter act more as reservoirs
and are of epidemiological importance (Camus et al., 1996). The disease occurs in
different forms ranging, from peracute to innapparent forms, and is characterised by a
febrile reaction followed by disorders in the nervous, respiratory and/or
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gastrointestinal systems (Alexander, 1931; Neitz, 1968). Nervous symptoms are the
most distinct signs of the disease although not always present (Neitz, 1968).
The pathogenesis of the disease remains unclear and many hypotheses have
been put forward concerning this; it has been suggested to be centred in factors which
cause increased capillary permeability, and allow seepage of plasma proteins resulting
in transudation through the serous membranes, and cardiac insufficiency (Clark, 1962;
Owen et al., 1973; Duplessis, 1975a; 1975b; Prozesky and Du Plessis, 1984), but the
underlying causes are not known. Although vascular lesions were suggested to be due
to the presence of C. rwninantium in the vascular wall (Pienaar et al., 1966), later
studies showed that there was no direct link between the presence of the infectious
agent and cytopathic changes (Pienaar, 1970; Du Plessis, 1985b). Other studies have
suggested that the increase in permeability may be due to mediators produced as a
result of the disease. Some ascribed the vascular defect to a toxin (Pienaar et al.,
1966; Pienaar, 1970; Ilemobade, 1976) but such a toxin was not identified; others
suggested inconclusively that this was due to release of vasoactive substances by mast
cells (Du Plessis, 1975a; 1975 b).
Cell-mediated immune responses have been reported to be important in
protection against C. rwninantium infections (Du Plessis, 1982; Du Plessis et al.,
1991; 1992; Mahan et al., 1994; 1996; Totte et al., 1993; 1994). C. ruminantium
infects and multiplies primarily in endothelial cells (Cowdry, 1926) and also
phagocytic cells (Logan et al., 1987). C. ruminantium parasites are, therefore, in
obligatory association with the intracellular compartments of the host cells and the
implication of this cell-parasite association may be important in understanding the
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host-parasite interactions and, hence, the pathogenesis and immune responses of the
disease as a whole. This was the basis of the hypothesis from which these studies
were developed: Infection of endothelial cells (and other phagocytic cells) by Cowdria
ruminantium may result in induction of a number of responses leading to changes in
the micro-environment of the endothelium and, hence, a disturbance in the
homeostatic function of the cardiovascular system as a whole. This may result in a
complexity of activities bringing into play body defence mechanisms involving
induction of mediators such as cytokines, reactive nitrogen intermediates and oxygen
intermediates, as part of the body defence mechanisms as well as contributors to
pathology. The extent to which clinical signs and pathology are a consequence of the
infectious agent and to what extent they are as a result of the immune responses are
not well known. Host defence mechanisms which fight against uptake and
establishment of C. ruminantium organisms in the intracellular ecological niches will
control infection and increase survival, hence the importance of the right extracellular
and intracellular ecological environment at the right time.
The aim of this study was, therefore, to investigate the pathogenesis and
immune responses induced by the host-parasite interactions in C. ruminantium
infections, with special emphasis on cytokines and nitric oxide in relation to pathology
and immunity to the disease. This involved:
1. Investigation of the disease kinetics induced in sheep of different susceptibility to C.
ruminantium, by examining the profiles of selected cytokines (interferon gamma
(IFN-y), tumor necrosis factor alpha (TNF-a ) and interleukin 8 (IL-8)), nitric oxide
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(NO) and enzymes involved in antioxidation processes (superoxide dismutase (SOD)
and glutathione peroxidase (GPX)).
2. Examination of the effects of bovine recombinant interferon gamma (BorlFN—y)
and NO on C. ruminantium infection of bovine pulmonary endothelial cells in vitro.
3. Investigation of the role played by Type II (IFN-y) and Type I (IFN-a/P)
interferons in the protective and pathological mechanisms of C. ruminantium infection
in vivo using mice deficient in IFN-y and IFN-a/(3 receptors.
4. Investigation of Th 1 cell type and Th 2 cell type immune responses including
cytokines and NO profiles in mice infected with C. ruminantium.
5. Assessment of the immune and pathological responses elicited by inoculations of






1.1.1. History and geographical distribution
The first record of what was probably heartwater was according to Neitz
(1968) made in South Africa by the voortrekker pioneer Louis Trichardt in 1838. He
had noticed a fatal disease "nintas" amongst his sheep which he suspected was caused
by massive tick infestations. He described these observations in his dairy on the 17th,
of February 1838. About 50 years later a farmer, John Webb, reported to the Cattle
and Sheep Disease Commission in Grahamstone (South Africa) on a disease similar to
the one described by Trichardt, which had by this time come to be referred to as
heartwater. He was of the opinion that the disease was introduced into the Eastern
Cape at about the time that William Bowker found a bont tick on a cow which had
been imported from Zululand in about 1837. Subsequently, according to Henning
(1956), the disease was reported from various parts of South Africa (Provost and
Bezuidenhout, 1987).
Heartwater has, since then, been described in different areas under
different local names; Kaboa meaning trembles (Fulani), Enguruti (Masai), Daji
(Hausa), Khader, Magak (Sudanese), Heartwater, blacklung or Dronkgalsiekte
(Afrikaans) (Camus et ai, 1996). The disease is also widely distributed in Eastern
Africa. Prior to 1925, only the signs of the disease were recognised and it was not
until 1930 that Daubney (1930) diagnosed the disease first in Kenya by demonstrating
the presence of C. ruminantium organisms in brain and kidney sections of infected
sheep. He also stated that Amblyomma habraem, the vector of heartwater in South
Africa was not present in Kenya and showed that the disease was transmitted by the
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so called "tropical bont tick", A. variegatum, the most common member of the genus
in Kenya.
The disease was originally found only in the African continent but has been
diagnosed in the Caribbean and there is danger of the disease being introduced in the
American continent (Camus and Barre, 1982). There is however no answer as to
whether the disease is indigenous to the African continent and the fact that the
Amblyomma species of ticks occur in the Asian and American continent further
confuses the issue (Camus et al., 1996). A list of countries were the disease has been
diagnosed including the year and author was compiled by Provost and Bezuidenhout
(1987) based on summary of articles, according to Camus and Barre (1982).
1.1.2. Aetiological agent
1.1.2.1. Classification
Heartwater is caused by a rickettsial organism, Cowdria ruminantium,
measuring about 0.2-0.5u (Cowdry, 1925) which is found in the cytoplasm of vascular
endothelial cells of the mammalian host. In the Bergy's Manual of Systemic
Bacteriology, C. ruminantium is classified as being in the family Rickettsiaceae, tribe
of Erhlichiae (Ristic and Huxsoll, 1984). Cowdria and many of the Erhlichia were
originally named rickettsia but were renamed later in honour of the German
bacteriologist Paul Ehrlich and the American bacteriologist E. V. Cowdry
(Moshkovski, 1945; 1947). A taxonomic position near to that of Erhlichia was found
to be logical after serological cross reactions were shown to exist between Cowdria
and Ehrlichia and DNA sequencing found the two genera to be closely related (Van
7
Vliet et al., 1992). The close relationship between Cowdria and Erhlichia was further
supported by the finding that Cowdria also multiplies within granulocytes, the same
host cells for several Ehrlichia species (Logan et al., 1987). A close relationship has
also been reported between Cowdria and Chlamydia (Pienaar, 1970; Uilenberg, 1983;
Scott ,1987).
1.1.2.2. Morphology and staining characteristics
C. ruminantiwn has been described in sections stained in Giemsa stain as a
coccal, gram-negative organism staining lilac to purple blue (Cowdry, 1925; 1926).
Cowdry described the morphology of the organism in infected endothelial cells of
experimentally induced cases of heartwater and also in intestinal epithelial cells of the
tick Amblyomma habreum. His description of the morphology was based on its
appearance in paraffin-embedded sections and smears made from the alimentary tract
of the invertebrate host. The organism was described as uniform, coccus-shaped
bodies of 0.2-0.5u in diameter which occur in dense masses varying from a few
individual cells to several hundred in the cytoplasm of infected cells (Cowdry, 1925;
1926). These findings were further confirmed by other researchers (Bezuidenhout,
1984; Kocan et al., 1987). Several researchers have described the pleiomorphic forms
of Cowdria ruminantium (Jackson and Neitz, 1932; Sahu, Dardiri and Wool, 1983;
Stewart and Howell, 1981). Donatien and Lestoguard (1937) observed initial bodies
which were described as homogenous masses in the cytoplasm, stained purple with
Giemsa stain and measured between 1-2(1 and up to 5(1. Jackson (1931) and Jackson
and Neitz (1932) described the variations of the clumps or colonies in size and shape;
they described the different forms as small (coccoid), medium and large forms. The
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large forms were described as having irregular shapes varying from coccoid, ring to
horse shoe shapes. There are many other stains which have been used including
Loefflers methylene blue, methyl-green pyronine, fuchsin (Prozesky, 1987a), Mallory
(Yunker et al. 1987), acridine orange and Diff-quikR (Camus and Barre 1988).
The morphology of the organism in the vertebrate host is similar to that in the
vector (Cowdry, 1926). Apart from the coccoid forms described by Cowdry (1925
and 1926) and initial bodies described by Donatien and Lestoquard (1937), bulky dark
blue forms have been described measuring 2-4(1 (Camus et al 1996). Electron
microscopy enabled the precise morphology to be determined and showed that the
colonies are situated inside membrane-lined vacuoles in the cytoplasm of the
endothelial cells and that each organism is surrounded by a two unit membrane
(Pienaar, 1968; 1970; Du Plessis, 1975a; Stewart and Howell, 1981) .
1.1.2.3. In vitro cultivation
Until 1985, in vitro cultivation of C. ruminantium was a long-story of
frustrations due to lack of suitable culture system. In 1985 Bezuidenhout et al.
managed to propagate C. ruminantium in irradiated endothelial cell. It was also
demonstrated that cultures can be initiated without the need to retard cell growth
(Bezuidenhout, 1987; Byrom and Yunker, 1990). Since 1985, several stocks of C.
ruminantium (Ball 3, Welgevoden, Senegal, Gardel, Crystal springs, Highway,
Palmriver, Mbizi, Lemco, Kiswani) have been successfully used to infect bovine or
ovine endothelial cells (Camus et al., 1996). C. ruminantium has also been grown in
neutrophils in vitro (Logan et al., 1987a).
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1.1.2.4. Hosts and transmission
Heartwater is a tick-borne disease of both wild and domestic ruminants,
although only domestic ruminants (sheep, cattle and goats) suffer the clinical disease,
wild ruminants act more as reservoirs (Camus et al., 1996). Heartwater is transmitted
by the three host ticks of the genus Amblyomma (Bezuidenhout, 1987). Amblyomma
variegatum has been described as the most important vector and is wide spread in
savannah areas of tropical Africa and surrounding islands (Daubney 1930; Walker and
Olwage 1987) while Amblyomma hebraeum is the most important vector in southern
Africa (Lounsbury, 1900, cited by Camus et al., 1996). Other species which have
been reported to transmit the disease include Amblyomma gemma (Lewis, 1949),
Amblyomma pomposum (Neitz, 1947), Amblyomma lepidum (Karrar, 1966),
Amblyomma thollon (Mackenzie and Norval 1980) and Amblyomma sparsum (Norval
and Mackenzie 1981). Transmission is transtadial, although transovarial transmission
has also been implicated (Bezuidenhout and Jacobsz, 1986).
1.1.3. The Disease
1.1.3.1. Clinical manifestations
The incubation period and the course of the disease are influenced by the
species of animal affected, the virulence of the isolate, the amount of the infectious
agent administered, the route of infection, the age and the immune status of the animal
(Alexander 1931; Neitz, 1968; Uilenberg 1983). Goats are the most susceptible
experimental animals (Camus et al., 1996). In natural infections the incubation period
is a day or two longer than in experimental infections (Donatien and Lestoquard,
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1937) but is variable. The disease is manifested in different forms in ruminants,
ranging from peracute, acute, subacute to mild forms (Camus et al., 1996). In the
peracute form, sudden death of animals without any clinical signs is common (Aklahu,
1980). The acute form is the most common form of the disease, with a course of
disease ranging from 2-6 days (Camus et al., 1996). It is characterised by a rapid
temperature increase of up to 41°C, with other clinical signs occurring 1-2 days after
the onset of fever, other clinical signs include respiratory distress and nervous signs,
but the latter may not always be present (Alexander, 1931; Clark, 1962; Owen et al.,
1973). The subacute form of the disease is similar to the acute form but the clinical
signs are less prominent (Camus et al., 1996). The mild form of the disease, also
called heartwater fever, has a transient fever followed by natural recovery and this
form is considered to be of epidemiological value due to its carrier status (Camus et
al., 1996). The mild and subacute forms of the disease have been said to be more
frequent among indigenous cattle of all ages, partially immune animals and young
calves of all breeds (Uilenberg, 1981).
1.1.3.2. Pathogenesis
Steck (1928), Alexander (1931), Henning (1956), Clark (1962) and Prozesky
and Duplessis (1985c) are some of the workers who have described increased
capillary permeability leading to lung oedema as the most prominent lesion and as the
cause of death. However, the underlying cause of this lung oedema and hydrothorax
remains unknown. Gross brain lesions are rare and, even when present, not
pathognomonic. Brain oedema, hyperemia and haemorrhages are some of the findings
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which have been reported in cattle, sheep and goats (Pienaar et al. 1966); the
relationship between these and the pathogenesis of the nervous lesions observed in
heartwater cases is not clear. Swelling of kidneys, splenomegaly, oedematous lymph
nodes and haemorrhages in various surfaces have also been reported (Prozesky and
Du Plessis, 1985b).
1.1.3.3. Pathology
The gross lesions are similar in all species and have been well described by
Steck (1928), Currason and Delpy (1928), Alexander (1931), Henning, (1956) and
Pienaar et al., (1966), Uilenberg, (1971) and Prozesky, (1987c). The main lesions are
those associated with increased vascular permeability. These include hydrothorax,
lung oedema, hydroperitoneum, haemorrhages on the pericardium and intestines and
congested lung. Enlarged spleen was described as common by some authors
(Alexander 1931) and as rare by others (Uilenberg, 1971a); these differences were
postulated to be strain linked (Camus et al., 1996). Oedema and congestion in the
brain have also been described (Pienaar et al., 1966). Lesions in mice have been said
to be similar to those described in the ruminants described above and are mainly
characterised by effusions in body cavities and splenomegaly (Prozesky and Du
Plessis, 1985b).
Microscopic lesions were described by Cowdry (1926), Steck (1928) and
Prozesky and Du Plessis, (1985b). The lesions described in the brain of infected
animals include necrotic foci and microcavitation in the cerebella cortex, oedema and
accumulation of cells in the perivascular spaces and presence of the infectious agent in
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the cytoplasm of endothelial cells, although this was found to be rare in mice as
compared to ruminants (Prozesky and Du Plessis, 1985b). Cytopathic changes in lung
alveolar endothelial cells were described as mild with swelling of mitochondria,
dilatation of the endoplasmic reticulum and presence of the infectious agent in the
lung endothelial cells (Prozesky and Du Plessis, 1985b).
1.1.3.4. Clinical pathology
Disappearance of eosinophils before onset of the febrile reaction is
documented (Clark, 1962; Owen et al., 1973; Ilemobade, 1976; Van Amstel et al.,
1988; Mutunga, 1992). Darkening of the plasma in infected animals was reported by
Clark, (1962) and was attributed to bilirubin (Van Amstel et al., 1987). Some authors
reported the occurrence of leukopaenia (Ilemobade, 1976; Abdel Rahim and Shomein,
1978; Van Amstel et al., 1987) while leukocytosis was reported by Van Amstel et al.,
(1994). Anaemia has also been reported to occur after onset of fever (Van Amstel et
al., 1988; 1994). An increase in glucose and blood urea nitrogen were reported
(Mutunga, 1992) and Ilemobade (1976) found increased levels of pyruvate and lactate
levels in sera of C. ruminantium infected animals.
1.1.4 Diagnosis
Heartwater is often misdiagnosed even by the most experienced veterinarians,
because gross lesions are not pathognomonic to the disease. A combination of proper
history taking, clinical observations, macroscopic and microscopic pathological
findings and serological tests have been used. Currently DNA probes have been
developed and are being tried for detection of C. ruminantium (Waghela et al.,
1991; Yunker et al., 1993.
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Detection of C. ruminantium in capillary endothelial cell smears has been for a
long time the only method of confirming the disease (Purchase , 1945). Treatment of
heartwater infected animals has been reported to alter the amount of infectious
material (Prozesky, 1987b). Some animals treated of the disease, although not fully
recovered, were reported to have fewer macroscopic changes and no organisms were
detectable in the brain (Prozesky, 1987a). Identification of C. ruminantium in the
brain smears 48-60 hours after an animal has been treated is often difficult. The small
forms of C. ruminantium organisms are more severely affected than the larger forms
(Prozesky, 1987a). Confirmation of C. ruminantium infection in mice differs to some
extent from those in ruminants infected with C. ruminantium, as they are not easily
found in brain endothelial cells (Prozesky and Du Plessis 1985a). Hyrothorax,
hydropericardium, oedema of the lungs and splenomegaly are found in the majority of
mice inoculated with C. ruminantium isolates infective for mice (Du Plessis, 1975a;
Prozesky and Du Plessis, 1985a). The highest concentration of organisms in mice has
been seen in the lungs (Prozesky and Du Plessis, 1985b). It is not clear why organisms
are detected in very low concentrations in the brains of mice as compared to the
brains of ruminants (Prozesky, 1987b; Du Plessis, 1985a). Morphologically there are
no differences seen between different isolates (Prozesky, 1987a; Du Plessis, 1985a).
1.1.5 Control of heartwater: treatment and immunisation
Sulphonamides and antibiotics have been used successfully for the treatment
of heartwater. Tetracyclines constitute the drug of choice in the treatment of
heartwater, with the long acting formulations of oxytetracyclines being preferred
(Camus et al., 1996). Prophylactic methods include quarantine, effective tick control
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and immunisation methods. Immunisation using infective material (blood or ground-
up tick homogenates) followed by treatment after fever onset has been used for a long
time (Bezuidenhout, 1989). This is currently the method of immunisation adopted in
Southern Africa, using a moderately pathogenic strain of C. ruminantium (the Ball 3
isolate) but protection is not fully achieved (Du Plessis et al., 1989). This
immunisation principle of infection and treatment has been applied using other stocks
of C. rwninantium, and, in later trials, infectious agent grown in tissue culture and
from the results, it has been concluded that some stocks are difficult to control using
others due to lack of cross-protection (Du Plessis et al., 1989; Jongejan et al., 1988).
Use of attenuated vaccines has also been attempted; vaccinations using the Senegalese
stock, attenuated by passaging in bovine endothelial cells in culture, was reported, but
this stock is not cross-protective with other isolates due to differences in its antigenic
profile (Jongejan et al., 1993c). Lately, more success has been reported in
vaccinations using inactivated C. ruminantium organisms; Martinez et al., 1994,
reported some success in goats vaccinated with inactivated C. ruminantium
elementary bodies (EBs) of the Gardel stock. Use of proteins which are common to
most isolates, like the 32 kDa, (MAPI) protein, has been attempted (Van Kleef et al.,
1993), but this method of immunisation has the antigenic diversity of some of C.
ruminantium isolates as its major drawback (Camus et al., 1996).
1.1.6. Immune response to C. ruminantium infection
Indigenous breeds may acquire a strong innate resistance to Cowdria through
natural selection (Spreull, 1922; Alexander, 1931; Du Plessis et al., 1983). Variation
in the susceptibility to C. ruminantium in cattle, sheep and goats has also been
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recorded (Du Plessis and Malan, 1987a; Uilenberg, 1971; Spreull, 1922). Differences
in the resistance of cattle to C. ruminantium infection have been documented. There is
general agreement that local breeds developed in endemic areas are more resistant
than exotic breeds and it was suggested that they acquire this strong innate resistance
through long natural selection (Matheron et al., 1987). However, there have been
conflicting reports on the resistance of different breeds to C. ruminantium infection
(Du Plessis and Malan , 1987a; 1987b), with some authors reporting that Bos indicus
are more resistant than Bos taurus breeds (Van der Merwe, 1979), while others
reported that the innate resistance found in African breeds had nothing to do with the
breed influence (Uilenberg, 1983).
Some breeds of sheep and goats, like the Persian breed, exhibit strong natural
resistance to C. ruminantium (Lounsbury, 1904 cited by Camus et al., 1996) while the
Angora goat is considered the most susceptible domestic ruminant to heartwater
followed by the Boer goat, the Merino and the Merino crossbreeds (Spreull, 1922).
Younger animals have also been shown to be more resistant to C. ruminantium than
older animals, and this resistance was suggested to be independent of the immune
status of the dam (Neitz and Alexander, 1941). Lambs younger than 8 days and kids
up to 6 weeks of age have been found to be resistant to heartwater with calves being
resistant for longer periods (3 weeks to 6 months) (Neitz and Alexander, 1941). It
was suggested that 78 % of flocks continually exposed to heartwater were immune to
heartwater disease (Neitz and Alexander, 1941).
Animals which recover from C. ruminantium infection have been shown to be
resistant to the disease (Alexander, 1931; Neitz, 1939). Vaccination has been
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attempted over the years using materials ranging from bile (Dixon, 1898) to the
current vaccination attempts using recombinant antigens (Van Kleef et al., 1993).
Theiler (1906) produced a polyvalent serum by combining serum, from infected cattle
and sheep, and reported that 20 ml of the vaccine protected goats and sheep against
challenge with 5 ml of infected blood injected subcutaneous but not against
intravenous challenge. Antibodies were shown not to be protective in C. ruminantium
infections (Alexander, 1931; Du Plessis, 1970; 1982), but immune serum was
reported to inhibit infectivity of the infectious agent in the presence of complement
and mouse peritoneal macrophages (Du Plessis et al., 1991). Byrom et al., (1993)
showed that hyperimune serum from DBA/2 and Balb'c mice as well as bovine sera
had a strong neutralising effect on the infection of endothelial cells in vitro but that
there was no protection of these mice against intravenous challenge of C.
ruminantium, and that addition of complement had no beneficial effect.
Cell-mediated immunity has been documented as important in protection
against C. ruminantium infection (Du Plessis, 1982; Du Plessis et al., 1991; 1992;
Mahan et al., 1994; 1996; Totte et al., 1993; 1994). Du Plessis (1982) was able to
show that transfer of immune spleen cells protected naive mice against challenge with
the Kumm isolate of C. ruminantium given 30 and 60 days later. This immunity was
reported to be largely mediated by CD8+ T lymphocytes, as immune spleen cells
depleted of Lyt-2+ T cells (CD8+ cells) were unable to confer resistance to recipient
mice challenged with C. ruminantium, whereas the depletion of L3T4+ cells (CD4+
cells) had no effect on this protection (Du Plessis et al., 1991).
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Infection of bovine brain endothelial cells was shown to induce expression of
IL-1B, IL-6 and IL-8 mRNAs and that this effect was potentiated by IFN-y
(Bourdoulous et al., 1995).
1.2. Mechanisms of immunity and pathological damage
Cell mediated immunity is documented as important in the control of C.
ruminantium infections (Du Plessis, 1982; Du Plessis et al., 1991; 1992a; Mahan et
al., 1994; 1996; Totte etal., 1993; 1994). Cytokines, including interferons, tumor
necrosis factor and interleukins, and other related mediators (secondary mediators)
such as reactive oxygen and nitrogen radicals play important roles in immunological,
pathological and physiological processes in humans and animals. This section
reviewes some of the literature relevant to this study as concerns immune responses to
intracellular infections including cell mediated immune responses, cytokines and
secondary mediators in pathological and immunological mechanisms. These included:
macrophages and T cells in immune responses; interferons, tumor necrosis factor,
interleukins including interleukin 12, interleukin 8, interleukin 4 and interleukin 10;
reactive nitrogen intermediates with special emphasis on nitric oxide, and reactive
oxygen intermediates and antioxidants.
1.2.1. Immune responses to intracellular Infections
1.2.1.1. Cellular responses: macrophages and T cells
Macrophages play a key role in the control of diseases as they are involved in
innate resistance phenomena, initiation, and effector mechanisms of specific host
response (Bienhoff et al., 1992). Much research has gone into this cellular immunity
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mechanism with the early studies being done in tuberculosis where it has been found
that the immune response in this disease is cell mediated without humoral antibody
responses (Green et al., 1993). Macrophages play a central role as antigen-presenting
cells and their activation depends on T cell-derived products such as IFN-y for killing
of intracellular pathogens (Bancroft et al., 1987). IFN-y has been described as one of
the primary T cell products which has macrophage activating properties (Bancroft et
al., 1987; Nathan and Sporn, 1991). IFN-y increases MHC Class I and Class II
expression and stimulates the cells to become more active in killing parasites (Pontzer
and Russel, 1989; Rhodes et al., 1986).
Although the major macrophage activating cytokine is IFN-y (Nathan et al,
1983) other cytokines have also been found to activate macrophages e.g. TNF-a, IL-
4 (Myers and Murtaugh, 1995). However, TNF-a does not seem to play a clear role
in antiviral immunity in animals (Myers and Murtaugh, 1995). In parasitic infections
IFN-y produced by either CD4+ T cells (DeMaeyer and DeMaeyer, 1988) and CD8+
cytotoxic T cells (Frasca et al., 1985) appear to play the major role in macrophage
activation.
Some products secreted by macrophages have been implicated in microbicidal
activity, including cytokines e.g. TNF, reactive oxygen and nitrogen metabolites and
enzymes (Richards et al., 1995). Some of these mediators are released by resting
unstimulated cells while others like nitric oxide and superoxide anion are released by
activated cells upon stimulation of the macrophages and related cells (Elsasser et al.,
1995). These molecules may act as cytotoxic effector molecules depending on the
susceptibility of the organism in question (Lancaster, 1992).
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The most common diseases encountered in domestic animals and, indeed,
mammals as a whole, are respiratory diseases, in particular those caused by infectious
agents and to a lesser extent allergic and chemically induced lung diseases (Bielefeldt-
Ohmann, 1995). The respiratory system is a target of micro-organisms, dust, gases. It
has been suggested recently that the respiratory system in particular the lung may play
a major role in immune responses and regulation (Bielefeldt-Ohmann, 1995), due to
the lung being situated at the interface between the external and internal environments
and containing all the cellular constituents of a lymphoid tissue (Holt et.al., 1990).
The cascade of events begins with induction of interferon by epithelial cells (IFN-
P)and by resident macrophages (IFN-a) (Bielefeldt-Ohmann et al., 1991 and 1995).
This is followed by production of IL-6 and IL-8 initially by resident macrophages
(Hennet et al., 1992 and Vacheron et al., 1991) and then by bronchial epithelial cells
(Becker et al., 1991), pulmonary type II epithelial cells (Standford et al., 1990),
fibroblasts (Van Damme et al., 1989), endothelial cells and by macrophages
(Vacheron et al., 1991). It has been suggested that TNF-a and IL-1 are the main
stimuli to the macrophages for production of IL-6 and IL-8 as well as the pathogens
themselves (Van Damme et al., 1989). Although TNF-a may have a cytotoxic effect
on EC, the indications are that the main mechanisms for microvascular injury and
increased permeability are indirectly mediated via PMN-dependent effects (Bielefeldt-
Ohmann, 1995).
The interaction of resting T cells with antigen and cytokines results in their
activation, proliferation and differentiation (Hamblin, 1993). The clonal expansion of
T cells is dependent on the presence of antigen presenting cells (APCs) which, for
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CD4+ T cells, are mononuclear phagocytes or dendiritic cells expressing Class II
MHC and for CD8+ T cells are any cells expressing Class I MHC (Hamblin, 1993).
The types of cytokine released by different subpopulations of CD4+ T cells are
thought to influence different facets of the immune response (Pace et al., 1983; Tripp
and Unanue, 1996). According to Mosmann and Coffman (1989), there are two
subpopulations of CD4+ T cells which secrete different cytokines; Th 1 cells secrete
IFN-^y and IL-2 while Th 2 cells secrete IL-4, IL-6 IL-5 and IL-10. The activities of
the cytokines synthesised suggest that the two types of T cells have different
functions; Th 1 cells secrete cytokines associated with cellular immunity, where as Th
2 cells secrete cytokines associated with B cell activation, proliferation and
differentiation and the two types of cells seem to regulate each other (Hamblin, 1993;
Trinchieri, 1993). IFN—y secreted by Th 1 cells inhibits cytokine production by Th 2
cells and IL-10 secreted by Th 2 cells inhibits cytokine production by Th 1 cells. In
high doses TNF-a leads to hemodynamic, pulmonary, metabolic and pathological
consequences indistiquishable from endotoxemia and septic shock. It further induces
vascular permeability leading to oedema and injury to endothelial cells and appears to
play a key role in hypotension and altered metabolism. TNF-a has been incriminated
in lung injury in sheep (Redl et al., al; 1990), cattle (Kenison et al; 1987) and goats
(Van Miert et al; 1992). The clonal expansion of CD4+ and CD8+ T cells is critically
dependent on the cytokine milieu present, e.g., IL-12, IL-2 (Trinchieri, 1993).
The following are reviews of activities of the various cytokines relevant to the
experiments carried out in the studies described in this thesis.
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1.2.1.2. Interferons in health and disease
The interferons are divided into two families: Type I (a/b) and Type II (g)
interferons and they have also been classified according to the producer cells as
leukocyte (a), fibroblast (b) or immune (g) interferons (Pestka, 1983; 1986) but this
classification has now changed to type I and II interferons.
1.2.1.2.1. Type I Interferons (IFN-a and IFN-P)
Type I (a /b) were grouped together due to extensive sequence homologies in
their amino acid sequences and the observation that they bind to a common cell-
surface receptor (Mariano et al., 1992). Type I interferons act on target cells exerting
a variety of effects including anti-viral, antiproliferative and immunomodulatory
activities. All Type I interferons compete for binding to a single cell-surface receptor
complex which initiates the signalling mechanisms for the cellular effects observed.
The cellular response to the binding of interferon to the cell induces activation of
specific DNA-binding proteins that complex with the promoters of interferon
stimulated genes (ISG) at the interferon stimulated response element (ISRE) resulting
in the induction of several gene products 2-5A synthatase, MHC class I surface
antigens, P 68 kinase and the Mx family of proteins as well as several other proteins
whose function is not yet known (Seng and Lengyel, 1992).
EFN-a/p receptors are generally found on all cells poorly responsive to
interferon. Cells showing no binding at all of one of the family are relatively rare or
deliberate constructs. The IFN-a R chain is implicated in the binding and activities of
all IFN- a/(3 species (Uze et al., 1992).
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Following the binding of IFN to its receptor the immediate early response is
the activation of transcription of a set of genes containing a conserved response
element called ISRE (IFN stimulated response element) in their promoter (Kerr and
Stark, 1991). ISRE binds the ISGF -3 transcription factor which consists of four
proteins (Schindler et al., 1992).
1.2.1.2.2. Type II Interferons (IFN-y)
IFN-y is a glycoprotein of monomer molecule weight 20-25 KDa which is
secreted from T cells and natural killer (NK) cells. IFN-^y was originally identified by
its in vitro anti-viral activity nearly 30 years ago (Wheelock, 1965). IFN-y exhibits
many different biological activities in vitro, including anti-viral, anti-proliferative,
macrophage activation and induction of MHC class I and II molecules; plays a key
role in host defence and in inflammatory processes and exhibits a potential in the
treatment of infectious diseases and neoplasia. IFN-y induces expression of many key
antigens including Class I and Class II MHC antigens (Basham and Merrigan, 1983;
King and Jones 1983), nitric oxide synthase and other cytokines such as IL-1 ( Farrar
and Schreiber, 1993; Corbett et al; 1991). The activity of IFN-y is synergistic with
other cytokines; IFN—y enhances the cytotoxic activity of TNF-a and other antiviral
activities of IFN-a or EFN-(3. IFN-y activates macrophages to become tumouricidal
and kill intracellular parasites (Pace et al 1983) and enhances B cell maturation and
immunoglobulin secretion (Vilcek et al., al; 1985, O'Garra et al., 1988). IFN is
responsible for inducing non-specific cell mediated mechanisms of host defence
through its ability to activate macrophages (Bancroft et al., 1987; Nathan and Sporn,
1991).
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The IFN-y receptor consists of 2 integral membrane polypeptides that are
members of the type II cytokine receptor family; an alpha receptor and a beta subunit
that participates in signal transduction only. Human and murine IFN-y receptors bind
their respective ligands with high affinity in a strictly species specific manner.
IFN—y binds to IFN-y receptor alpha chain expressed at cell surfaces to form
a complex which then associates with IFN-y receptor beta chain. In brief, this process
activates enzymatic reactions and interactions with specific sequences resulting in the
development of IFN-y inducible biologic responses (Shuai et al., 1992).
1.2.1.3. Tumour Necrosis Factor
Tumor necrosis factor is a pleiotropic cytokine capable of altering physiological
and immunological sequel as well as mediating the patho-physiological responses of
several disease conditions (Myers and Murtaugh, 1995). The central role of the
endothelium in homeostasis, especially in the control of vascular permeability,
involves complex interactions with the blood components (Myers and Murtaugh,
1995) and studies of the interactions between the endothelium and cytokines such as
TNF have contributed significantly to the current appreciation of endothelial
participation in homeostasis (Matthews et al., 1987;). TNF-a has modulatory effects
on permeability properties of the endothelium. TNF binds to high affinity endothelial
cell surface receptors (Matthews et al., 1987;).
Protection mediated by TNF includes its antimicrobial and tumoricidal effect. Most
cells have TNF receptors and respond to TNF and lymphotoxin. Cells that are
resistant to TNF are different from sensitive cells in that they appear to express
proteins that protect them from TNF cytotoxicity (Goeddel et al., 1986; Wallach,
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1984). TNF has been shown to increase the formation of superoxide anions (O2),
hydrogen peroxide (H2O2) and hydroxyl radicals (OH) (Radeke et al., 1990).
Anaerobic conditions, the antioxidant butylated hydroxyl toluene (BHT) and other
agents, that diminish the formation of oxygen free radicals such as glucocorticoids and
dimethly sulfoxide (DMSO), all block TNF cytotoxicity in vitro (Radeke et al.,
1990)). It has been suggested that TNF kills cells by generating intracellular oxygen
radicals (Matthews et al., 1987; Wong and Goeddle, 1988a; Hepburn et al., 1987). In
vivo TNF protects animals from some diseases and other insults, such as hyperoxia,
that appear to be associated with the production of reactive oxygen and nitrogen
radicals (White et al., 1989).
TNF has been found to induce production of SOD (the MnSOD but not the
CuZnSOD) with the TNF resistant cells producing more SOD than TNF susceptible
cells (Wong and Goeddle, 1988b). MnSOD requires very low levels of TNF (0.1
ng/ml) (Wong and Goeddle, 1988b). Glucorcoticoids and glucose have been shown to
inhibit MnSOD induction in some cells (Warner and Wisp, 1990; Cornelius et al.,
1987).
The liver is important in regulating metabolism and nutrient use. The liver is both a
source and target for TNF (Lancaster, 1992). The functions of hepatocytes change
dramatically during the disease state possibly due to the localised production of TNF
and other cytokines(Lancaster, 1992). Induction of acute-phase response proteins
leads to changes in protein metabolism. Lancaster, 1992, suggested that disturbances
of liver function during disease are related to Kupfer cell production of cytokines that
misdirect hepatocytes to generate increased amounts of NO and self destruction.
25
1.2.1.4. Interleukin 12
Interleukin 12 (EL-12) is a heterodymeric glycoprotein composed of unrelated
subunits of 35 KDa (p35) and 40 kDa (p40) (Kobayashi et al., 1989; Chan et al.,
1991; Trinchieri, 1993) and co-expression of both chains is necessary for biological
activity of IL-12. EL-12 is produced by monocyte-macrophages, B cells and possibly
other accessory cells in response to bacterial products and parasites (Trinchieri,
1993). IL-12 has been identified to be responsible for bridging innate resistance,
involving phagocytes and NK cells, and adaptive immunity, involving Th cells,
cytotoxic T cells and B cells (Trinchieri, 1993). Activities of IL-12 include induction
of IFN—y production by resting and activated T and NK cells (Kobayashi et al., 1989;
Chan et al., 1991) and enhancement of T cell proliferation in combination with other
cytokines, such as IL-2 (Kobayashi et al., 1989; Gately et al., 1992; Perusia et al.,
1992). In addition, IL-12 has been demonstrated to induce cell mediated immunity
through enhancement of NK and T cell cyotolytic activity (Kobayashi et al., 1989;
Gately et al., 1992). Cells induced to proliferate by IL-12 include CD4+ and CD8+ T
cells (Gately et al., 1992).
1.2.1.5. Interleukin 8
Interleukin 8 (IL-8) belongs to the chemokine superfamily group of cytokines
which exhibit between 20 and 45 % similarity in their amino acid sequences and act on
various inflammatory cell types (Taub and Oppenheim, 1993; Oppenheim et al.,
1991). IL-8 has been reported to induce directional migration of various cell types,
including neutrophils and T lymphocytes (Oppenheim et al., 1991). The cytokine
plays a key role in the accumulation of leukocytes at site of inflammation, and, in
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addition to being a potent chemoattractant, IL-8 also has a wide range of pro¬
inflammatory effects (Nicola, 1994). A number of human respiratory diseases exhibit
increased IL-8 expression at both the protein and RNA levels in lung histological
sections and interstitial fluid (Nicola, 1994). In some disease states, increased levels in
IL-8 in body fluids correspond to increased neutrophils (Koch et al., 1992). IL-8 are
implicated as major participants in acute as well as more prolonged inflammatory
responses (Taub and Oppenheim, 1993).
In vitro biological effects of IL-8 include activation of neutrophils including
chemotaxis, shape change, degranulation, respiratory burst, increased cytosolic Ca2+,
increased adhesion to endothelial cells, fibrinogen, and extracellular matrix proteins,
increase expression of CDlla, CDllb, CDllc and CD18 and release of lysosomal
enzyme (Nicola 1994; Oppenheim et al; 1991; Taub and Oppenheim 1993; Schall,
1991; Matsushima et al., 1992). In vivo biological effects of IL-8 on target cells
include: neutrophil infiltration in human, primates, mouse, rat, rabbit and dog,
neutrophilia, angiogenesis, synovial inflammation and plasma leakage (Oppenheim et
al; 1991; Taub and Oppenheim, 1993).
1.2.1.6. Interleukin 4
Interleukin 4 is a 18-20 kDa glycoprotein produced primarily by activated T
lymphocytes (Nicola, 1994). To date, five natural sources of IL-4 have been
identified: some subpopulations of CD4+ peripheral T cells (Mosmann and Coffman,
1989); a minor subpopulation of T lymphocytes in spleen and thymus (Zlotinik et al.,
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1992); a subpopulation of CD3+ CD4+ CD8" thymocytes that briefly continue to
secrete IL-4 after they emigrate to the spleen (Bendelac and Schwartz, 1992).
The many immunoregulatory functions of IL-4 include induction of immunoglobulin
isotype switching to IgE expression, and induction of the subpopulation of helper T
cells, designated as Th 2 cell, which regulate humoral immunity, eosinophilia, and
inflammatory macrophage deactivation (Nicola, 1994). It has been demonstrated that
administration of anti-IL-4 in some disease conditions diverts the ensuing response
away from a Th 2 cell immune response toward a Th 1 cell immune response ( Sadick
etal., 1990)
1.2.1.7. Interleukin 10
Interleukin 10 (IL-10) is a secreted 17-21 kDa protein produced by some
subclasses of T-lymphocytes, primarily Th 2 type cells, B cells and macrophages after
activation by antigen or bacterial products (Nicola, 1994). IL-10 acts on macrophages
to down regulate class II MHC molecules on the surface of monocytes and
macrophages (de Waal Malefyt et al., 1991a). IL-10 inhibits production of reactive
oxygen and nitrogen intermediates including nitric oxide, and cytokine synthesis by
activated Th 1 cells and natural killer (NK) cells suggesting that it has anti¬
inflammatory activities (Moore et al., 1993,; Fiorentino et al., 1991). Production of
IL-10 is inhibited by IFN-7. IL-10 can result in a switch in the immune response from
a Th 1 type (cell-mediated) to a Th 2 type (antibody-type response) immune
responses (Nicola, 1994).
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1.2.2. Reactive nitrogen and oxygen intermediates and antioxidants
1.2.2.1. The endothelium and reactive nitrogen intermediates (Nitric Oxide)
In 1980 Furchgtt and Zawadzki demonstrated the phenomenon of
endothelium- dependent relaxation (vasodilatation) in vascular tissue and its mediation
by a humoral factor which later became known as endothelium-dependent relaxation
factor (EDRF). Bioassay studies revealed the ephemeral nature of this mediator which
is protected from breakdown by a superoxide dismutase (SOD) indicating that it is
inactivated by superoxide anions (0"2) (Furggott, 1984; 1988). EDRF was found to be
a potent activator of guanylate cyclase, the enzyme catalysing cyclic guanosine-3'5'-
monophosphate (GMP) synthesis. EDRF was also found to inhibit platelet
aggregation and adhesion. This property together with its vasodilator effect were
shown to be mediated by activation of the soluble guanylate cyclase, leading to
increases in cyclic guanosine monophosphate (cGMP) within the platelet or smooth
muscle (Furchgott, 1984). It was later suggested that EDRF may be nitric oxide (NO)
or closely related (Furchgott, 1988). This was confirmed experimentally by comparing
the effects of EDRF and NO on vascular smooth muscle and platelets (Palmer et al.,
1987).
Organic nitrates have been used for the treatment of hypertension and they are
known to activate the soluble guanylate cyclase. These nitrates have also been shown
to generate NO in vitro by a non-enzymatic reaction and the activation of guanylate
cyclase by these compounds was found to be inhibited by haemoglobin which binds to
NO (Moncada et al., 1988).
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Evidence has shown that activated macrophages form nitrite (NO2) and
nitrate (NO 3) from L-arginine and suggested that L-arginine is a potential precursor
of NO (Hobbs and Ignarro, 1997). Despite extensive research, the precise mechanism
by which nitric oxide synthase (NOS) catalyzes the oxidation of L-arginine to NO
remain unclear (Hobbs and Ignarro, 1997). The initial reaction may involve N-
hydroxylation of guanidium nitrogen to form N-hydroxyl -L-arginine to NO. However
subsequent steps in the conversion of N-hydroxyl -L-arginine to NO and L-citrulline
remain unclear (Hobbs and Ignarro, 1997).
NO is now regarded as a unique messenger molecule with diverse biological
activities including regulation of vascular smooth muscle tone and platelet activity,
non-adrenergic and non-cholinergic neurotransmission, cytotoxic and cytostatic
activities to cells and as an immune effector molecule in eliminating certain pathogens
(Hobbs and Ignarro, 1997). NO has been said not to have a distinct receptor on target
cells; however, the target site for NO was suggested to be iron, bound within certain
proteins as heme group or iron-sulfur complex (Hobbs and Ignarro 1997). The
mechanisms by which NO kills cells or halts replication is not clear but probably
involves inhibition of DNA synthesis by inactivation of ribonucleotide reductase and
by direct deaminantion of DNA (Kwon et. a., 1991; Wink et al. 1991). Also due to its
affinity for iron-sulfur-containing proteins, NO may bind and inhibit cis-aconitase and
ubiquinone reductase preventing cells from generating ATP (Staimler et al., 1993).
The endothelium has the ability to constantly generate a powerful vasodilator that
controls vessel wall diameter and consequently plays a decisive role as a determinant
of blood flow and blood pressure (Hobbs and Ignarro, 1997). Importantly the host
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cells producing NO possess some inherent immunity against its toxic effects and
thereby are not destroyed themselves but the reason for their insusceptibility is
unknown (Hobbs and Ignarro, 1997).
Nitric oxide and prostacyclin are both cytoprotective, vasodilators and inhibitors of
platelet aggregation and adhesion but it is not known if they act synergestically or not
(Rees et al., 1989). Facts still not known about NO are the biological significance and
mechanism of this mediator and also whether NO in the vessel wall modulates white
cell activation or controls smooth muscle proliferation. NO has been said to possibly
participate in nitrosative reactions leading to deamination of DNA and mutagenesis
(Wink et al., 1991). Reactions of NO with superoxide leads to formation of the highly
toxic oxidant peroxynitrite (Beckman et al. 1990). Reaction of NO with iron-sulfur
centres in proteins may lead to the inhibition of their activity (Hibbs, 1991).
NO exposure has been incriminated as being able to cause severe lung injury
(WHO, 1977; Gaston et al., 1994a). Thiols play an important role in disarming NO.
Levels of glutathione rise in lung tissue in response to oxidant stress, such as exposure
to high levels of NO contained in cigarette smoke and endogenous RS- NO (RS-NO=
S-nitrosothiol or thionitrite) levels increase in the lung in response to immune
activation and inflammation (Gaston et al. 1994a).
In the central nervous system, RS-NO has been found to also exert protection
against NO-mediated toxicity. NO reacts with superoxide to produce peroxynitrite
(Lipton et al. 1993). In contrast, formation of RS-NO provides a mechanism for
limiting the reaction of NO with oxygen radical. Reduced oxygen species are highly
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toxic to endothelial cells and are believed to play an important role in the vascular
related morbidity seen in patients with hypercystenaemia (Staimler et al., 1993).
Under normal physiological circumstances EDRF (NO) interacts with
homocysteine to form S- nitroso-homocysteine ( a potent vasodilator and antiplatelet
agent) (Staimler et al., 1993). S- nitroso proteins are present in plasma of normal
subjects (Staimler et al., 1993) and in the exudate of airway lining fluid in some
disease states (Gaston et al., 1994). NO group transfer reactions to plasma membrane
proteins containing reactive sulfhydryls has been demonstrated (Lipton et al. 1993).
NO has been implicated as having a major role in host defence mechanisms against
viruses, bacteria and other intracellular parasites (Green et al. 1990). Many
investigators readily accept the notion that NO is toxic given its reputation as a
reactive radical with a short biological half-life. NO is known to react with molecular
oxygen to give nitrogen dioxide which is a strong oxidant and a potent toxin in any
biological system, but significant nitrogen dioxide occurs only at NO concentrations
far in excess of those seen in vivo (Green et al. 1990).
1.2.2.2. Reactive oxygen intermediates and antioxidants
Aerobic metabolism and the process of generating ATP from glucose and
oxygen by cytochrome oxidase leads to reduction of oxygen (O2) to water (H20) (and
occasionally to the superoxide radical (02)) (Grisham et al., 1992a; 1992b). Further
reduction of 02 by one or two additional electrons yields hydrogen peroxide (H202)
and the hydroxy 1 radical (OH) respectively. Catalase, superoxide dismutase(SOD) and
glutathione peroxidase (GPX) complete the reduction of H202 to H20. These
enzymes, SOD, GPX and catalase, process the 02~ and H202 and prevent them from
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interacting to produce OH and singlet oxygen (.02) through an iron-dependent
reaction (Grisham et al., 1992a).
Enhanced generation of superoxide (02-.) or reduced levels of SOD have been
implicated in a wide range of pathological conditions (Wond and Goeddle, 1988b).
Molecular oxygen is readily reduced by one electron to give superoxide anion
(Pauling, 1979). Superoxide radical has been referred by biochemists as a highly
reactive and destructive radical (Deng et al, 1993). At physiological pH it has little
potential to oxidise other molecules. Thus, superoxide acts as an oxidant only in a
more acidic environment or when the molecule under attack is a good one-electron
donor such as reduced Fe(II)-sulfur centres (Deng et al, 1993). Superoxide dismutase
(SOD) protects against oxidant stress and ischemic injury in many model systems by
an unclear mechanism (Flaherty and Weisfeldt, 1988).
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1.3. Concluding remarks
Research on heartwater has advanced knowledge in some aspects of the disease
such as the aetiology (morphology and classification) and some aspects of
epidemiology including transmission (Camus et al., 1996). However, the knowledge
of the pathogenesis and immune mechanisms of the disease remain unclear, with
contradictory findings being reported and inconclusive implications of involvement of
complement and vaso-active substances (Du Plessis and Malan, 1987a). The disease is
of major economic importance in Africa and is a major constraint against
improvement of livestock industry, with an estimated loss of millions of dollars
incurred every year due to the disease, as summarised by Camus et al., 1996.
Currently there are no effective methods of controlling the disease, other than the
cumbersome and expensive tick-control methods. Development of an effective
vaccine to the disease, would, therefore, be of great importance. This can only be
achieved with sufficient knowledge of the pathological and immunological
mechanisms elicited by the infection (host-parasite interactions). Armed with these
facts, this study was designed to examine the responses elicited by C. ruminantium
infection of endothelial and phagocytic cells, and how these responses influence the
final outcome of the disease. The role played by cytokines, nitric oxide and reactive
oxygen intermediates in the pathological and immunological mechanisms of C.





2.1. In vitro cultivation of Cowdria ruminantium in endothelial
cells
2.1.1. Cowdria ruminantium isolates
Three isolates of C. ruminantium (Cowdry, 1925), Gardel isolated in Guadeloupe
(Uilenberg, 1983), Welgevonden isolated in South Africa (Du Plessis, 1982) and
Kathiani isolated in Kenya (Ngumi et al., 1997) were used in this study. The
Welgevonden and Gardel isolates were propagated in tissue culture in bovine
endothelial cells as described in section 2.2.3. and were used in studies carried out in
Edinburgh. The Kathiani (Kenyan) isolate of C. ruminantium used was a blood
stabilate (blood stabilate No. 327B of 25-10-1994) and was stored at -196°C in
liquid nitrogen. This was a generous gift from Kenya Agricultural Research Institute
(KARI), Veterinary department, Muguga, and was used in studies in Kenya. The
stabilate was transported in ice, snap thawed and used to infect sheep within 30
minutes after thawing.
2.1.2. Bovine Endothelial Cell Cultures
Bovine pulmonary endothelial cells (BPEC), bovine aorta endothelial cells (BAEC)
and bovine brain endothelial cells (BBEC) were used in these studies. The BBEC
were a gift from Dr Martinez, Guadeloupe (Martinez, 1993 ) while the BPECs and
BACs were isolated and cultured from vascular tissues obtained from abattoir-
slaughtered cattle using a modification of the method described by Byrom et al
(1990). In brief, short segments of the pulmonary artery were immersed in phosphate
buffered saline containing antibiotics (PBS/A). Collagenase solution at 1 mg/ml in
PBS/A was used to detach the cells which were then cultured in Glasgow minimal
36
essential medium (GMEM) (Gibco Laboratories, U.K.) supplemented with 20% heat
inactivated foetal calf serum, 2 mM/100 ml L-glutamine, 100 IU/ 100 ml penicillin G
and 100 fig/ 100 ml streptomycin. The cells were used for the different studies at
passages ranging from 7-10. The cells were passaged by detaching with trypsin and
versene (Gibco Laboratories) and stored in 10% DMSO under liquid nitrogen (-
196°C).
2.1.3. Ovine Vascular cells
An attempt was made to isolate ovine vascular endothelial cells from peripheral
blood of sheep by a method described by Albert Bensaid (Personal Communication,
1995). Peripheral blood mononuclear cells (PBMC) were isolated using the Ficoll
Hypaque method (Pharmacia, Uppsala, Sweden). Ten millilitres of heparinised blood
was centrifuged at 3000g for 20 minutes to separate different cell fractions of blood.
The buffy coat, containing the leucocyte fraction was then removed and mixed with 9
mis PBS containing heparin at 10 U/ml. This was layered on Ficoll Hypaque (sodium
metrizoate) (Pharmacia Chemicals, UK) and centrifuged at lOOOg for 35 minutes.
PBMC were obtained from the Ficoll-PBS interface and washed twice with 20 ml
PBS containing heparin by centrifuging at 450g for 10 minutes for each wash. The
cells were then cultured in RPMI 1640 medium supplemented with 8% foetal calf
serum (Gibco Laboratories and Life Technologies, UK) at 107 cells /ml and
incubated at 37°C in a moist atmosphere with 5 % C02 for 2 hours. Unattached cells
were removed by washing the flasks twice with warm complete RPMI 1640 medium.
The adherent cells were then grown in Glasgow Minimal Essential Medium (GMEM)
containing 20% foetal calf serum and 300 |ig/ml endothelial cell growth supplement
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(Sigma Chemicals Ltd., UK Chemicals) and incubated at 37°C in 5% CO2. The
medium was changed every 3 days until the cells were confluent and the cells were
propagated and stored as already described for bovine endothelial cells. The cells
were identified as endothelial cells based on their morphology.
2.1.4. Infection of endothelial cells
The endothelial cell cultures were ready for infection when the monolayer was almost
confluent (90%). The medium was discarded and the cells infected with C.
ruminantium and fresh medium for infected cells added. This medium for infected
cells was comprised of the following (all reagents were obtained from Gibco
Laboratories, UK); 100ml Glasgow Minimum Essential Medium (GMEM / BHK-
21), 10% Tryptose Phosphate Broth, 10% heat inactivated foetal bovine serum
(FCS), 0.02 mM L-glutamine per ml, 0.2 mM HEPES buffer per ml (Gibco
Laboratories), 100 IU penicillin G and 100 fig streptomycin per 100 ml of medium.
The medium from these infected cultures was replaced after 7 days. Level of
infection with C. ruminantium was scored in cytospin smears ranging from low
(denoted as 1+) to moderate (++2) to high level of infection (3+++). When the cells
were heavily infected, C. ruminantium elementary bodies (EBs) were passaged to
fresh cell cultures or the cells were harvested and stored in culture medium
containing 10% dimethyl sulfoxide (DMSO) (Sigma Chemicals Ltd., UK) in liquid
nitrogen (-196°C).
2.1.5. Assay for viable C. ruminantium EBs by a fluorescein diacetate
staining technique
The viability of C. ruminantium EBs was quantified by a fluorescein diacetate
staining method. The principle behind the test is that fluorescein diacetate is taken in
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by all cells but is hydrolysed only within live cells to produce green fluorescence
(Rotman and Papermaster 1966). Fluorescein diacetate (FD) (Sigma Chemicals Ltd.,
UK) was prepared at 5mg /ml in acetone and stored in a tightly capped container at -
20°C. Ninety jil volume of medium from the test plates was mixed with lOp.1 of
diluted fluorescein diacetate (1:50 in PBS) and incubated for 15 minutes at room
temperature in the dark. Viable EBs appeared bright green and were counted using a
graded eye piece in a fluorescent microscope and the number of viable cells
calculated as follows:
Viable cells/ml =(average number of viable cells in large square) xl04/ml x 1/dilution
% Viable cells = number of viable cells x 100%
number of viable cells + number of dead cells
2.1.6. Assay for viable endothelial cells:
The endothelial cell monolayer was examined microscopically for evidence of
apoptosis in experiments which were aimed at determining the effect of added
interferon gamma on endothelial cell infection with C. ruminantium. At the end of the
experiment (7 days) the medium from the cultures was removed and the cell
monolayer on cover slips stained in Diff quik (Baxter Diagnostics, Germany) using
standard manufacturer's procedure, and acridine orange (Sigma Chemicals Ltd., UK)
to identify and quantify viable and non-viable endothelial cells. For the acridine orange
staining, a modification of a previously described method was used (Polunovsky et
al., 1994). Acridine orange at 3p.g / ml was used. A cytospin preparation of the
scraped cells was fixed in 70% ethanol for 10 minutes before staining with acridine
orange for 3 h in the dark. A drop of buffered glycerol on a coverslip was placed on
the stained cells and the morphology examined using fluorescence microscopy.
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Apoptotic cells were identified morphologically by condensation of chromatin, nuclear
fragmentation, blebbing of the nuclear membrane and presence of membrane-bound
bodies. Non viable cells were counted in five fields at a magnification of x 1000 and
expressed as a percentage mean + SD.
2.1.6.2. DNA extraction and analysis for apoptotic cell death in infected cell
cultures
Infected endothelial cells were assessed for DNA fragmentation, a characteristic
finding in apoptotic cells. Endothelial cells were detached from culture wells using a
rubber policeman and washed twice in PBS by centrifuging at 1500g for 10 min, then
resuspended in 1ml lysis buffer (25 mM EDTA, lOmM Tris pH 8, lOOmM Nacl, 0.05
% SDS and 0.1 mg /ml proteinase K). The cells were then incubated at 50°C for18 h.
Samples were then extracted twice with equal volume of phenol/chloroform and
centrifuged at 13000 g for 5 minutes. The top layer was then drawn into a fresh tube
and an equal volume of phenol/chloroform added for the second time and 0.2 (ig/ml
of Rnase A added and incubated at 37°C for 1 h. A further incubation at 37°C for 1 h
followed addition of 0.25|ig/ml of RNase T. DNA was precipitated overnight in 2
volumes of ethanol, 0.5 volumes of ammonium acetate (7.5pM) and centrifuged at
13,000 g for 10 minutes. The pellet was then resuspended in 50 |il of TE buffer (0.01
M Tris pH 8 and 1 mM EDTA) containing 10|ig/ml ethidium bromide and
electrophoresed at lOV/cm for 2 h in 1.5 % agarose gel. DNA was visualised under
UV fluorescence and photographed with Polaroid MP-4 Land Camera (Polaroid
Corporation, USA) using type 55 Polaroid film.
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2.2. Nitric oxide and in vitro studies
2.2.1. Detection of nitric oxide by the Griess Assay.
Nitric oxide (NO) reacts rapidly with water and oxygen to produce nitrite (NO'2).
Since this compound is both stable and quantifiable, its concentration in culture
medium and plasma may be taken as a measure of nitric oxide production. Nitrite
levels were measured as described by Migliorini et al., (1991). NO2" levels were
assayed in culture supernatants using the Griess assay method. One hundred jil of the
test sample were mixed with an equal volume of the Griess reagent (0.1%
naphthylethylene diamine 2HCL and 1% sulphanilamide in 5% phosphoric acid ) and
incubated at room temperature for 10 minutes. The OD value was read at 492 nM on
a microplate reader. A standard curve was generated by doubling dilutions within a
range of 0 and 100 p.M of sodium nitrite in culture medium. All reagents, unless
otherwise stated, were from Sigma Chemicals Ltd., UK. Samples were tested in
triplicate and results expressed as means ± standard deviation (SD). The basal level
of NO2" in cell-free medium was determined for each assay and deducted from that of
the test samples.
2.2.2. Nitric oxide production in bovine pulmonary endothelial cells
infected with C. ruminantium and stimulated with bovine recombinant
interferon gamma (BorlFN-y), and the NO inhibitor, L-NMMA
Thermanox glass coverslips (Nunc Inc., USA) of about 13 mm in diameter
were sterilised in absolute alcohol for 10 minutes then rinsed in sterile PBS before
inserting them in 24 well culture plates (Gibco Laboratories Ltd.) using sterile
forceps. BPEC were seeded in the plates and incubated at 37°C in 5% C02. At
confluence, the cells were infected with C. ruminantium EBs obtained from the
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supernatant of an infected BPEC culture. The supernatant was centrifuged at 1500 g
to spin down endothelial cells, then at 15,000 g to pellet the EBs. The EBs were then
resuspended in complete medium and this was used as the inoculum to infect the
cells. The plates were then incubated at 37°C for 4 hours after which all the medium
was removed and fresh medium was added to the cells containing 0, 25, 50, 75 and
lOOU/ml bovine recombinant interferon -gamma (BorlFN—y) provided by Ciba-
Geigy Ltd, Basle, Switzerland.. The effect of the NO synthase inhibitor N-
monomethyl - L arginine (L-NMMA) (Sigma Chemicals Ltd., UK) at a final
concentration of 1 mM was also assessed by culturing infected endothelial cells with
or without BorlFN-y. Twelve replicates were used for each treatment. The other
wells were left as uninfected control wells.
2.2.3. Nitric oxide production in ovine vascular cells; Effect of BorlFN-y,
ovine recombinant tumor necrosis alpha (OVrTNF-a) and NO inhibitor
L-NMMA
Ovine vascular cells were seeded in 2x24 well plates at a concentration of 4xl06 cells
per ml. At confluence the media on all the wells was removed after assaying for NO
(day 0) and the following added in four wells per plate for each ; bovine recombinant
interferon gamma (BorlFN-y) (Ciba Geigy, Basle Switzerland) at 100 U/ml, ovine
recombinant TNF-a (OvrTNF-a) ( a generous gift from Gary Entrican, Moredun
Research Institute) at lOOU/ml, ImM L-NMMA (Sigma Chemicals Ltd., UK), ImM
L-NMMA and lOOU/ml BorlFN-y, ImM L-NMMA and 100 U/ml TNF-a, and
complete medium (non-infected control). Nitrite levels indicative of nitric oxide
production were assayed using the Griess assay described in section 2.2.1 at 0, 6, 20,
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48 and 72 hours post-stimulation from all the wells and the means for each treatment
and the control determined. The tests were carried out in triplicates.
2.2.4. The effect of SNAP-generated NO on C. ruminantium infectivity
and viability in vitro
Source, establishment and maintenance of endothelial cell lines infected with the
Gardel isolate of C. ruminantium have been described elsewhere (sections 2.1.2. and
2.1.4). S- Nitroso - acetyl - DL - penicillamine (SNAP), a nitric oxide releasing
molecule were obtained from Sigma Chemicals Ltd., UK. ThermanoxR coverslips
(Nunc. Inc., USA) of about 13 mm diameter were resterilised in 70 % alcohol and
rinsed in PBS before being inserted in wells of 24 well culture plates. Endothelial
cells from a confluent plate were trypsinised and subcultured in all the wells at the
same concentration. At confluence NO concentration was assayed using the Griess
assay before discarding the medium and infecting 16 wells with Cowdria
ruminantium EBs from a 3+++ culture plate. Eight wells were not infected
(controls). SNAP solutions at concentrations of 100 pM, 50 pM and 25 pM were
prepared and the level of NO generated by each concentration determined by the
Griess assay described previously (section 2.2.1.) . The effects on the viability and
infectivity of C. ruminantium were assessed by pre-treating EBs with SNAP and also
by culturing infected cells in the presence of SNAP in the growth medium.
2.2.4.1. Assay for the effect of NO pre-treatment of C. ruminantium.
The effect of NO on C. ruminantium was assessed by infecting BPEC with EBs pre-
treated with different concentrations of the NO donor molecule S - nitroso - N - acetyl -
DL - penicillamine (SNAP) (Affiniti U.K.). C. ruminantium EBs were pre-treated for 2
hours at 37°C in 0, 25, 50 and 100 pM SNAP dissolved in culture medium. The NO level
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for each concentration of SNAP was determined using the Griess assay method
described above. Viability count of the treated EBs was performed prior to infection
using fluorescein diacetate staining method as described above. The EBs were then spun
down at 15,000 g for 20 minutes and washed in fresh medium before resuspending them
in complete medium and infecting confluent cell monolayers in 24 well culture plates
containing coverslips prepared as already described. The plates were incubated at 37°C in
5 % CO2 for 4 h to allow infection of the cells after which the inoculum was removed
from all the wells and replaced with fresh medium. To assess the level and rate of
infection, the number of fluorescent foci (colonies) per covcrslip and the percentage of
infected endothelial cells were determined on specified days post-infection by indirect
fluorescent antibody test (IFAT) and giemsa staining of endothelial cells on coverslips
respectively. Briefly for IFAT, the coverslips were fixed in 20 % acetone for 10 minutes.
An anti-Cowdria 32 Kda monoclonal antibody (Mab) at 1:200 in PBS was added to the
cells on the coverslips and incubated in a humidified chamber at room temperature for 1
h. After 3X5 min washes in PBS the cells were incubated with a biotin-labelled anti-
mouse antibody at a dilution of 1:250 and incubated for 1 h in room temperature in a
humidified chamber followed by another wash. A further 1 h incubation followed
addition of streptavidin FITC at 1: 300 dilution. The cells were viewed under
fluorescence microscope and the number of fluorescent foci of infection estimated for the
total area of the coverslip. Infection rate was assessed in giemsa-stained coverslips and
the number of infected cells per field was expressed as a percentage of the cell count.
Counts were made on coverslips per treatment and the mean recorded.
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2.2.4.2. Assay for the effect of co-culturing NO in C. ruminantium-infected
cultures.
Effect of incubating infected cultures with different concentrations of SNAP on viability
and multiplication were assessed. BPEC were cultured on coverslips as already described
and infected at confluence with C. ruminantium EBs in medium containing 0. 25, 50 and
100 JJ.M SNAP, which was left in the cultures through out the experiment. Viability of C.
ruminantium EBs in these cultures was determined on days 1, 2, 4 and 7 post-infection.
This was done by taking aliquots from wells for each treatment, which were then
centrifuged at low speed (1000 g) for 5 minutes to spin down endothelial cells and
viability of EBs in the supernatant determined by the fluorescein diacetate staining
method as described above. To estimate the level of infection in cultures at the end of the
experiment, cytospin smears were prepared on day 7 post-infection from each of these
treatments and stained in giemsa and a mean estimate of the number of organisms per
field assessed for each treatment. This was taken as a reflection of the multiplication rate
of the infectious agent in these cultures.
2.2.4.1. Effect of NO on C. ruminantium EBs pre-treated with different
concentrations of SNAP in vitro
The effect of NO on infectivity of C. ruminantium was assessed by infecting BPEC
with EBs pre-treated with different concentrations of the NO donor molecule S -
nitroso - N - acetyl - DL - penicillamine (SNAP) (Affiniti U.K.). C. ruminantium
EBs were incubated in 0, 25, 50 and 100 (J.M SNAP solutions for 2 hours at 37°C
after determining the NO level for each concentration of SNAP using the Griess
assay method described in section 2.2.1. Viability count of the EBs was performed
prior to infection using fluorescein diacetate staining method as described in section
2.1.5. The EBs were then spun down at 15,000 g for 20 minutes and washed in fresh
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medium before resuspending them in complete medium and infecting confluent cell
monolayers on coverslips set up as described above (section 2.2.4.). The plates were
incubated at 37°C in 5% CO2 for 4 h to allow infection of the cells after which the
inoculum was removed from all the wells and replaced with fresh medium. (An
aliquot of 500 pi of EBs in the different SNAP concentrations were left at 37°C in
5% CO2 during the whole course of the experiment and viability of the EBs
assessed). Infectivity was assessed by an indirect fluorescence antibody test (IFAT).
Briefly, the coverslips were mounted on glass slides (Chance Propper LTD., UK)
using a glass glue (Lochtite Glass Bond from Lochtite Ltd., UK) and fixed in 20%
acetone for 10 minutes. An anti-Cowdria 32 Kda monoclonal antibody (Mab) ( a gift
from Dr Jongejan, Utrecht) at 1:200 in PBS was added to the cells on the coverslips
and incubated in a humidified chamber at room temperature for 1 h. After 3X5 min
washes in PBS the cells were incubated with a biotin-labelled anti-mouse antibody
(Sigma Chemicals Ltd., UK) at a dilution of 1:250 in PBS and incubated for 1 h at
room temperature in a humidified chamber followed by another wash. A further 1 h
incubation followed addition of streptavidin FITC (Sigma Chemicals Ltd., UK) at 1:
300 dilution in PBS. The cells were viewed under fluorescence microscope and the
number of fluorescing cells estimated for the total area of the coverslip. Also to
assess infectivity of the EBs to the endothelial cells, infection rates were determined
for the different treatments. Two coverslips for each treatment were removed
aseptically from wells and stained with giemsa and the mean number of infected cells
per field determined and expressed as a percentage of the mean total cell count in the
same fields. Counts were done in ten fields for each treatment. The two methods
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(giemsa and IFAT) were compared as an assessment of infectivity of EBs after NO
treatment.
2.2.4.2. Effect of NO on C. ruminantium infected cells cultured in growth
medium containing different concentration of SNAP
C. ruminantium EBs were added in BPEC cultures maintained in medium containing
0. 25, 50 and 100 jlM SNAP. Viability of C. ruminantium was assessed on days 0, 1,
2, 4 and 7 post-infection using the fluorescein diacetate method described previously
(section 2.1.5.). This was done by taking 90ul aliquots of the supernatant overlying
the cells from all the wells and the viability of EBs assessed after spinning down the
endothelial cells at lOOOg for 5 minutes.
Cytospin smears were also prepared and stained in giemsa and the mean number of
colonies per field was determined after counting colonies from ten fields.
2.3. Cowdria ruminantium infections in vivo
2.3.1. Experimental animals
2.3.1.1. BALB/c mice
These were obtained from B & K Ltd., UK, and they were 8-10 weeks old at the
beginning of experiments. The mice were kept in cages in groups of not more than 5
and allowed 4 days to acclimatise before any inoculations were given.
2.3.1.2. Interferon gamma, and interferon alpha/beta knock out mice
Three groups of specially bred strains of mice were obtained from Department of
Veterinary Pathology, Faculty of Veterinary Medicine, University of Edinburgh, with
prior consent for experimental work from the originator, Dr Huang, Harvard
University, USA. The groups used were as follows; 15 IFN-y receptor knock out
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mice (G 129) in which deletion of the a-chain of IFN type II (y) receptor had
occurred (Huang et.al; 1993 ); 15 IFN-oc/P receptor knock out mice (A 129) in
which deletion of IFN type I (a and P) receptor signalling sub unit had occurred
(Muller et. al.„ 1994) and 15 wild type control strain of the same genetic
background (WT 129). The mice were kept in double cleaned cages in groups of not
more than five and given food (pellets) and water ad libitum.
2.3.1.3. Sheep
Studies on C. ruminantium infections in sheep were carried out in the Faculty of
Veterinary Studies in Kenya and also at the CTVM, Edinburgh. In studies carried out
in Kenya, two breeds of sheep, the Dorper and Red Maasai, were used. Six Red
Maasai sheep were obtained from a farm in Ngong, about 15 km south of Nairobi,
Kenya. The farm had a history of good management practices including regular tick
control practice. Six Dorpers were obtained from the Faculty of Vet. Medicine farm,
University of Nairobi, Kabete, Kenya. This farm practices very strict tick-control
regime and has no history of cases of heartwater. The different breeds were housed
separately in stalls in the isolation unit of the department of Clinical Studies and
allowed feed of hay, concentrates and water ad libitum.
In the studies carried out in Edinburgh, a total of 16 sheep were used. 10 Scottish
black face crosses and 6 merino crosses were obtained from Blythe Bank and South
Bank Farms respectively, in Peebleshire, Scotland. They were housed in groups of
two and supplied with feed and water ad libitum. Prior to infection, all the animals
were kept under quarantine and until shown not to be excreting Salmonella, and
dosed with anthelmintics.
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2.3.2. Clinical disease monitoring and sampling in mice
The incubation period was determined from daily rectal temperatures in which onset
of hypothermia was taken as the start of clinical disease (Du Plessis, 1982). The
mean incubation period, mean course of the disease from onset of hypothermia to
death or recovery, morbidity and mortality rates for each group were determined and
the differences subjected to statistical analysis for determination of any significant
differences. Morbidity and severity of clinical disease was based on visual
observation of symptoms, posture, gait, appetite, skin elasticity, awareness, shivering
/ tremors, any behavioural changes and any other abnormal finding. Blood samples
were collected for sera from the tail vein and also from the heart in sacrificed mice
immediately after death, on designated days defined for each experiment.
2.3.3. Pathological investigations in mice
Comparative gross, histological and ultrastructural pathological studies were
carried out between the groups for both the sacrificed and non-sacrificed mice. On
post-mortem examination, the main things noted were the amount of oedema fluid
which was measured with one ml syringes and presence of any gross lesions in the
lungs, liver, spleen and brain. Brain crush smears were prepared, fixed in 10%
methanol for 10 minutes and stained in giemsa for 40 minutes and examined for
infected endothelial cells under the light microscope. Twenty fields per slide were
examined at a magnification of x 1000 for the presence of infected endothelial cells
and the mean counts determined and data for each group of mice analysed
statistically using the chi-square method.
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2.3.3.1. Histopathological procedures of lung and brain sections.
Lung and brain specimens were fixed in 4 % buffered formaldehyde for
histopathological studies. They were processed and stained with haematoxylin and
eosin (H&E) and also in giemsa stains as per standard procedures, by the
histopathology laboratory of the Veterinary Pathology Department of the University
of Edinburgh. Pathological changes and infection rates were assessed from these
specimens.
2.3.3.2. Transmission electron microscopy procedures of lung and brain
sections.
The transmission electron microscopy work was carried out in the Pre-clinical
department, Faculty of Veterinary Medicine of the University of Edinburgh. Lung
and brain sections of the sacrificed mice were fixed in 3 % glutaraldehyde in 0.1 M
sodium cacodylate buffer immediately after removal. The sections were post-fixed in
1% osmium tetroxide in 0.1 M sodium cacodylate buffer and then dehydrated in
graded ethanol (50, 70 and 90%) for 10 minutes each, and then in 100% ethanol
three times for 10 minutes each. After embedding in araldite, 60nm sections were
cut on a diamond knife using a Reichert OMU4 Ultracut Ultramicrotome, and
mounted on 200 mesh copper grids. The sections were then stained in uranyl acetate
and lead citrate using a LKB Ultrostainer. The sections were then viewed and
photographed using a Philips 400 Transmission electron microscope. The objective
was to compare the pathology and infection rate between the different groups using
lung and brain sections .
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2.3.4. Preparation of spleen homogenates in mice
Spleens were weighed for all the groups including uninfected controls and their
weights compared. Spleen tissue was collected immediately after sacrificing mice or
during necropsy examination using aseptic techniques and rinsed and stored in sterile
PBS at -20°C. Individual spleens were homogenised in 1% (3-(3 cholamidopropyl
dimethylammoni)-l-propanesulfonate (CHAPS; Sigma Chemicals Ltd., UK) in a
Dounce tissue homogenizer and 10% wt/vol. homogenates were prepared. They
were then left in ice for 1 h and the insoluble debris removed by centrifugation at
2000 g for 20 minutes The clear supernatants were stored at -70°C for cytokine and
nitrite assays.
2.3.5. Monitoring of infection in sheep
Rectal temperatures were taken daily and blood samples collected every other day.
Heparinised and clotted blood was collected every two days until death or recovery;
heparinised blood was used for analysing glutathione peroxidase (GPX) and
superoxide dismutase (SOD) levels. Plasma was obtained after centrifugation of the
heparinised blood at 2000g for 20 minutes and used for assaying of glucose-6-
phosphate dehydrogenase (G-6-PDH), TNF-a, IL-8, IFN-y, nitrite assays and for
DNA extraction for the quantification of infection (parasitaemia) using PCR. Serum
was separated from the clotted blood after centrifugation at 1000 g for 20 minutes for
use in an indirect ELISA antibody assay test. The plasma and sera samples were
stored at -20 °C before use.
2.4. Serology
2.4.1. Preparation of ELISA antigen from Cowdria ruminantium EBs
(EBs)
Culture supernatant from a three positive infected cells was harvested and centrifuged
at lOOOg for 5 mins in MSE Centaur 2 centrifuge to pellet the endothelial cells. The
supernatant was then centrifuged to pellet the EBs at 15,000g for 20 minutes at 4°C
and the supernatant discarded. The EBs were resuspended in 20 ml of sterile PBS and
centrifuged as above. The pellet was then resuspended in 1 ml PBS and transferred to
a 1.5 ml eppendorf and centrifuged in a microcentrifuge at 13,000 g for 10 minutes to
pellet the cells. This was repeated a second time and the EBs stored in 500 pi PBS at
-20 °C or used to prepare the antigen as follows; After pelleting the EBs, the pellet
was resuspended in lysis buffer, at 1 pi of buffer for every 1 pi of culture supernatant.
The lysis buffer was comprised of 0.5% Np.40 and 0.5% Sodium deoxycholate in
TEN (50mM Tris pH 7.4, 150 mM Sodium chloride and 2 mM EDTA). The mixture
was incubated at 37°C in a waterbath for 30 minutes and then passed through a 26G
needle several times. The mixture was incubated in the water bath for a further 5
minutes and then centrifuged at 16,000 g for 30 minutes at 4°C (Biofuge 17RS). The
supemate was then stored in small aliquots as ELISA antigen at -20°C.
2.4.2. Sero diagnosis of C. ruminantium infection by an ELISA method
An indirect ELISA method was used. A 96 well flat bottomed Immulon 1 plate
(Nunc. Ltd. UK) was coated with an 100 pi ELISA antigen (EL 14) (Section 2.4.1.)
at a dilution 1:1600 in 0.1 M carbonate-bicarbonate buffer (Sigma Chemicals Ltd.,
UK) and incubated overnight at 4°C. After washing four times with PBS containing
0.05% Tween 20 (hereafter to be referred to as PBST) 100 pi of test and control
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(positive and negative) sera samples diluted 1:50 in PBST were added to the wells in
duplicates and incubated for 1 h at 37°C on a horizontal shaker. After another wash,
100 pi of the conjugate, anti-sheep IgG peroxidase (Sigma Chemicals Ltd., UK,
product code No. A 3415) at 1:6000 dilution in PBST, was added to all the wells and
incubated at 37°C for 1 h. A final wash was followed by colour development using
100 pi of the chromogen substrate(OPD) (Sigma Chemicals Ltd., UK). One 30 mg
OPD tablet was dissolved in 75 ml distilled water before adding 40 pi/100ml of 30%
hydrogen peroxide. The colour development was stopped by adding 100 pi per well
of 1 M sulphuric acid to all the wells and the optical density read at 492 nm.
2.4.3. Detection of IgG isotype responses in mice infected with C.
ruminantium by an indirect ELISA protocol
A modification of the method described by Soldan et al (1993) was used. Blood was
collected for sera from test and control mice and the sera was used in an indirect
ELISA for IgGl, IgG2a, IgG2b and IgG3 isotyping. A 96 well flat-bottomed plate
(Immulon 1, Dynatech Laboratories) was coated with 50 pi of a C. ruminantium
soluble antigen (EL. 15) at a dilution of 1:1000 in 1 M carbonate bicarbonate buffer
pH 9.6 (Sigma Chemicals Ltd., UK) and incubated overnight at 4 °C. The plate was
then washed three times with PBST (washing buffer), as was done for all the other
subsequent steps. The plate was then blocked with 100 pi of normal rabbit serum
diluted 1:50 in PBST (blocking buffer) for 1 h at room temperature. Fifty microlitres
of the test and control sera diluted at 1:50 in blocking buffer were then added to the
wells and the plate incubated at 37°C for 1 h. Fifty microlitres of rat anti-mouse
monoclonal antibodies with specificity for mouse, IgGl, IgG2a, IgG2b and IgG3,
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product code numbers MCA 336, MCA 421, MCA 422, and MCA 42 (Serotech,
UK) diluted 1:1000 in blocking buffer were added and incubated at 37°C for 1 h. An
anti-rat IgG whole molecule peroxidase conjugate (Sigma Chemicals Ltd., UK,
product code NO. A9037) at 1:1000 dilution in blocking buffer was then added and
incubated at 37°C for 1 h. Fifty microlitres of tetramethyl benzimidamine (TMB)
microwell peroxidase substrate (Kikergaard and Perry Laboratories, USA) was
added and the reaction was stopped after 15 minutes with 50 |il 1 M sulphuric acid
and the optical density (OD) value read at 450 nm using an ELISA reader (Multiscan
plus, version 2.03 Labsystems) after blanking the plate with negative control and the
results were expressed as OD values and the ratio of IgGl: IgG2a was especially
noted. To minimise plate variations, the same negative control serum was used for all
the plates (serum NO. IV al) and plate values were adjusted to reduce plate to plate
variations by computing an adjustment value from the ratio of the control values on
each plate.
2.4.4. Detection of IgG isotype responses in sheep
The same principle as for mice IgG isotyping was essentially utilised. Blood was
collected for sera from sheep every 2 days for the detection of IgGl and IgG2
isotypes. A 96 well flat-bottomed plate was coated with 100 fil of C. ruminantium
soluble antigen (EL 15) at 1:1000 as already described for mice in section 2.4.3.
After washing and blocking the plate with 200 p.1 of 4% normal rabbit serum at 1:50
in blocking buffer as described for mice in section 2.4.3., 100 |il the test and control
samples at dilutions of 1:50 in blocking buffer were added and incubated at 37°C for
1 h. After washing the plate, rat anti-mouse monoclonal antibodies for IgGl and
IgG2 (Sheep Hybridoma IgGl and IgG2 ) (a gift from Dr Harrison, CTVM), at a
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dilution of 1:50 were added and incubated at 37°C for a further 1 h. 100 (il of goat
anti-rat IgG whole molecule peroxidase conjugate (Sigma Chemicals Ltd., UK,
product code No. A 9037) was then added at1:1000 in blocking buffer and incubated
at 37°C for 1 h after which 100 ul of the substrate tetramethyl benzimidamine (TMB)
microwell peroxidase substrate (Kirkegaard and Perry Laboratories, USA) was
added and the reaction was stopped after 15 minutes with 100 ul of 1 M sulphuric
acid and the OD value read at 450 nm. The ratio of IgGl: IgG2a was compared for
the different groups of sheep. Known positive and negative control sera (positive
control serum number G476; negative control serum number S68) were used in all
the tests to minimise plate variations.
2.5. Biochemical tests;
2.5.1. Glutathione peroxidase assay
The Ransel kit for glutathione peroxidase (GPX) assay was obtained from Randox,
UK and the test carried out as per manufacturers instructions. The assay principle is
that GPX catalyses the oxidation of glutathione (GSH) by cumene hydroperoxide. In
the presence of glutathione reductase (GR) and NADPH the oxidised glutathione
(GSSG) is immediately converted to the reduced form with a concomitant oxidation
of NADPH to NADP+ and the decrease in absorbance at 340 nm is measured.
2GSH + ROOH ROH + GSSG + H20
GSSG + NADPH + H+ NADP+ + 2GSH
Heparinised whole blood was diluted 6 fold and the mean of the decrease in
absorbance used to calculate the actual GPX concentration in Units per litre using the
formula below (Randox Manual, 1995).
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U/l of Haemolysate = 8412 x Change in absorbance at 340 nm per minute x dilution .
2.5.2. Superoxide dismutase assay
The Ransel kit for superoxide dismutase assay was obtained from Randox (UK) and
the test carried out as per manufacturers instructions. The assay principle takes into
account the role of superoxide dismutase to accelerated dismutation of the toxic
superoxide radical (02), which is produced during oxidative energy processes, to
hydrogen peroxide and molecular oxygen. The method employs xanthine and xanthine
oxidase (XOD) to generate superoxide radicals which react with 2 -(4-iodophenyl) -3-
(4-nitrophenol)-5-phenyltetrazolium chloride (I.N.T.) to form a red formazan dye.
The superoxide dismutase activity is then measured by the degree of inhibition of this
reaction.
Xanthine —XOD Uric acid + O2
I.N.T. °2 Formazan dye
OR
o2 500 o2 + H2O2
Heparinised blood was centrifuged at 3000 g for 10 minutes and the plasma aspirated.
The erythrocytes were then washed three times with 0.9% NaCl solution and
centrifuged at 3000 g for 10 minutes after each wash. The washed and centrifuged
erythrocytes were then made up to 2.0 ml by adding cold distilled water and left to
stand for 15 minutes at 4°C. The lysate was then diluted 50 fold with 0.01 M
phosphate buffer pH 7.0 giving a final dilution factor of 200.
The degree of inhibition was converted to a percentage using this formula:
% inhibition = 100- change in absorbance of sample/min x 100
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change in absorbance of blank/min
Actual SOD levels were obtained from a standard curve (plotted using the %
inhibition obtained with the standards of known concentrations) using the following
formula (Randox Manual, 1995):
SOD units/ml of whole blood = SOD units/ml from std curve x dilution factor.
2.5.3. Nitrite assay in plasma.
The Griess assay described in section 2.2.1. was used for detection of nitrite levels in
plasma, substituting culture supernatants with plasma.
2.6. PCR to detect Cowdria ruminantium infection in Plasma of
infected Sheep
A method was developed in an attempt to detect and assess level of parasitaemia in
plasma of infected animals as well as enable us to compare the level of infection and
severity of disease in Dorpers infected with a virulent Kenyan strain (Kathiani) and
Merinos / Scottish blackface infected with a virulent South African strain,
Welgevonden. Previous studies have demonstrated the presence of the parasite in
plasma using C. ruminantium antigen ELISA method (Viljoen et. al.„ 1987). In this
study amplification of C. ruminantium DNA extracted from plasma was undertaken
using oligonucleotide primers derived from the 16S rDNA sequences for Cowdria
(Dame et. al.„ 1992 and Van Vliet et.al., 1992) (see section 2.6.2.).
2.6.1. Protocol for DNA extraction from plasma
Two hundred and fifty microtitres of mixed plasma was processed by centrifuging at
15,000 g to pellet C. ruminantium EBs. The supernatant was removed and the pellet
resuspended in lysis buffer (25 mM EDTA, lOmM Tris (pH 8), lOOmM Nacl, 0.05 %
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SDS and 0.1 mg /ml proteinase K). The mixture was incubated at 55°C in a water
bath for 1 h then boiled for 5 mins. to inactivate the enzyme. The samples were then
kept at -20°C before PCR. As the positive control and also to derive a 'calibration
curve' for the PCR, EBs from tissue culture were counted by the fluorescein diacetate
staining method described in section 2.1.5. and centrifuged at 15,000 g to pellet the
EBs. Known concentrations of EBs of 10,000, 5,000, 2,500, 1,600, 800, 400, 200,
100, 50, and 0 EBs / ml were resuspended in plasma obtained from normal sheep and
the EBs processed for DNA extraction as described for the samples. Distilled water
was used as negative control.
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2.6.2. DNA Primers and their sequences and theoretical amplification
specificity
TABLE 1
Primer code Sequence Theoretical Primer Specificity
pCS20 derived primer set from 5'-3'
Forward HE primers derived from the 16S rDNA sequences from 5'-3'
HE l(cr) CAGTTATTTATAGCTTCGGCTATGAG C. ruminantium (Crystal
Spring) (Dame et.al; 1992;
Van Vliet et. al.„ 1992)
HE l(cow) CAGTTATTTATAGCTTCGGCTATRAGTATCTG C. ruminantium (Senegal,
Crystal Springs), Sumption,
unpublished data)
R= an ambiquous base
Reverse
HE 2 GTGGCAGACGGGTGAGTAATGC E. canis, E.
phagocytophila, E.
chajfeensis, E. equi, E ewingi,
E. risticii, C. ruminantium
and A. marginale
HE 3 (s) GGTACCGTCATTATCTTCCC E. canis, E. phagocytophila,
E. chajfeensis, E. equi, E
ewingi, E. risticii, C.
ruminantium and A. marginale
HE 3(1) CTATAGGTACCGTCATTATCTTCCC C. ruminantium (Senegal, Crystal
Springs), E. canis, E. chaffensis,
E. ewingii
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2.6.3. Polymerase chain reaction
PCR master mix was prepared comprised of MilliQ water, the primers HE 1 (forward)
and HE 2 or 3 (reverse) at a final concentration of 2 (lM, nucleotides (dNTPs) at 2
jiM, Magnesium chloride at 50uM, TAQ polymerase at 0.5 (iM and PCR Buffer
containing lOmM Tris HCL, pH 8.3; 50 mM KCL; 0.001% w/v gelatin, adding the
enzyme, TAQ polymerase, last. All the preparations were carried out in a laminar flow
hood. The hood surface and the all the tubes, racks and pipettes had been sterilised
with UV light. The reagents and samples were kept on ice thoughout the procedure.
Forty five microlitres of PCR master mix was put into 0.5 ml reaction tubes and each
tube was overlayed with 50 pi of mineral oil. Five microlitres of each test sample and
control was added through the oil into the PCR master mix.
2.6.2.2. PCR conditions
The sample mixtures were placed in an Omnigene PCR machine (Hybaid)
programmed as follows: denaturation at 94°C for 4 minutes, annealing at 55°C for 1
minutes and extension at 72°C for 1 minutes (1 cycle) followed by 37 cycles of 1
minutes at 94°C, 2 minutes at 45°C and 2 minutes at 72°C with a final extension of 10
min at 72°C.
2.6.2.3. Preparation of agarose gel to visualise PCR products
PCR products were analysed by running the samples in a 1 % agarose gel. Briefly, 0.5
g of agarose (standard grade - Sigma Chemicals Ltd., UK) was put into 50 ml
loening buffer (1 x TBE =Tris/Boric acid/EDTA) and heated gently to melt the
agarose in a microwave and cooled before adding 0.2 pg/ml of ethidium bromide.
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Ten |il of the PCR products were aliquoted into microcentrifuge tubes and 1 p.1 of
loading buffer (80% glycerol, 0.02% bromophenol blue, 19.98% Tris:EDTA) was
added. Five p.1 of each sample and 5 |il Kb ladder was loaded into the gel, which was
run at 90 V and visualised under UV light and recorded by photography.
2.7. Cytokine studies
2.7.1. Cytokine studies in mice
2.7.1.1. Quantification of mouse interferon gamma by an ELISA method
A commercial kit for mouse IFN-y assay was obtained from Genzyme (IFN-y Duo
set kit). Preliminary tests were done using different dilutions of the capture antibody
and secondary antibody for optimisation of the reaction to determine the optimal
dilutions of the reagents. In summary, a 96 well Maxisorb immunoassay plate (Nunc.
Ltd., UK) was coated with 100 (J.1 per well of capture antibody (Hamster anti-mouse
IFN-y) diluted in 0.1 M carbonate buffer (coating buffer) at a concentration of 0.75
(Ig /ml and incubated overnight at 4°C. The plate was then washed 2-3 times with
250 p.1 of wash buffer (PBST). The plates were then blocked by incubating with 250
|il per well blocking buffer (PBS with 1% fatty-acid free bovine serum albumen
(BSA) (Sigma Chemicals Ltd., UK, product code No. A 6003) for 2 h at 37 °C. A
hundred microlitres of the samples (spleen homogenates) and standards
(recombinant mouse IFN-y) diluted in 1% 3-(3 cholamidopropyl dimethylammoni)-l-
propanesulfonate (CHAPS) (Sigma Chemicals Ltd., UK) were added to respective
wells and incubated for 1 h at 37°C in a horizontal shaker. The standards
concentrations ranged from 20 to 1620pg/ml. Initially the standards were diluted in
both CHAPS and culture medium to find out if CHAPS as a medium for samples
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caused any variations from those in culture medium. The plates were then washed 4-
5 times with wash buffer and incubated with 100 |il of the second antibody, biotin-
labelled goat anti-mouse IFN-y diluted in PBST containing 1% BSA (PBST/BSA) at
a concentration of 1.0 (ig/ml and incubated for 1 h 30 minutes at 37°C in a shaker.
After 4-5 washes 100 |il of detection reagent (Horseradish-peroxidase (HRP)
conjugated streptavidin) at 1:4,000 in PBST/BSA was added and incubated for 30
min at 37°C in a shaker. One hundred microlitres of tetramethyl benzimidamine
(TMB) microwell peroxidase substrate (Kirkegaard and Perry Laboratories, USA)
was then added and incubated for 10-30 mins. The reaction was stopped with 100 |il
per well of 0.5M H2SO4 and the plate read at 450nm within 30 minutes. A calibration
curve was derived from the OD of the standards and the amount of IFN-y in each
sample calculated in values of pg/ml.
2.7.1.2. Quantification of mouse total Interleukin 12 (IL-12) by an ELISA
method
IL-12 is secreted from cells in three identified forms; heterodimeric p70,
homodimeric p402 and monodimeric p40; heterodimeric p70 is responsible for all the
known biological activities (Kobayeshi et al., 1989; Trinchieri et al., 1992). The
InterTest ™ Total Mouse IL-12 ELISA kit obtained from Genzyme (USA) was used
for assaying for total IL-12. A 96 well plate pre-coated with anti-mouse IL-12 was
used to capture mouse IL-12 from the standards and test samples. A hundred
microlitres of the standards (recombinant mouse IL-12) and test samples diluted 1:2
in the assay diluent, a buffered protein solution containing 0.2% chloroacetamide
(provided by the manufacturer) were added to the wells and incubated for 30 minutes
at room temperature. The concentration of the standards were 0, 60, 180, 540 and
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1620 pg/ml. The wells were washed with wash buffer provided by the manufacturer
(a buffered detergent containing 0.2% chloroacetamide) to remove any unbound
material. 100 pi per well of an anti-mouse IL-12 biotinylated antibody diluted 1:50
in assay diluent was added and the plate incubated for 30 minutes at room
temperature. The wells were washed again and 100 (il of horseradish peroxidase
(HRP)-conjugated streptavidin added and incubated for 30 minutes at room
temperature. 100 p.1 of a ready to use chromogen-substrate solution containing
hydrogen peroxide, which had been provided in the kit was added and incubated at
room temperature for 10 minutes. The reaction was stopped by adding 100 fil of 1
M sulphuric acid and the absorbance was read at 450 nm. A standard curve was
obtained by plotting the concentrations of the mouse IL-12 standards versus the
absorbance.
2.7.1.3. Quantification of mouse Interleukin 12 p70 (IL-12 p70) by an ELISA
method
The capture ELISA test was performed using an Intertest mouse IL-12 p70 kit
obtained from Genzyme (USA). The procedure for the assay was similar to that for
total IL-12 except for the primary and secondary antibodies, the standards and also
the incubation times were longer for the IL-12 p70 than for total IL-12. The primary
antibody used in this assay was an anti-mouse IL-12 p35, while the secondary
antibody was a biotinylated mouse anti-EL-12 p70 antibody. The test samples and the
standards, recombinant mouse IL-12 p70, at doubling concentrations ranging from
25 to 1600, were incubated for 2 h at room temperature in a shaker. After adding the
biotin-labelled anti-mouse IL-12 p70, the plate was incubated for 1 h, and then for 15
minutes after adding the horseradish peroxidase-conjugated streptavidin. All
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incubations were performed at room temperature and on a horizontal shaker. The
ready to use chromogen - hydrogen peroxide substrate, TMB (Kirkegaard and Perry
Laboratories, USA) was then added and the plate incubated for 20 minutes before
stopping the reaction with 1M sulphuric acid and the absorbance read at 450 nm.
2.7.1.4. Quantification of mouse interleukin 4 (IL-4) by an ELISA method
A commercial kit for mouse IL-4 assay was obtained from Genzyme (IL-4 Duo set
kit). All the volumes added in this assay were 100 (il/well. A 96 well Maxisorb
immunoassay microtitre plate (Nunc. Ltd., UK) was coated with the capture
antibody, a monoclonal rat anti-mouse IL-4 diluted in 0.1M carbonate buffer , pH 9.5
(coating buffer) and incubated overnight at 4°C. The plate was then washed 5x with a
wash buffer (PBST) before blocking the plate with PBS containing 4 % BSA
(blocking buffer) and incubated for 2 hours at 37°C. The standards, recombinant
mouse IL-4, at concentrations of 0, 100, 200, 400, 600, 800 and 1000 pg /ml and test
samples were then added to the wells and incubated for 1 hour at 37°C. The standards
were diluted in (CHAPS) since this detergent was used in processing of the mouse
spleen homogenates. After washing, the second antibody (biotinylated polyclonal goat
anti-mouse IL-4) diluted in PBST containing 1% BSA was then added and incubated
at 37°C for 1 hour. The detection reagent (horseradish peroxidase (HRP) conjugated
streptavidin) was then added at a dilution of 1:300 in PBST containing 1% BSA and
incubated at 37°C for 15 minutes. The ready to use chromogen - hydrogen peroxide
substrate, TMB (Kirkegaard and Perry Laboratories, USA) was then added and
incubated for 10 minutes at room temperature. The reaction was stopped by adding
64
lOOjil of 1 M H2S04 and the absorbance was read using an ELISA reader at 450 nm
and the values of IL-4 calculated after plotting a calibration curve from the standards.
2.7.1.5. Quantification of interleukin-10 by by an ELISA method
A commercial ELISA kit for mouse IL-10 assay was obtained from Genzyme Ltd.
Fifty microlitres of standards and test samples were added into a microtitre wells of a
plate which had been supplied by the manufacturer and coated with an anti-mouse IL-
10 antibody, and incubated for 2 hours at room temperature on a horizontal shaker.
The standards were diluted with an assay diluent containing a protein at a
concentration of 0, 30, 60, 180, 540, and 1080 pg /ml. The plate was then washed 3
times with a wash buffer (provided with the kit as a detergent in buffer). Fifty p.1 of
the detection antibody, biotynylated anti mouse IL-10, was then added and incubated
for 1 hour at room temperature on a horizontal shaker. Fifty p.1 per well of horseradish
peroxidase conjugated streptavidin was then added and incubated for 30 minutes at
room temperature on a horizontal shaker. Fifty jil of the the ready to use substrate
(peroxide) TMB (Kirkegaard and Perry Laboratories, USA) was then added and
incubated for 15 minutes or until colour developed and the reaction was stopped with
50 |il of 1 M H2SO4 and the absorbance read on an ELISA reader at 450 nm. The
values of IL-10 in pg/ml were calculated from the standard curve based on the
absorbance obtained from the standards.
65
2.7.2. Cytokine assays in sheep
2.7.2.1. Immunoassay for ovine interferon gamma (IFN-y) by an ELISA method
IFN-y was assayed using two bovine sandwich ELISA kits, one from Lifescreen Ltd.,
UK, and one from CSL Biosciences, Australia. In summary, 100 p.1 of plasma test and
control samples, and positive and negative controls provided by the manufacturers
were added into 96 well microtitre plate, coated with anti- bovine IFN-y. Fifty (il of
incubation buffer provided by the manufacturer was added into all the wells and the
plate incubated for 1 hour at room temperature on a horizontal shaker set at 700 rpm.
The plate was then washed 3 times with washing buffer, provided by the
manufacturer, diluted in distilled water. 100 p.1 of the conjugate (anti- EFN-y bovine
HRP conjugate) was added and incubated for 1 h at room temperature on a horizontal
shaker at 700 rpm. After a wash, 100 (il of the substrate -chromogen solution, TMB
(Kikergaard and Perry Laboratories, USA) was added and incubated at room
temperature for 15 minutes on a horizontal shaker as above. 200 fll of stop solution,
provided with the kit, was then added and the absorbance read at 450 nm„ The results
were interpreted on the basis of the negative and positive control readings, in which
the expected responses in optical density (OD) were between 0.05 and 0.011 OD's for
the negative control and 1.5 and 2.1 OD's for the positive control.
2.7.2.2. Immunoassay for Ovine IL- 8 by an ELISA method
This procedure was carried out in Moredun Research Institute using a procedure
optimised for ovine IL-8 assay by David Haig and colleagues. A Dynatech 129B, flat-
bottomed plate was coated with 100 (il/well of a 5 |ig/ml solution of monoclonal
antibody 8MG diluted in 0.1 M carbonate buffer, pH 9.6. The plate was incubated
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overnight at 4 °C wrapped in cling film. After a 6 x wash with PBST, the plate was
blocked with PBST / 3 % BSA for 1 hour at room temperature. All subsequent steps
were followed by a 6 x wash. Fifty microlitres per well of plasma test samples at 1:4
dilution in PBST / 3 % BSA and standards were then loaded in duplicate and
incubated at room temperature for 1 hour. The standards were prepared in doubling
concentrations ranging from 50 to 6,000 pg/ml in PBST / 3 % BSA. 100 (ilAvell of
polyclonal rabbit anti-IL-8 sera was then added at a dilution of 1:2000 in PBST / 3 %
BSA and incubated for 1 hour at room temperature. 50 |d /well of the conjugate, goat
anti-rabbit diluted 1:1000 in PBS was then added and incubated for 1 hour at room
temperature. 50 |il /well of the chromogen (OPD)-substrate (peroxide) was added and
incubated until colour had developed but before colour developed in the blank wells.
The reaction was stopped with 50|il/well of 2.5 M H2S04 and the absorbance was read
using an ELISA reader and the values of IL-8 calculated after plotting a calibration
curve from the standards.
2.7.2.3. Immunoassay for Ovine Tumour Necrosis Factor alpha (TNF-a) by a
radioimmunoassay method
This assay was carried out in Moredun Research Institute, courtesy of Dr Chris
Hodgson and Gordon Moon, and the method used was that reported by Kenison et
al., (1990). All antibody dilutions were prepared in assay buffer consisting of 0.15
PBS, pH 7.4, containing bovine serum albumin (BSA, Sigma Chemicals Ltd., UK)
and 0.1% Tween 20 (Sigma Chemicals Ltd., UK). The antigen used, recombinant
bovine TNF-a (rboTNF-a) was produced, cloned and expressed in E.coli and purified
by HPLC and SDS-PAGE (kindly donated by Dr Gary Entrican, Moredun Research
Institute, and obtained from CIBA-GEIGY Ltd., Switzerland). First antibody, anti-
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bovine TNF-a antiserum, was raised in rabbit 378 at Moredun Research Institute,
1994. An initial subcutaneous injection (2 sites) of 50 ug rboTNF-a (conjugated to
itself using glutaraldehyde) with complete Freunds adjuvant was followed by a similar
booster injections at 4 and 8 weeks post-immunisation. Incomplete Freunds adjuvant
was used for these booster injections. Blood was collected 12 days post-the second
boost, allowed to clot and the serum harvested. Dilutions of this polyclonal antiserum
were used in the assay. Second antibody was prepared by mixing 2 parts of a 1:40
dilution of donkey anti-rabbit IgG (Scottish Antibody production Unit, Lanarkshire)
with 7 parts of a 6% solution of polyethylene glycol 6000 (BDH) in assay buffer. A
radiolabelled TNF-a was used a tracer and was prepared by a modification of the
iodogen method used by Peel et al (1990). Briefly, lOug of rboTNF-a was mixed
with 0.5m Ci Nal25 (Amersham International pic) in 95 ul of borate-buffered saline
(BBS), pH 8.3. The reaction was carried out in a glass tube coated with lOug iodogen
(tetrachlorodiphenyglycouracil, Pierce Chemicals) and the reaction allowed to
proceed , with the occasional agitation, for 20 minutes at room temperature. Unbound
iodine was removed using Sephadex G25 gel filtration column (Uni-Quick, Eldan
Scientific) pre-equilibrated with 15 ml elution buffer (BBS containing 0.2% bovine
serum albumin and 0.5% Tween 20). The specific activity of the tracer produced by
this procedure was approximately 24mCi/mg. A dilution which yielded approximately
10,000 cpm/tube was used in the assay. For each run, dilutions of rboTNF-a
containing 500, 100, 20, 4, 0.8 and 0.16 ng/ml in fetal bovine serum were included as
standards. The assay was performed in 75 x 11mm polystyrene tubes (Sardedt). 100
ul of the standards, controls and test samples in duplicate were mixed with 100 ul of
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polyclonal antibody (1:4000 to 1:8000) and 100 ul of assay buffer and incubated at
4oC for 24 h. At the end of this period, 100 ul of radiolabelled rboTNF-a was added
to all the tubes, vortexed and incubated for a further 18h at 4oC. The second antibody
(400ul) was then added to all the tubes except total count (TC) tubes and incubated
for 2 h at 4oC To enhance pellet formation, lOOul of 1% rabbit serum was added to
the tubes and the incubation continued for a further 30 minutes. All tubes except TC
were then centrifuged at 3838g for 15 minutes, Bechkman GS-15) and the
supernatant aspirated with a glass Pasteur pipette. The radioactivity in the pellet was
measured in gamma counter (Canberra-Packard Cobra, UK) and the results were
calculated with Cobra software.
2.7.3. RT-PCR for mouse cytokines
2.7.3.1. Isolation of mice spleen cells for RNA extraction
Spleens from the sacrificed mice were weighed and 20 mg of spleen tissue disrupted
and homogenised by using aseptic techniques in sterile mortar and pestle within the
shortest time possible. RNA extraction of spleen tissue was carried out using RNeasy
kit (Qiagen) (Rneasy Mini handbook, 1997). This procedure utilises the selective
binding properties of a silica-gel membrane, in which a specialised high-salt buffer
system allows upto lOOug of RNA longer than 200 bases to bind to the RNeasy
silica-gel membrane. The samples were lysed and homogenised in the presence of a
highly-denaturing guanidinium isothiocyanate-containing buffer (RTL buffer) which
immediately inactivates RNases to ensure isolation of intact RNA. Complete
homogenization was carried out as this shears the high molecular weight genomic
DNA. In summary, the tissues were disrupted in 350 ul of RTL buffer and the lysate
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was then placed in a QIAshredder column sitting in a 2 ml collection tube and
centrifuged for 2 mins. at maximum speed to homogenise. The extraction of total
RNA was then done in the shortest time possible, as per the Qiagen commercial kit
instructions. The extracted RNA was stored in -20oC in RNAse free water after
determining the concentration of RNA by measuring the absorbance at 260 nm
(A260) in a spectrophotometer. An absorbance of 1 unit at 260 nm corresponds to
40 ug of RNA per ml (A260 = 1 = 40 ug/ml). The RNA was used in RT-PCR for
expression of mouse cytokines in spleen.
2.7.3.2. Reverse transcription of mice RNA to cDNA
Samples of 5 pg of RNA were used for reverse transcription to cDNA using the
Super Script pre-amplification system (Life Technologies Ltd., UK) with oligo dT as
a primer, according to the manufacturers instructions. 1 pil of Oligo dT primer (500
ug/ml) was added into 5 fig of RNA in 12 pi RNase free water and incubated at 70°C
for 10 min on an Omnigene PCR machine (Hybaid). The mixture was then chilled on
ice. This allowed the RNA to separate and the oligo dT to bind to the poly A tails of
the mRNA molecules. Into each sample 8 pi of superscipt mix containing 4 pi
synthesis buffer, 2 pi of 0.1 M dithiothreitol (DTT/reducing agent), 1 pi of 10 mM
nucleotides (dATP,dCTP, dGTP and dTTP) and 200U per pi of Superscript reverse
transcriptase were added and left to stand at room temperature for 5 minutes. The
samples were then heated at 42°C for 50 min in an Omnigene machine followed by
90°C for 5 minutes to denature the enzyme. They were then chilled and centrifuged at
10000 g for 15 sec. and the cDNA stored at -20°C.
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2.7.3.4. Polymerase chain reaction analysis of cDNA in mice
Polymerase chain reaction (PCR) was performed using 2 ul of the cDNA and primers
for cytokine sequences were used to amplify the cDNA during a 40 cycle PCR. All
the cytokine primers used were a generous gift from Dr Mark Lawson, Medical
School, University of Edinburgh. The PCR mix used in each reaction contained 19 ul
milliQ water, 1.2 ul of 50 mM MgCL, 2.4 ul dNTP mix (dATP, dCTP, dGTP,
dTTP, each at 10 mM), 1 ul of 25 pM positive and negative primer, 2 ul cDNA
suspension, 3 ul PCR buffer and 0.4 ul (2 units) Taq polymerase (Thermometric Ltd.,
UK). A layer of 20 ul of paraffin oil was added to prevent evaporation and the PCR
programme was carried out on an Omnigene PCR machine (Hybaid) with the
following conditions; 95°C for 3 mins (denaturation step) for 1 cycle, 95°C X 1 min
(denaturation step), 55°C X 1 min (primer attachment step), 72°C X 5 min
(elongation step) for 30 cycles and 72°C X 5 min (elongation step) for 1 cycle. The
samples were then stored at -20°C before electrophoresis at 90 V was carried out in
2 % agarose gel containing 4 pg/ml ethidium bromide and the PCR products
visualised under UV light.
2.7.4. RT-PCR for sheep cytokines
2.7.4.1. PBMC isolation from blood of infected sheep for extraction of RNA
Heparinised blood was collected from infected sheep at days 4, 7, 11 and 13 pos-
infection and PBMC separated using Ficoll Hypaque method already described in
section 2.1.3. The cells were then cultured in RPMI 1640 for 24 hours before
scraping the cells and extracting RNA using an RNeasyR kit (Quiagen Ltd., UK) as
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described in section 2.7.3.1. The RNA was used in RT-PCR for detection of
expression of sheep cytokines in spleen.
2.7.4.2. Reverse transcription of sheep RNA to cDNA
The procedure was as already described for mouse RT-PCR, section 2.7.3.2.
2.7.4.3. Polymerase chain reaction analysis of sheep cDNA
Polymerase chain reaction (PCR) was performed using 2 pi of the cDNA and primers
for cytokine sequences were used to amplify the cDNA during a 40 cycle PCR. All
the cytokine primers sets used (IL-4, IL-10 and TNF-a) were a generous gift from
John Campell, CTVM, University of Edinburgh, and are as listed below.













The PCR mix used in each reaction contained 19 ul milliQue water, 1.2 pi of 50 mM
MgCL, 2.4 pi dNTP mix (dATP, dCTP, dGTP, dTTP, each at 10 mM), 1 ul positive
and negative primer, 2 pi cDNA suspension, 3 ul PCR buffer and 0.4 pi (2 units) Taq
polymerase (Thermometric Ltd.). A layer of 20 pi of paraffin oil was added to prevent
evaporation and the PCR programme was carried out on an Omnigene PCR machine
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(Hybaid) in the following conditions; 95°C for 3 mins (denaturation step) for 1 cycle,
95°C X 1 min (denaturation step), 55°C X 1 min (primer attachment step), 72°C X
min (elongation step) for 30 cycles and 72°C X 5 min (elongation step) for 1 cycle.
The samples were then stored at -20°C before electrophoresis at 90 V was carried out
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The clinical manifestations and pathology of C. ruminantium infection are
mainly associated with severe respiratory distress, cardiac and nervous embarrassment
due to increased capillary permeability leading to oedema (Clark, 1962). Whilst
increased capillary permeability may explain the marked fall in blood and plasma
volume which occur prior to death in heartwater (Clark, 1962), the cause of such
alterations remain obscure.
Despite immunisation and specific chemotherapy, heartwater remains a major
obstacle against introducing highly-producing animals into Africa with the aim of
upgrading or replacing local stock (Uilenberg, 1981; 1983). Variation in the
susceptibility to C. ruminantium in cattle, sheep and goats has been recorded (Du
Plessis et al., 1987, Uilenberg, 1971, and Spreull, 1922). Differences in the resistance
of cattle to C. ruminantium infection have been documented and there is general
agreement that local breeds developed in endemic areas are more resistant than exotic
breeds and it was suggested that they acquire this strong innate resistance through
long natural selection (Matheron et al., 1987). There have been conflicting reports on
resistance of different breeds to C. ruminantium infection (Du Plessis et al., 1987). For
instance, Bos indicus were reported to be more resistant than Bos taurus breeds by
Van der Merwe (1979), but Uilenberg (1983) reported that the innate resistance found
in African breeds had nothing to do with the breed influence, thus two conflicting
reports. The reports on the resistance of indigenous sheep and goats is also
controversial with indigenous breeds being reported by some authors to possess a
higher degree of natural resistance to the disease than exotic breeds (Spreull, 1922;
Alexander, 1931; Uilenberg, 1971; Du Plessis et al., 1983) while some authors
reported heavy losses among indigenous breeds (Ilemobade, 1976; Karrar, 1960).
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Existence of natural selection among goat populations raised in endemic areas has been
suggested (Matheron et al., 1987). The resistance rate acquired in such
epidemiological conditions was suggested to depend on the intensity of infectious
contact experienced by the population (Matheron et al., 1987). All these reports
emphasise the obscure nature of the non-specific factors which play important roles in
pathogenesis and resistance to C. ruminantium infection.
The anti-microbial role of interferons and other cytokines has been reported in
several diseases to be mediated through production of reactive nitrogen and / or
oxygen radicals (Seguin et al., 1994). Exposure of cells to certain stimuli including
pathogens, cytokines, mediators and chemical products results in increased uptake of
oxygen leading to production of reactive oxygen radicals and nitric oxide (Dugas et al.,
1995). Nitric oxide is a powerful vasodilator which has been found to play a major role
in enhancing vascular permeability, and the latter is a key phenomenon in the
pathogenesis of C. ruminantium infection (Furchgott et al., 1984). Infection of
endothelial cells by Rickettsia rickettsii, an organism closely related to C.
ruminantium, was reported to induce increased production of intracellular peroxide as
well as a sustained increase in the levels of superoxide dismutase, but a decrease in
glutathione peroxidase and glucose-6-phospatase, scavengers of oxidising radicals
(Santucci et al., 1994). These reports prompted the studies reported here, to
investigate levels of some of the enzymes involved in antioxidation processes and relate
these to the levels of some cytokine and nitric oxide levels and how these may
influence the degree of resistance to the disease. The cytokines studied included IFN-y,
TNF-<x , which are known to be involved in activation of macrophages and endothelial
cells, and IL-8, which is known to activate neutrophils leading to their migration and
may have a role in lung damage and exudation.
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The aim of this study was, therefore, to investigate the relationship between
inflammatory cytokines and biochemical markers of free radical production in relation
to C. ruminantium infection in both indigenous and exotic breeds of sheep. The work
included studies on the levels of enzymes involved in scavenging oxidising agents,
nitric oxide and cytokines in sheep infections of C. ruminantium. This involved
infecting sheep considered to be highly susceptible to the disease (Merino and Black
face crosses, and Dorper), sheep immunised with a recombinant antigen of C.
ruminantium and infection of indigenous African breeds (Red Maasai), which are
considered to be resistant to the disease. The initial objectives included investigation of
the innate resistance found in most African breeds. However, these objectives were
reviewed after all the Red Maasai were found to be serologically positive, an indication
of prior exposure to C. ruminantium antigens, before entering the experiment as the
animals were obtained before my arrival to Kenya to carry out the work. As the field
trip to Kenya was only for 7 weeks and given financial constraints, it was not possible
to obtain other more suitable animals for the work.
3.2. Materials and Methods
3.2.1. Experimental animals;
Six Scottish Black face and Merino crosses were infected with a virulent South African
strain of C. ruminantium, the Welgevonden isolate, while six Dorpers were infected
with a virulent Kenyan strain , the Kathiani isolate, as the Welgevonden isolate could
not be imported into Kenya where this experiment was performed. The reactions were
compared to those in animals which had prior exposure to Cowdria antigens and which
were expected to show clinical signs on infection: six Black Face and Merino crosses
immunised with a recombinant antigen, the 58kDa GroE/L of C. ruminantium
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(Kibor, 1997) and challenged with the Welgevonden isolate at a dose of 3xl05 EBs;
and six Red Maasai sheep which had been exposed naturally to Cowdria antigens and
challenged with the Kenyan strain (Kathiani). The sheep were individually identified
with numbers as shown in the table below (Table 3.1). Although the Red Maasai were
raised in a farm which had not reported heartwater, they were all serologically positive
with antibodies to C. ruminantium prior to infection as compared to the Dorper which
were sero-negative, as tested using an indirect ELISA assay, described below. All the
animals were about 12-24 months old. The source and maintenance of the animals has
already been described in section 2.3.1.1.
Table 3.1.
Welgevonden sheep infections identification
numbers
Kathiani sheep infections identification
numbers
Primary sheep Immunised sheep Dorpers Red Maasai
67 66 12 1
68 69 15 2
70 71 17 3
73 72 18 4
75 74 19 5
77 76 20 6
3.2.2. Infectious agent
The Welgevonden (South African) isolate of Cowdria ruminantium propagated in
tissue culture in bovine endothelial cell lines was used to infect the Scottish Black face
and Merino crosses using an infectious dose of 3xl05 elementary bodies (EBs) as
described in section 2.1.1. The viability count to determine the infectious dose was
performed by a fluorescein diacetate staining technique as described in section 2.1.5.
The Kenyan isolate of Cowdria ruminantium (Kathiani; blood stabilate No. 327B of
25-10-1994) was used as a blood stabilate to infect the Dorpers and the Red Maasai as
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described in section 2.1.1. The stabilate had previously been shown to be virulent but
the strain had not been isolated in tissue culture and therefore the infectious dose could
not be determined.
3.2.3. Clinical disease monitoring and sampling
The disease was monitored in the sheep daily and blood samples collected from all
sheep every two days, as described in section 2.3.5. Serum was separated and tested by
indirect ELISA assay test, and also used for immunoglobulin isotyping, for C.
ruminantium antibodies; heparinised blood was collected for assays of glutathione
peroxidase (GPX) and superoxide dismutase (SOD) levels; plasma was collected for
assays of TNF-a, IL-8, IFN-y, nitrite and for extraction of C. ruminantium DNA for
the quantification of infection by PCR.
3.2.4. Serology
3.2.4.1. ELISA for antibody assay prior to infection
An indirect ELISA method was used to assay for C. ruminantium antibodies in 12
sheep infected with the Kathiani isolate, as described in section 2.4.2. using a C.
ruminantium soluble antigen (batch No. 14 (EL14)) prepared as described in section
2.4.1. All the Red Maasai had high antibody optical density prior to infection with a
mean value of more than 0.900 as compared to the Dorpers which had low levels of
less than 0.060 (Figure 3.2), indicating that, although the Red Maasai were chosen
because of no history of heartwater, they were found to have high and uniform
antibody levels prior to infection.
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3.2.4.2. Anti-Cowdria immunoglobulin isotypying
Serum anti-Cowdria IgGl and IgG2 antibody levels were assayed by an ELISA
method in 12 sheep infected with the Kathiani isolate, as described in section 2.4.4.,
using a C. rwninantiwn soluble antigen (batch No. 15 (EL 15)) prepared as described
in section 2.4.1.
3.2.5. Biochemical tests;
3.2.5.1. Glutathione peroxidase assay
Glutathione peroxidase (GPX) levels were measured in heparinised blood for all the
24 sheep using a commercial kit (Randox) as described in section 2.5.1. The levels
were measured prior to infection from day 0 and there after every 2 days post-infection
until death or recovery, up to day 30. The assay principle and method were performed
as described in section 2.5.1. The levels were compared and contrasted between the
Welgevonden infections (Scottish Black Face and Merino crosses) and the Kathiani
infections (Red Maasai and Dorpers). The levels were also compared between days for
each group.
3.2.5.2. Superoxide dismutase assay
SOD levels were assayed in heparinised blood for all the 24 sheep using a commercial
kit (Randox) as described in section 2.5.2. The levels were measured before and after
infection, as for GPX and compared between different groups and for different days
within each group.
3.2.5.3. Nitrite assay
Nitrite levels were measured in plasma collected every 2 days for all the 24 sheep after
infection with C. ruminantium using the Griess assay method, as described in section
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2.2.1., with the modification that plasma was used in place of culture supernatants. The
levels were compared and analysed between the different groups of sheep and different
days for each group.
3.2.6. Cytokine assays by Enzyme Linked Immunosorbent Assay (ELISA)
3.2.6.1. Interferon gamma assay
IFN-y was measured in plasma collected from all the 24 sheep from day 0 prior to
infection and every 2 days thereafter using two bovine sandwich ELISA kits, one from
CSL Biosciences, Australia, and one from Lifescreen Ltd., UK, as described in section
2.7.2.1. The OD values obtained from positive and negative controls were used as
basis for interpretation of results.
3.2.6.2. Interleukin 8 assay
IL-8 was assayed in the sheep plasma samples of all the 24 sheep collected from day 0
and every 2 days there after up to day 30 by an ELISA test. The procedure for ovine
IL-8 assay had been optimised by David Haig and colleagues (Moredun Research
Institute) and was performed as described in section 2.7.2.2. The IL-8 values were
calculated from a calibration curve and analysed and compared between the different
sheep breeds and also between different stages of infection.
3.2.6.3. Tumour necrosis factor assay (TNF-a)
A radio-immunoassay method was used to assay the levels of TNF-a in all the 24
sheep using a bovine recombinant TNF-a cloned and expressed in E. coli as antigen,
rabbit anti-bovine TNF as primary antibody, donkey anti-rabbit sera as secondary
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antibody and radio-labelled TNF-a as tracer as described in section 2.7.2.3. For each
run, dilutions of rboTNF-a containing 500, 100, 20, 4, 0.8 and 0.16 ng/ml in fetal
bovine serum were included as standards. The assay was carried out in Moredun
Research Institute, courtesy of Dr Chris Hodgson and Gordon Moon, using the
method reported by Kenison et al., (1990). TNF-a levels were assayed in plasma
samples collected before and after infection for all the sheep infections. TNF-a levels
were calculated using the calibration curve of the standards and the results analysed
and compared for different breeds of sheep and also for different days during infection.
3.2.7. PCR to detect and estimate level of C. ruminantium infection in
Plasma
A method to assess relationship between level of infection and severity of disease in the
Welgevonden and Kathiani infections was attempted using PCR. For positive control,
and also to derive a 'calibration curve' for the PCR, EBs from tissue culture were
counted by the fluorescein diacetate method and centrifuged at 15,000 g to pellet the
EBs. Known concentrations of EBs (10s, 102'5, 10125, 800, 400, 200, 100 50, and 0
EBs / ml) were resuspended in plasma from normal sheep and the EBs processed for
DNA extraction as before. DNA extraction from plasma was performed as already
described in section 2.6.1. PCR was performed in a total of 57 samples for days 0, 4, 8,
10, 12 and 14 using C. ruminantium DNA primers, HE 1 (forward) , HE 2 or HE
3(reverse) whose sequences and theoretical amplification specificity have been
described in section 2.6.2. These primers were not analysed using southern blotting
during this study but are routinely used in the laboratory. The PCR conditions used and
procedure were as described in section 2.6.3. PCR products were analysed by running
the samples in a 1 % agarose gel. The results were visualised under UV light and
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recorded by photography (see section 2.6.3.2). The results were compared between the
animals and a relationship between the PCR and the other results including levels of
cytokines and antioxidants compared.
3.2.8. RT-PCR for expression of Cytokines
Forty ml heparinised blood was collected from 2 Merino and Blackface cross sheep
identification numbers 222 and 225, infected with the Welgevonden isolate of C.
ruminantium at days 4, 7, 11 and 13 post-infection (due to the large amount of blood
required for enough PBMC, these 2 other sheep had to be used so as not to interfere
with the other experiment by overbleeding). PBMC were then separated using Ficoll
Hypaque method as described in section 2.1.3. The cells were cultured in RPMI 1640
for 24 hours before scraping the cells and extracting RNA using a Qiagen kit as
described in 2.7.3.1. RT-PCR was carried out using the extracts as described in section
2.7.4.2. and the resultant cDNA used in a PCR using cytokine primers (TNF-a , EL-4
and IL-10) as described in section 2.7.4.3.
3.2.10. Data Analysis
The students t-test, Analysis of Variance (ANOVA) or Mann-Whitney test were used
for statistical data analysis of the biochemical and cytokine data sets and results
expressed at 0.05 level of significance.
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3.3. Results
3.3.1. Clinical and pathological manifestations
3.3.2.1. Welgevonden infections
The disease onset was acute in all the sheep, with severe clinical signs being noted 2
days after fever onset. The mean rectal temperatures in the sheep infected with the
Welgevonden isolate were noted to be increased to or more than 41°C by day 8 in both
groups (Figure 3.1 and Appendx 1.10) but the trends and the temperature reactions
were not significandy different between the infections of naive and primary and
immunised groups of sheep (t-test; p=0.355). The mean incubation period, course of
fever and days to death were not significandy different between the primary and
immunised animals (t test; p>0.05 for the three parameters) (Table 3.2). Clinical signs
seen in these sheep included laboured breathing with increased respiratory rate, loss of
appetite, depression, unsteady gait, recumbency and in some animals nervous signs just
prior to death. Hydropericardium was a common pathological feature and routine brain
squash smears stained in giemsa confirmed the disease by demonstrating C.
ruminantium colonies in each of the dead sheep. Differences were noted in the mean
infection rates of endothelial cells of the immunised and primary infections, with the
immunised showing an infection rate of 30% with a range of 20-45 while the mean
infection rate in the primary infections was 62.95% with a range of 43 -75 as
calculated by Kibor (1997). Death occurred within 5-6 days after the febrile reaction
(Table 3.2).
3.3.2.2. Kathiani Infections
The mean incubation period for animals which succumbed to the disease was 16 and
20 days for the Dorpers and the Red Maasai respectively (Figure 3.2a and Appendices
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1.1 and 1.2). The morbidity rate was higher in the Dorpers with 6 out of 6 showing
clinical disease as compared to 2 out of 6 in the Red Maasai (Figure 3.2b and
Appendices 1.1 and 1.2). The reacting sheep in both groups showed mild signs and a
prolonged course of disease of more than 10 days. The clinical picture was
characterised initially by a febrile reaction followed by a slight depression. Other
clinical signs included reduced appetite, slight tremors, nasal discharge and slight
respiratory distress. Four sheep, two from each group which suffered clinical disease
were sacrificed on day 22 post-infection otherwise there were no deaths recorded and
spontaneous recovery was seen in the other sheep in the groups.
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Fig. 3.1.
Mean temperature changes in primary and immunised sheep
infected with the Welgevonden isolate of C. ruminantium
Days post-infection
Mean (Primary) —■— Mean (immunised)
Fig. 3.2.
A. Mean temperature of Red Maasai (RD) and Dorper (D) sheep
infected with the Kathiiani isolate of C. ruminantium
Days post-infection
Mean (RD) M Mean (D)
B. Temperature reactions in individual Red Maasai sheep Nos. 1-
6 infected with the Kathiani isolate of C. ruminantium. Only
sheep No. 3 and 6 had temperature reactions of more than 41 °C
Days post-infection
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Table 3.2: Clinical data of the Welgevonden infections
Primary infections Challenge infections of immunised sheep
Mean LP. 7.5+/-0.84 6.83+/-0.
Mean CF 5.3+/-0.52 6.2+/-1.7






3.3.2.1. Anti-C. ruminantium antibodies
An indirect ELISA test for anti-Cowdria antibodies revealed that all the Red Maasai
had high optical density (OD) value indicative of antibody levels in serum prior to
infection (Figure 3.3a and b and Appendix 1.3.2) with a mean value of more than
0.900 as compared to the Dorpers which had levels with a mean of less than 0.060 as
stated above in materials and methods. After infection, all the Red Maasai recorded a
decline in the OD value up to days 12/16 after which an increase was noted. A gradual
increase in OD value was noted in all the Dorpers with the highest levels being
recorded at day 22.
3.3.2.2. IgGl and IgG 2 immunoglobulin isotypes to C. ruminantium
And-Cowdria immunoglobulin isotypes IgGl and IgG2 were assayed in the sheep
infected with the Kathiani isolate of C. ruminantium from day 0 to day 30 post¬
infection. There were major variations in IgGl but not IgG2 in individual sheep in the
Red Maasai sheep during infection, with those showing a febrile reaction recording
higher but transient levels of IgGl (on day 14) as compared to non-febrile sheep
(Figure 3.4a and b and Appendix 1.3.1). Significantly higher mean levels of IgGl (t
test; p=0.002) were recorded in the Red Maasai as compared to the Dorpers but not in
the mean IgG2 levels (Figure 3.4c). The Red Maasai had significantly higher mean




A. Indirect ELISA results in Red Maasai sheep
infected with the Kathiiani isolate of C. ruminantium.
Only sheep No. 3 and 6 showed a temperature
reaction of more than 41 °C







B. Indirect ELISA results in Dorper sheep infected
with the Kathiiani isolate of C. ruminantium. Note
that all the sheep had temperature reactions of more
than 40.5°C Sheep Nos. 12 and 15 had the earliest
and most acute reaction to the disease.
8 12
Days post-infection
12 15 17 -*-18 -*-19 20
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Fig. 3.4.
A. IgGl levels in Red Maasai sheep
Nos. 1-6 and Dorpers sheep Nos. 12,15,
17,18, 19, and 20 infected with the















B. IgG2 levels in Red Maasai sheep
Nos. 1-6 and Dorpers sheep Nos. 12,17,
18, 19, and 20 infected with the





































Mean Immunoglobulin levels of lgG1 and lgG2 in Red Maasai (RD) and






lgG1 (RD) lgG2(RD) lgG1(D) —X— lgG2(D)
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3.3.3. Glutathione peroxidase (GPX)
3.3.3.1. Welgevonden infections
There were no significant differences in GPX levels between the primary and challenge
infections in the Welgevonden infections (t-test, p=0.15). The GPX levels were not
significantly different between days 0 to day 6 in infected animals for both groups
(ANOVA; p>0.05), but a significant two fold increase was recorded on day 8, and 12
post-infection as compared to day 0 (ANOVA; pcO.OOl) (Figure 3.5 and Appendix
1.10).
3.3.3.2. Kathiani infections
Significant differences were noted in GPX levels between the Dorpers and the Red
Maasai, with the Dorpers showing significantly higher levels as compared to the Red
Maasai through out the course of disease (ANOVA; p=0.009) (Figure 3.6 and
Appendix 1.5). The levels increased gradually after infection in both breeds, with peak
levels coinciding with the febrile reaction and higher levels being recorded in Dorpers
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Mean glutathione peroxidase (GPX) levels in Red Maasai
(RD) and Dorper (D) sheep infected with the Kathiani
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3.3.4. Superoxide dismutase (SOD)
3.3.4.1. Welgevonden infections.
There was a dramatic and significant increase in mean SOD levels in both primary and
immunised sheep after infection with C. ruminantium (ANOVA, p=0.04). The increase
was noted to occur early during the disease with about a 3 fold increase in primary
infections and 2 fold increase in immunised sheep by day 2 post-infection. The
differences between the two groups were only significant on day 2 post-infection as
compared to day 0 (t test, p=0.03) but not significant on the other days (ANOVA;
p=0.3). The high mean SOD levels were sustained through out the course of the
disease in both groups, except on day 10 when there was a slight drop in the
immunised group, and the highest mean SOD levels were recorded during the febrile
reaction ( 4-12 days) post-infection (Figure 3.7 and Appendix 1.10).
3.3.4.2. Kathiani infections
There were significant changes in SOD levels in both Red Maasai and Dorper after
infection (Anova, p<0.001 for the Dorpers and p<0.05 for the Red Maasai). The
increase was noted to occur earlier and also to be highly significant in the Dorpers as
compared to the Red Maasai during the febrile reaction when the increase was about




Mean superoxide dismutase (SOD) levels in primary and
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Fig. 3.8.
Superoxide dismutase (SOD) levels in Dorper (D) and Red

























There was increased mean nitrite levels after sheep infections with the Welgevonden
isolate of C. ruminantium in both primary and immunised animal infections as
compared to day 0 value, with the increase being significant in immunised sheep (t-test,
p=0.04) but not in the primary infections. Significant differences were also found
between the primary and immunised animal infections on day 10 post-infection, with
the immunised group recording significantly higher levels as compared to the primary
infections (t-test, p=0.04) (Figure 3.9 and Appendix 1.12).
3.3.5.2. Kathiani infections
There were significant increases in mean nitrite levels in both the Red Maasai and the
Dorpers on day 19 to 21 which also coincided with the mean febrile reaction period
following infection with C. ruminantium (t test, p=0.04) (Figure 3.10c). The Dorpers
had two peaks of nitrite increase as compared to one peak in the Red Maasai; the first
peak, which was not significantly different from day 0 values, was recorded on days 4
to 8 (about 40 (iM) while the second peak, which was significantly different from day 0
values, was on days 19-21 (about 55 (iM). In the Dorpers, an increase was noted from
day 16 which coincided with the febrile reaction period, with maximal levels being
recorded on day 22 post-infection (Figure 3.10c). Individual variations were noted in
all the sheep with the animals showing clinical reaction also recording the highest levels
(Figure 3.10a and b and Appendix 1.6).
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Fig. 3.9.
Mean Nitrite levels in Primary and immunised infections of






B. Nitrite levels in individual Dorper
sheep Nos. 12,15,17,18,19 and 20
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Fig. 3.10.
A. Nitrite levels in individual Red
Maasai sheep Nos. 1-6 infected























C. Mean nitrite levels in Red Maasai (RD) and Dorper (D) Sheep infected
with the Kathiani isolate of C. ruminantium
Days post-infection
-•—Mean (RD) —•- Mean (D)
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3.3.6. Cytokine assays
3.3.6.1. Interferon gamma (IFN-y) levels
3.3.6.1.1. Welgevonden infections
Although IFN-y levels were very low in plasma, they were measurable and
reproducible. There were some differences noted in the mean IFN-y levels in primary
and immunised sheep after infection with C. ruminantium but the differences were not
significant (Anova, p=0.06). Mean IFN-y levels in the Welgevonden infections
remained relatively the same from day 0 to day 10 in the immunised group of sheep,
with a slight increase on day 12 post-infection which was not significant (Figure 3.11).
The primary infections had a significant reduction (p<0.05) in mean IFN-y levels
recorded on day 10, which was then followed by a dramatic increase on day 12, during
the terminal stages of disease (Figure 3.11 and Appendix 1.11).
3.3.6.1.2. Kathiani infections
Significant differences (t-test, p<0.05) were noted in the mean levels of IFN-y in the
Red Maasai and the Dorpers after infection with C. ruminantium (Figure 3.12). OD
value reflecting the IFN-y levels were low in the Dorpers until day 12 post-infection
after which there was a gradual increase with peak levels being recorded on day 19
post-infection which also coincided with the febrile reaction. These levels were not
sustained and decreased by day 22. In the Red Maasai, two peaks of IFN-y levels were
noted during post-infection period, one on days 4 to 12 and the other on day 22, which
recorded also the highest IFN-y levels. Except for day 16 and day 19, the mean IFN-y
levels were significantly higher in the Red Maasai than in the Dorper (t-test, p<0.05),
with the levels on day 22 post-infection being 5 times higher in the former than in the
latter (Figure 3.12 and Appendix 1.8).
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Fig. 3.11.
Mean IFN-y levels in primary and immunised sheep



















Mean IFN-y levels in Red Maasai (RD) and Dorper (D)






















3.3.6.2. Interleukin 8 (IL-8) levels
3.3.6.2.1. Welgevonden infections
Significant increase in EL-8 levels were recorded in infections of primary and
immunised sheep (Figure 3.13). There was an initial decrease recorded on day four in
both groups followed by an increase which was sustained through the course of
disease. Significant differences (t-test, p=0.02) were noted between infections in naive
and immunised sheep with the primary infections recording a dramatic 3 fold increase
in IL-8 by day 6 as compared to the levels in the immunised infections. The primary
animals recorded peak mean levels of over 17,000 pg/ml on days 8 and 10 , which
were about two fold the mean peak level recorded in the immunised group on day 10,
of about 9,000 pg/ml (Figure 3.13 and Appendix 1.10).
3.3.6.2.2. IL-8 in Kathiani infections
There was significant increase in mean IL-8 levels in both the Dorpers and Red Maasai
after infection with C. ruminantium. Significant differences between the two groups
were noted on day 19 post-infection with the levels in Dorpers being 3 times higher
than in the Red Maasai infections and this coincided with the highest and most
consistent febrile reaction in the Dorpers. There were large variations in the levels of
IL-8, with animals which did not manifest a febrile reaction, having lower IL-8 levels
as compared to those that did (Figure 3.14 and Appendix 1.9).
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Fig. 3.13.
Mean IL-8 levels in primary and immunised sheep
infected with the Welgevonden isolate of C. ruminantium
Mean-Primary —Mean -immunised
Fig. 3.14.
Mean IL-8 levels in Red Maasai (RD) and Dorper (D)
sheep infected with the Kathiani isolate of C.
Days post-infection




There were no significant differences noted between infections of naive and immunised
sheep and also between day 0 and the other days in mean TNF-a levels (t test,
p>0.05). However, TNF-a levels were found to be increased in some sheep, with the
onset of the febrile reaction coinciding with the highest increases, with the mean TNF-
a levels being more than doubled on day 8 in some of the sheep (Fig 3.15 and
Appendix 1.10).
3.3.6.3.2. Kathiani infections
Increase in mean TNF-a over day 0 levels was recorded in the Red Maasai on day 10
post-infection (Figure 3.16) but the increase was not significant due to wide individual
variations, with the sheep which showed a febrile reaction showing the highest
increase. These levels were not sustained and the mean levels were at the basal level by
day 14. There were no significant changes noted following infection of the Dorper
sheep, with only a slight decrease on day 19-22, during the febrile reaction, followed
by a slight increase on day 30 post-infection (Figure 3.16 and Appendix 1.7).
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Fig. 3.15.
Mean TNF-a in sheep infected with the Welgevonden isolate of C.
ruminantium
Days post-infection
Means (Primary) —•—Means (Immunised)
Fig. 3.16.
Mean TNF-a levels in Red Maasai (RD) and Dorper (D) sheep
infected with the Welgevonden isolate of C. ruminantium
Days post-infection
Mean (RD) —■— Mean (D)
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3.3.7. PCR results in Parasitaemia
Positive results were obtained with DNA extracted from Welgevonden infections early
in the disease (day 4) as compared to the Kathiani infections where the first noticeable
positive result, characterised by a faint band, was on day 10 post-infection in the
Dorpers and 14 in the Red Maasai (Table 3.3, Figure 3.17, 3.18 and 3.19). This work
was, however, not conclusive and served more as a learning process.
3.3.8. RT-PCR for expression of Cytokines
RT PCR performed using RNA from primary Welgevonden infections of sheep showed
increased expression of TNF-a, IL-4 AND IL-10. TNF-a expression was more
prominent on day 7 post-infection as compared to days 4 and 11. Expression of IL-10
was found to be more prominent on days 4 and 11 whereas expression of IL-4 was
more prominent on day 7 (Table 3.4, Figure 3.19 and 3.20). However, non-specific
bands in the gels made it very difficult to the validity of these results and this part of
work, as for the one described in section 3.3.7., served more as a learning procedure.
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Table 3.3.
Data showing PCR results of DNA extracted from plasma of sheep infected with both
the Welgevonden and Kathiani isolates of C. ruminantium. Positive results (P)
showed amplification of a 388 bp product and these results were visualised in agarose
gel. Positive results were noted in the Welgevonden infections from day 4 while in the
Kathiani infections, the first positive results were noted on day 10 in the Dorpers and
day 14 in the Red Maasai.
PCR results
Sheep No Day 0 Day 4 Day 8 Day 10 Day 12 Day 14
66 - + + + + D
67 - + + + + D
68 - + + + + D
69 - - - + - D
70 ND ND ND ND ND ND
71 ND ND ND ND ND ND
72 ND ND ND ND ND ND
73 ND ND ND ND ND ND
74 ND ND ND ND ND ND
75 ND ND ND ND ND ND
1 ND ND ND ND ND ND
2 ND ND ND ND ND ND
3 - - - - - -
4 - - - - - -
5 ND ND ND ND ND ND
6 - - - - - +
12 - - - - + +
15 - - - - - +
17 - - - + - -
18 ND ND ND N ND ND
19 ND ND ND ND ND ND




ND = not done
D = Animal had died
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Fig. 3.17.
Agarose gel of PCR products of DNA extracted from plasma of sheep infected with
the Welgevonden isolate of C. rwninantium and compared with sheep infected with
the Kathiani isolate of C. ruminantium. DNA extracted from known levels of C.
ruminantium elementary bodies (EBs) at different dilutions was used as positive
control and to give an indication of the level of rickettsaemia. The results showed
amplification of a 388bp product in the Welgevonden infections at a much earlier
stage of the disease (day 8) but not in the Kathiani DNA.
A. Upper gel:
Lanes:
1 - KB ladder
2 - 10,000 EBs
3 - 5,000 EBs
4 - 2,500 EBs
5 - 1000 EBs - cut off point
6 - 500 EBs
7 - 100 EBs
8 - 46 EBs




2 - Welgevonden infection Day 0 (sheep No. 66)
3 - Welgevonden infection Day 0 (sheep No. 67)
4 - Welgevonden infection Day 0 (sheep No. 68)
5 - Kathiani (Dorper) infection Day 0 (sheep No. 12)
6 - Kathiani (Dorper) infection Day 0 (sheep No. 15)
7 - Kathiani (Dorper) infection Day 0 (sheep No. 17)
B: Lanes:
1. - KB ladder
2. - Positive control
3 - Welgevonden infection Day 8 (sheep No. 66)
4 - Welgevonden infection Day 8 (sheep No. 67)
5 - Welgevonden infection Day 8 (sheep No. 68)
6 - Kathiani (Dorper) infection Day 8 (sheep No. 12)
7 - Kathiani (Dorper) infection Day 8 (sheep No. 15)




Agarose gel of PCR products of DNA extracted from plasma of sheep infected with
the Welgevonden isolate of C. ruminantium and compared with sheep infected with
the Kathiani isolate of C. ruminantium. DNA extracted from known levels of C.
ruminantium elementary bodies (EBs) at different dilutions was used as positive
control and to give an indication of the level of rickettsaemia. The results showed
amplification of a 388bp product in the Welgevonden DNA on days 12 (A) and 4 (B)
but not in the Kathiani DNA.
A. Upper gel:
Lanes:
1 - KB ladder
2 - 10,000 EBs
3 - 5,000 EBs
4 - 2,500 EBs
5- 1000 EBs
6 - 500 EBs
7-100 EBs - cut off point
8 - 46 EBs




2 - Welgevonden infection Day 12 (sheep No. 66)
3 - Welgevonden infection Day 12 (sheep No. 67)
4 - Kathiani (Dorper) infection Day 12 (sheep No. 12)
5 - Kathiani (Dorper) infection Day 12 (sheep No. 15)
6 - Welgevonden infection Day 0 (sheep N0.66)
7 - Kathiani (Dorper) infection Day 0 (sheep No. 12)
B:
1 - KB ladder
2 - negative control (distilled water)
3 -Welgevonden infection Day 4 (sheep No. 66)
4 - Welgevonden infection Day 4 (sheep No. 67)
5 - Welgevonden infection Day 4 (sheep No 68)
6 - Kathiani (Dorper) infection Day 4 (sheep No. 12)
7 - Kathiani (Dorper) Day 4 (sheep No. 15)
8 - Kathiani (Dorper) Day 4 (sheep No. 17)
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Fig. 3.19 . Agarose gel of PCR products of DNA extracted from plasma of sheep
infected with the Welgevonden isolate of C. ruminantium and compared with sheep
infected with the Kathiani isolate of C. ruminantium. DNA extracted from known
levels of C. ruminantium elementary bodies (EBs) at different dilutions was used as
positive control and to give an indication of the level of rickettsaemia. The results
showed amplification of a 388bp product in the Welgevonden and Kathiani DNA on
days 10 (A), 12 (B) and 14 (C) (Kathiani infections only). There was indication of
higher levels of C. ruminantium DNA in the Welgevonden infections.
A. Lanes:
1 - KB ladder
2 - 10,000 EBs
3 - 5,000 EBs
4 - 2,500 EBs
5 - 1000 EBs
6 - 500 EBs
7 - 100 EBs - cut off point
8 - 46 EBs




2 - Welgevonden infection Day 10 (sheep No. 66 - immunised)
3 - Welgevonden infection Day 10 (sheep No. 67 -primary)
4 - Welgevonden infection Day 10 (sheep No. 68- primary)
5 - Welgevonden infection Day 10 (sheep No. 69- immunised)
6 - Kathiani (Dorper) infection Day 10 (sheep No. 12)
7 - Kathiani (Dorper) infection Day 10 (sheep No. 15)
8 - Kathiani (Dorper) infection Day 10 (sheep No. 17)
9 - Kathiani (Dorper) infection Day 10 (sheep No. 18)
B:
Lane:
1 - KB ladder
2 - negative control (distilled water)
3 - Kathiani (Dorper) infection Day 12 (sheep No. 12)
4 - Kathiani (Dorper) infection Day 12 (sheep No. 15)




2. - Kathiani (Dorper) infection day 14 (sheep No. 12)
3. - Kathiani (Dorper) infection Day 14 (sheep No. 15)
4. - Kathiani (Dorper) infection Day 14 (sheep No. 18)
5. - Kathiani (Dorper) infection Day 14 (sheep No. 3)
6. - Kathiani (Dorper) infection Day 14(sheep No. 6)




RT-PCR results performed using RNA extracted from sheep infected with the
Welgevonden isolate of C. ruminantium. The cDNA was amplified using TNF-a-a
, IL-4 and EL-10 primers. The results were not conclusive due to non-specific signals
and possibly due to degradation of DNA as shown by the smearing of the gel (Fig.
3.20 and 3.21)
Sheep No and Cytokine Day 4 Day 7 Day 11
222 -TNF-a-a + - -
225 -TNF-a-a - + -
222-IL-4 + - +
225-IL-4 + + -
222-IL-10 - - -






RT-PCR using RNA extracted from sheep infected with C. ruminantium on days 4, 7 and
11 post-infection. The cDNA was amplified with TNF-a primers (500 bp). Positive results
were obtained on days 4 and 7 but not on day 11.
Lanes:
1. - Marker
2. - Sheep No. 222 Day 4
3. - Sheep No. 225 Day 4
4. - Sheep No. 222 Day 7
5. - Sheep No. 225 Day 7
6. - Sheep No. 222 Day 11
7. - Sheep No. 225 Day 11




RT-PCR using RNA extracted from sheep infected with C. ruminantium on days 4, 7 and
11 post-infection. The cDNA was amplified with IL-4 (427 bp) and IL-10 (733bp) primers.
Positive results were obtained on days 4 and 7 but not on day 11 post-infection for IL-4 and







2. - Sheep No. 222 Day 4
3. - Sheep No. 225 Day 4
4. - Sheep No. 222 Day 7
5. - Sheep No. 222 Day 11
6. - Sheep No. 225 Day 11




2. - Sheep No. 222 Day 4
3. - Sheep No. 225 Day 4
4. - Sheep No. 222 Day 7
5. - Sheep No. 225 Day 11
6. - Sheep No. 225 Day 11
7. - negative control
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3.4. DISCUSSION
The Welgevonden infections manifested an acute course of the disease
characterised by short incubation periods (6-7 days), high temperature reactions,
pronounced respiratory distress signs and also short course of disease with a mortality
rate of 100%. There were no significant differences between primary infections and
those immunised with the recombinant antigen, in terms of incubation period and
course of disease (Table 3.2), although the infection rates in the brain endothelial cells
were found to be significantly higher in the primary as compared to the immunised
sheep (Kibor, 1997). The Kathiani infections in Dorper and Red Maasai showed a
significantly longer incubation period (p<0.05) with a mean of 16 and 19 days
respectively, and longer course of the disease (>10 days). Only 33% of the Red Maasai
showed a febrile reaction while the remaining 67 % had no overt clinical signs. All
Dorper sheep manifested a mild to acute form of the disease, with the fever as the main
clinical sign. There were no mortalities recorded as a result of infection with the
Kenyan strain, except four sheep which were sacrificed after fever onset. The short
incubation periods and the high mortality rates in the Welgevonden infections may
have been due to a dose effect, since 3xl05 EBs used in the Welgevonden infections
resulted in a 7-8 day incubation period and death by day 12 as compared to the longer
incubation periods and mild form of disease in the Kathiani infections where the
infectious dose in the blood stabilate was not known.
Glutathione peroxidase (GPX) and superoxide dismutase (SOD) act as
antioxidants and are involved in inactivation of reactive oxygen intermediates in the
body (Flaherty and Weisfeldt, 1988). The levels of these enzymes were noted to
increase significantly (p<0.05) after C. ruminantium infection. However, there were
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differences noted in the trends and time at which each enzyme increased, and these
differences could not be explained in this study. SOD was noted to increase early after
infection (about day 2 post-infection) in both groups of sheep infected with the
Welgevonden isolate of C. ruminantium, while the early SOD increase in the Kathiani
infections was noted in the Dorpers but not in the Red Maasai. On the other hand,
GPX levels remained relatively low early in the disease with increases occurring later
(after day 6 post-infection).
One possible explanation for the increase in antioxidising enzymes may be that
infection of animals with C. ruminantium results in activation of phagocytic cells
leading to changes in cell aerobic metabolism. The process of generating ATP from
glucose and oxygen by cytochrome oxidase leads to reduction of 02 to oxidising
radicals (reactive oxygen intermediates (ROI)) including superoxide, hydroxyl ions and
glutathione peroxide which are harmful to the body (Grisham et al., 1992). A positive
feedback machinery may then be stimulated as part of the body defence mechanism
leading to release of the relevant antioxidising enzymes, as seen in this study. The
release of oxidising radicals, has been reported by several authors to be part of the
body defence mechanisms to rid itself of pathogenic organisms and tumour cells, a
situation which may also increase the inflammatory response and therefore the
pathology (Wong et al., 1988a; Yamzuhin et al., 1989; Mathews et al., 1987).
Induction of SOD by TNF-a was reported to be a possible protective mechanism in
the body to rid itself of pathogens and tumour cells (Wong et al., 1988b; Yamzuhin et
al., 1989). Mathews et al. (1987) reported tumour cell killing by TNF-a was inhibited
by anaerobic conditions, free-radical scavengers and inhibitors of arachidonic
metabolism.
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The indirect indication of increase in ROI may also be linked to the high nitrite
levels, indicative of NO, noted in all the C. ruminantium infected animals. Higher
levels of nitrite indicative of NO were recorded in all the sheep after infection with C.
ruminantiwn, with the highest levels coinciding with the febrile reaction. It was also of
utmost interest to note that animals previously exposed to C. ruminantium antigens
(the group immunised with a recombinant antigen and the Red Maasai) showed earlier
production of nitrite levels as compared to that recorded in primary infections with the
maximal levels being attained on day 10 post-infection in the Welgevonden isolate
infections and day 19 post-infection in the Kathiani infected sheep. This may implicate
nitric oxide as being involved in, or released as a result of the immune responses to C.
ruminantium infections and this issue is addressed by the in vitro studies described in
chapter 4.
Mean IFN-y levels were found to be increased after infection in Dorper sheep
and the Red Maasai, with the latter recording IFN-y levels five times higher than the
susceptible sheep, but this increase in the latter was possibly not due to infection as the
levels were high even prior to infection. The increased IFN-y levels were found to
correspond to increased nitrite levels indicating a possible link between the two. Anti¬
microbial effects of IFN-y through induction of NO have been reported by several
workers (Lane et al., 1994; Sequin et al., 1994;. Oswald et al., 1994; Migliorin et al.,
1991); for instance, involvement of IFN—y and CD8+ T cells in the induction of nitric
oxide synthase has been shown to be protective against Plasmodium berghei infections
in mice (Sequin et al., 1994). IFN-y elevation in infection of immunised sheep as
compared to primary infections points to the already documented role of cell-mediated
immunity in C. ruminantium infection in both sheep and mice (Du Plessis et al., 1992;
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Mahan et al., 1996). EFN-^y also activates B cells to increase antibody production and
induces MHC class II molecules. The killing of organisms by IFN-y activated
macrophages, an important defence mechanism in cell-mediated immunity, has been
said to involve both ROI and reactive nitrogen intermediates (RNI) but the extent of
the contributions of ROI and RNI may differ from one pathogen to another and one
host to another (Adams et al., 1991; Barbior et al., 1975; Miyago et al., 1997). IFN-^y
activated macrophages were shown to induce bactericidal activity involving NO and
superoxide anion and this killing was found to be inhibited significantly by the
antioxidants, SOD and catalase (Miyago et al., 1997). This may imply a similar
mechanins is being induced in C. ruminantium infected animals in this study, as part of
the host defence mechanism.
The produced ROI and RNI may also lead to increased pathology due to the
destructive nature of some of their products including peroxynitrite, which is also a
potent bactericidal agent (Miyago et al., 1997). Since one mechanism that cells employ
to kill parasites is the release of toxic molecules and oxygen radicals (James, 1991),
these oxygen radicals released which include the superoxide ion O2, hydrogen
peroxide (H2O2), singlet oxygen (02) and hydroxyl (.OH) radicals can damage cell
membranes, unfold or inactivate proteins, degrade nucleic acids and kill cells and
eventually parasites. It seems fitting, therefore, to speculate that in these studies,
increase in antioxidation enzymes may be resulting in reduction of ROI produced as
part of the body defence mechanism, and therefore leading to reduction in C.
ruminantium killing. TNF-a has been reported to induce production of SOD (Wong
et al., 1988) but, although there was elevation of TNF-a after C. ruminantium
infection, there was no positive correlation between the levels of TNF-a and SOD.
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ROI and RNI play important roles in the immune and pathological mechanisms
of some infections. Increased antioxidants in the sera of sheep infected with C.
ruminantium may be a homeostatic response to counteract increased levels of oxidising
radicals elevated as a response to C. ruminantium infection but this requires further
research.
The sheep immunised with the recombinant antigen suffered an acute disease
with a fatal outcome inspite of showing higher levels in EFN-y, NO and reduced
infection rate in brain endothelial cells. This may be due to the high virulence of the
isolate and may imply that a compromise had to be reached to determine the outcome
of a disease, and may be in this case the attributes of virulence outweighed the
developing immune responses. The results here also have an indication of higher
amounts of C. ruminantium DNA in the Welgevonden infections as compared to
Kathiani infections, as shown by the size of the bands which were compared with
bands obtained using DNA extracted from known amounts on C. ruminantium EBs
propagated in tissue culture (positive controls), but the results were not conclusive.
Sheep infected with C. ruminantium had an elevation of IL-8 and TNF—a
levels during infection. In the Welgevonden infections, levels of IL-8 increased
gradually after infection, with the infection of naive animals recording significantly
higher levels than the immunised animals and with these same animals showing higher
infection rates in brain endothelial cells. There was a transient decrease in IL-8 on day
4 in all the infected animals and this was thought to be related to decreased absolute
numbers of circulating neutrophils but not monocytes, as counted by Kibor (1997).
This is in agreement with other reports in heartwater infections, where a neutropenia
occurs during the incubation period (Abdel Rahim and Shommein, 1977), and where
the only changes observed in monocytes have been increased evidence of activation
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seen as vacuolation of the cells but no changes in the counts (Van Amstel et al., 1987).
The levels of IL-8 in the Red Maasai remained relatively unchanged during the
infection until day 30 when some increase was noted as compared to Dorpers where a
significant increase was recorded between day 19 and day 30 corresponding to the
febrile reaction and also occurring 3-5 days after there was evidence of infection in
these sheep on PCR results.
TNF-a stimulates release of EL-8, among other cytokines. Increase in TNF-a
preceded increase in IL-8 in C. ruminantium infected sheep. TNF-a also stimulates
adhesion of EC, neutrophils, monocytes, eosinophils and basophils by increasing
expression of adhesion molecules and increases microvascular permeability (Mathew et
al., 1987), one of the main pathological findings of C. ruminantium infection. IL-8 is
chemotactic to both neutrophils and lymphocytes and induces tissue infiltration by both
cells (Taub and Oppenheim, 1993) and also promotes generation of ROI radicals and
platelet adhesion factor (Oppenheim et al., 1991). The promotion of ROI production
by IL-8 including increase in superoxide anions, may, therefore, explain the noted
increase in antioxidation enzymes which may be a consequence of this. It is possible
that in combination with the elevated NO levels seen in heartwater, this leads to the
release of damaging peroxynitrite produced by reaction of superoxide and NO.
Endogenously produced reactive oxygen metabolites also directly induce transcription
and translation of IL-8, and therefore a positive feedback between IL-8 and ROI (Taub
and Oppenheim, 1993). Increase in IL-8 later in the infection may be, in part, as a
result of induction by increased levels in ROI, RNI and activation of macrophages.
Increase in GPX and SOD, enzymes which protect against oxidative stress, was seen
especially after fever onset. Increasing levels of enzymes involved in antioxidation may
have a role in counteracting the cytotoxicity of activated macrophages, and therefore,
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these could be mechanisms of cellular resistance to oxidative stress. IL-8 and TNF-a
elevation during heartwater infection would therefore imply an increase in oxidising
agents and the increase in SOD and GPX levels may then be geared towards protecting
cells against oxygen radicals generated by the respiratory burst induced by increased
IL-8. Thus, increased EL-8, antioxidising enzymes, TNF-a and nitrite may all be part
of the immuno-pathological responses elicited by C. ruminantium infection.
Nitric oxide, once referred to as a vital poison inside the immune and
inflammatory network, plays an important role in the initiation and development of
various inflammatory and immune responses (Dugas et al., 1995; Moncada and Higgs,
1995). An excess of NO production regulates micro-environmental molecule and cell
toxicity, the production of pro-inflammatory mediators and induces cell death by
apoptosis (Girard and Poitier, 1993). The factors necessary to induce iNOS expression
differ between cell types, but a maximal inducing effect is generally obtained by the
combination of cytokines and microbial or viral products. Cytokines generated by Th 2
cells reduce production of NO by macrophages while those generated by Th 1 cells
(promoters of cellular host defences) induce NO production (Liew et al., 1991a;
1991b). IL-4, IL-8 and IL-10 have been suggested to suppress iNOS expression either
at transcriptional level or post-transcriptional level (Liew et al., 1991a). This agrees




This study has shown the possible involvement of reactive oxygen radicals,
nitric oxide and cytokines including TNF-a, IL-8 and IFN-y in the immune response
and the pathogenesis of C. ruminantium infection. Considerable evidence from this
study supported the idea that IFN-y and NO are protective to C. ruminantium infection
and may play a major role in cell mediated response in protecting animals against the
disease, as seen in animals with prior exposure to C. ruminantium infection. Increased
IFN-y levels in immunised sheep infected with the Welgevonden isolate, however, did
not alter the fatal outcome of the disease but there was noted reduction in the level of
infection in brain endothelial cells in these sheep pointing to a mechanism which
reduced dissemination of the infection. Higher levels in the nitrite levels in animals with
prior exposure to C. ruminantium antigens was also noted with interest and
investigated in the following chapter. The resistance observed in the Red Maasai could
not be conclusively defined; it could have been due to previous exposure to C.
ruminantium (acquired resistance), although the PCR results on day 0 were negative
for the animal tested in this group making it possible that it may also have been breed-
related and therefore innate resistance. However, the resistance in the Red Maasai
requires further investigation using more numbers of animals and sheep which arc
serologically negative to C. ruminantium antigens at the beginning of the experiment.
Since the cytokine levels were assayed in plasma, they may not reflect the true picture
in their biological activities at specific target cells, but act more as indicators of these
activities at tissue level. Also, the levels of IFN-y were expressed as OD values but not
real values. Use of standards of known units of IFN-y can be incorporated in any
future assays and the OD converted to units to counteract this.
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CHAPTER 4
IN VITRO STUDIES OF COWDRIA RUMINANTIUM
INFECTIONS IN BOVINE ENDOTHELIAL CELLS:
INVOLVEMENT OF NITRIC OXIDE AND INTERFERON
GAMMA IN ANTI-C0WDR/A ACTIVITY
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4.1. Introduction
The mechanisms underlying the pathogenesis and resistance to Cowdria
ruminantiwn infection have not been fully established. The clinical manifestations and
severity of the disease are mainly associated with severe respiratory, cardiac and nervous
embarrassment due to increased capillary permeability leading to oedema (Clark, 1962).
Whilst increased capillary permeability may explain the marked fall in blood and plasma
volume which occur prior to death in heartwater (Clark, 1962. ), the cause of such
alterations remain obscure. The work reported here was designed to investigate the role
of the association between C. ruminantium and endothelial cells in the pathogenesis of
heartwater and the development of host resistance to this infection.
The approach was prompted by reports that nitric oxide (NO), a powerful
vasodilator generated by the endothelium, is intimately related to mechanisms of oedema
formation and hyperaemia (Moncada et al., 1988; Moncada et al., 1990; Furchgott and
Zawadski, 1980). The multi-functional roles of NO have been been reported by several
authors. These include the anti-microbial effects through killing of microorganisms
(Adams et al 1990; 1991) and also the cytotoxic effects to host cells which contribute to
disease pathology (Radi et al., 1991). Cytokines including interferons have been reported
to play an important role in resistance to intracellular organisms including C.
ruminantium (Totte et al., 1993 and 1994; Mahan et al., 1996), Rickettsia conorii
(Walker et al., 1997), Plasmodium berghei (Sequin et al., 1994), Theileria annulata
(Visser et al., 1995) and Mycobacterium bovis (Molloy et al, 1994) possibly by NO
production.
This study was, therefore, designed to; monitor NO production in cultures of
bovine pulmonary endothelial cells (BPEC) infected with C. ruminantium; assess the
121
effect of interferon gamma (IFN-y) on NO production by BPEC, its effect on C.
ruminantiurn and the endothelial cell; assess the effect of an exogenous source of NO 011
the viability and infectivity of C. ruminantium elementary bodies (EBs) to BPEC in vitro.
Investigation of the effect of the inducible nitric oxide synthase inhibitor, L-NMMA was
also carried out.
4.2. Materials and Methods
4.2.1. Nitric oxide production by infected endothelial cells; effect of NO
on C. ruminantium infection.
A bovine pulmonary endothelial cell line (BPEC) and the Gardel isolate of Cowdria
ruminantium were obtained and cultured as described previously (see sections 2.1.1. and
2.1.2.). The cells were grown on glass coverslips of about 13 mm in diameter in 4 x 24
well culture plates and infected at confluence with C. ruminantium elementary bodies
(EBs) as described in section 2.1.4. Assessment of NO production from resting
endothelial cells and infected endothelial cells; infected endothelial cells with different
concentrations of BorlFN-y (0, 25, 50, 75 and 100 U/ml) or the NO synthase inhibitor
L-NMMA at 1 mM with or without BorlFN-y as additives, was carried out using the
Griess assay method described in section 2.2.1. and 2.2.2. The effects of BorlFN-y on C.
ruminantium viability was assessed using fluorescein diacetate staining method as
described in sections 2.1.5, while the effect of BorlFN-y on the endothelial cell viability
was assessed using Diff quik and acridine orange staining methods, as described in
section 2.1.6.1. The effects of different concentrations (0, 25 50 and lOOfiM) of an
exogenous source of the NO donor molecule, SNAP, on infectivity and viability of C.
ruminantium was assessed when C. ruminantium elementary bodies (EBs) were pre-
treated with SNAP prior to infection of endothelial cells or incubated with infected cell
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cultures as described in section 2.2.4. The time course effects of SNAP on C.
ruminantium EBs was carried out by incubating different concentrations of SNAP with
EBs in growth medium at 37°C and viability assessed after 4, 6, 24, 48, 72 and 96 hours
post-treatment using the fluorescein diacetate staining method. Twelve replicates were
done for each treatment.
4.2.2.Data analysis.
The student t-test, Mann Whitney, chi-square and Correlation Coefficient tests
were used for statistical data analysis as appropriate and depending on distribution of
the data, at 95% confidence intervals.
4.3. Results
4.3.1. Nitric oxide production by C. ruminantium infected BPEC.
NO levels measured at 24 h intervals revealed a gradual cumulative increase in BPEC
infected with C. ruminantium and incubated in medium alone (Figure 4.1 and Appendix
2.1). The highest levels were noted at day 7 post infection. The highest NO
concentration coincided with the period when the degree of infection was highest as
observed in cytospin preparations. Treatment of C. ruminantium infected cultures with
BorlFN-y resulted in increased NO production with attainment of peak levels being
recorded at 2 days post treatment (Figure 4.1). In the cultures supplemented with the L
arginine analogue L-NMMA, significant inhibition (P < 0.05) of NO production was
recorded in the absence or presence of BorfFN-y (Figure 4.1 and Appendix 2.1).
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Fig. 4.1.
Nitrite Levels in C. ruminantium- infected bovine
pulmonary endothelial cell cultures treated with
BorlFN-y and /or with L-NMMA, and infected (IC)
and uninfected UC) controls
4.3.2. Effect of BorlFN-yon C. ruminantium viability.
The proportion of viable EBs of C. ruminantium in cultures treated with different
concentrations of BorlFN-y was analysed at the end of the experiment. The percentage
of viable EBs was significantly lower (P < 0.05) in the presence of 100, 75, 50 and 25
U/ml of BorEFN-y than in the unexposed cultures. The reduced viability was dose
dependent with a much lower viability being recorded in the higher concentrations of
BorlFN-y (Figure 4.2a and Appendix 2.2).
4.3.3. Effect of BOrlFN-y on endothelial cell viability.
It was noted that BorlFN-y caused pronounced changes in the endothelial cells with the
effect being more evident in cells infected with C. ruminantium. Significant cellular
changes were visually noted within 48 h after exposure to BorlFN-y (P < 0.05)(Figure
4.2b and Appendix 2.3). These cytopathic changes increased in a dose - dependent
fashion. The cells were observed to be rounding up and detaching from the culture plate
when the cell monolayer was examined under dark-field microscopy. Apoptotic cell
death was morphologically identified in Diff QuikR and acridine orange stained cells
(Figures 4.3a and 4.3c) as compared to infected cells without stimulation (control)
(Figure 4.3b). The cells revealed nuclear fragmentation, chromatin condensation,
indiscernible nuclear organelles, blebbing of the nuclear membrane and presence of dark-
staining membrane-bound bodies. There was more evidence of apoptotic cell death in the
BorlFN-y exposed infected cultures (75%) than uninfected treated cultures (50%),
where as in the absence of BorEFN-y, there was an increase of only 5% in the percentage
of non-viable cells in infected (12%) as compared to non-infected (7%).
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Fig. 4.2a
Viability of C. ruminantium EBs in relation to nitrite
(NO) levels in bovine endothelial cell cultures treated
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Fig. 4.2b
Cell death of bovine endothelial cells infected or not
infected with C. ruminantium and treated with
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4.3.4. Effect of pre-treatment of C. ruminantium EBs with SNAP-
generated NO on infectivity.
Significant differences (p<0.05) were noted in the number of C. ruminantium colonies
and the infection rate of endothelial cells at days 2 and 4 post-infection in cultures
infected with SNAP pre-treated EBs as compared to cultures infected with non-treated
EBs (Figure 4.4a and Figure 4.4b and Appendix 2.4). The number of fluorescing
colonies in cultures which had been infected with SNAP pre-treated EBs was reduced as
compared to the non-treated controls. This reduction was in a dose dependent manner
with lower numbers of fluorescing colonies being recorded in cultures treated with
higher concentrations of SNAP (Figure 4.4a). Higher numbers of colonies were recorded
on day 4 as compared to day 2 post-infection indicating little or no effect of pre-
treatment of EBs on the subsequent multiplication rate of the viable organisms in the
cells (Figure 4.4a). The ratio of the number of fluoresceing colonies on day 4 to day 2
had a range of 2-3.4 in all treatments indicating almost similar rates of multiplication had
occurred after cell entry (Figure 4.4a). The rate of infection, defined as the percentage of
infected endothelial cells, was found to be closely related to the number of fluoresceing
colonies, with a higher proportion of infected cells being recorded in cultures infected
with EBs not treated with SNAP-generated NO and also on day 4 as compared to day 2
post-infection (Figure 4.4b). The organisms were noticeable by day 2 as small blue-
staining closely packed morulae in giemsa stained cells and the morulae were noted to be
increased in size and number by day 4 as compared to day 2.
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Fig. 4.4a
The mean number of fluoresceing foci in endothelial cells,
reflective of infectivity of C. ruminantium organisms pre-treated
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Fig. 4.4b
Rate of infection (%) of endothelial cells assessed on day 2 and 4
post-infection with C. ruminantium elementary bodies pre-
treated with different concentrations of SNAP
□ Day 2 ODay 4
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4.3.5. Effect of co-culturing SNAP with C. ruminantium-infected cells on
the rickettsial viability and growth.
Viability of EBs was assessed in supernatants overlying the cell monolayer on days 1, 2,
4 and 7 post-infection in all the cultures. In the cultures incubated in the presence of
SNAP, significantly reduced viability counts of C. ruminantium EBs were recorded as
compared to untreated control cultures (Table 4.1 and Appendix 2.4). The viability was
dose-related with the highest viability counts being recorded in the control cultures
without SNAP as compared to the lowest counts recorded in cultures treated with 100
|iM SNAP with similar trends being recorded for all the days assessed (Table 4.1).
Viability was also assessed in EBs incubated with medium containing different
concentrations of SNAP alone the time required for 50% reduction in viability. Time
required for 50% reduction in viability of EBs was about 10.5 h in 100 (im SNAP, 24 h
in 50 pM of SNAP and 60 hours in 25 pM SNAP.
Cytospin smears prepared on day 7 post-infection showed the number of C. ruminantium
colonies per field was negatively correlated to the level of SNAP (r = -0.96) but was
more or less a reflection of the viability counts with a very high correlation coefficient
(r=0.97). (Figure 4.5a). The concentration of NO in the culture medium did not decline
during the experiment, but rather showed an increase during the period of infection
(Figure 4.5b). Although the SNAP - containing cultures had higher cumulative final
nitrite levels as a result of the NO released by this molecule, the rate of increase of nitrite
during the period of infection was found to be higher in heavily infected cultures i.e.
those which had been incubated without or with low levels of SNAP, as compared to
lightly infected ones. (Figure 4.5a).
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Table 4.1. Effect of co-culturing SNAP with C. ruminantium-infected cells on the
rickettsial viability. Mean viability counts of C. ruminantium EBs was assessed on
days 1, 2, 4 and 7 post-infection in cultures incubated with different concentrations of
SNAP and expressed as percentages +/- standard deviation (SD). Viability was found
to be inversely related to the concentration of SNAP and consequently, nitric oxide
levels (r=-0.96) but highly correlated with the number of colonies per cover slip
(r=0.97) on day 7 post-infection.
SNAP Viability(%) SD +/- Viability(%) SD +/- Viability(%) SD +/- Viability(%) SD (+/-)
Cone. (uM) Day 1 Day 2 Day 4 Day 7
0 90 8 82 4 75 4.5 82.5 14
25 79 3 68 5 52 4 57.9 7
50 56 7 45 3 28 2.5 25.5 4.2
100 38 5 37 4 20 3 5.4 1
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Fig.4. 5a
Mean number of C. ruminantium colonies 7 days post¬
infection, reflective of the infectious yield, in bovine endothelial
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Fig. 4.5b
Nitrite (NO) levels on days 0, 2, 5 and 7 in C. ruminantium -
infected endothelial cell cultures incubated with different
concentrations of SNAP
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4.3.6. Time course effect of co-culturing SNAP with C. ruminantium EBs
in medium on the rickettsial viability
A reduction in C. ruminantium viability was recorded in the EBs incubated with SNAP
as compared to the control (Figure 4.6). This reduction was in a dose and time-
dependent fashion. A significant reduction in viability (P<0.05) was recorded as early as
4 hours post-infection in EBs treated with 100 |iM SNAP concentration, where the NO
level was also highest (>35 fiM) as compared to those treated with 50 and 25 pM
SNAP, where the NO levels were less than 15 and 10 pM respectively (Figure 4.5b and
4.6, and Appendix 2.4).
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Fig. 4.6
Reduction of viability, over a period of 96 hours, of C.
ruminantium elementary bodies (EBs) incubated with
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4.4. Discussion
Previous observations have indicated strongly that the interferon system, and
probably other cytokines as well, plays a key role in natural resistance to C. ruminantium
infections (Totte et al., 1993 and Mahan et al., 1996). This study looked for the
production of NO by cultures of resting or BorlFN-y activated BPEC infected with C.
ruminantium as well as the effect of the cytokine on the viability of C. ruminantium and
BPEC in vitro. The effect of SNAP as an exogenous source of NO on the viability and
infectivity of C. ruminantium to BPEC was also examined.
The results of this study demonstrated that infection of resting BPEC with C.
ruminantium resulted in induction of NO production as compared to uninfected cells.
Addition of BorlFN-y to these cultures resulted in enhancement of the NO production in
a dose dependent fashion. Suppression of NO production in both resting and BorlFN-y -
stimulated BPEC by the L-arginine analogue L-NMMA, implied involvement of the
inducible nitric oxide synthase (iNOS) pathway in these responses, as reported for other
bovine systems (Adler et al., 1995; Visser et al., 1995). Both viability and infectivity of
C. ruminantium EBs were markedly reduced in a dose dependent fashion when
incubated with the NO donor molecule, SNAP, prior to infection of endothelial cells.
The study also demonstrated induction of apoptotic cell death of infected cells seen as
alterations in the morphology and viability of the BorlFN-y treated endothelial cells as a
significant finding in this study. The decreased viability of the infectious agent may have
been associated with the apoptosis of endothelial cells in BorlFN-y treated cultures, or
resulted from other effects including increased NO production. However, the maximal
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NO levels induced in 100 U/ml BorlFN-y exposed cultures was 10 |im (Figure 4.2a)
which was much lower than that recorded in 100 |lM SNAP in culture medium (35 pM)
(Figure 4.4b), yet the rickettsial viability was lower in the BorlFN-y-treated than in the
SNAP-treated cultures.(Figure 4.2a and 4.4a). The inhibition of Cowdria growth by
IFN-y in concanavalin A stimulated T cell supernatants has been reported (Mahan et al.,
1996) without detectable increases in nitric oxide production. However the activity of
IFN-y was detected by neutralisation and may have been lower than that used in this
study. Our findings were consistent with the up-regulation of NO generation with bovine
IFN-y reported for bovine macrophages (Visser et al., 1995; Jungi et al., 1997). TNFa
has also been reported to induce NO synthesis in bovine endothelial cells (Umansky et
al., 1997) in contrast to bovine macrophages (Visser et al., 1995; Jungi et al., 1997). NO
synthesis in bovine macrophages is suppressed by IL-4 but unchanged by IL-10 or TGFfJ
(Jungi et al., 1997) whereas the latter is reported to increase NO production in bovine
aortic endothelial cells (Inoue et al., 1995). Regulation of NO synthesis would therefore
appear to differ between bovine endothelial cells and macrophages, but the upregulation
by a Thl cytokine (IFNy) in both cell types is of interest. Apoptosis in infected cell
cultures occurred at a higher rate than in uninfected cells in response to BorlFNy. It is
possible this was associated with NO synthesis, since apoptosis in tumor cells by bovine
endothelium derived NO has been reported (Umansky et al., 1997) However cytotoxicity
of IFNy to cells has been reported to occur on exposure to the cytokine alone or in
combination with a second signal, including intracellular infectious agents (Hanson,
1991; Walker et al., 1997).
138
IFN-y has been reported to have the capacity to directly lyse rickettsial agents or
infected cells (Hanson, 1991). We are suggesting here that the killing of C. ruminantium
in the BorlFN-y treated cultures was also associated with the cell apoptotic event.
Similar findings were reported by Molloy et al., (1994) on viability of intracellular
Mycobacteria bovis in monocytes in vitro. They reported that toxic mediators that
killed the monocytes by necrosis had no effect on the viability of the organism while
those that killed the cells by apoptosis reduced viability of the organism by 60-70%. It
has been suggested that since apoptosis is accompanied by nuclear fragmentation of the
cells, the integrity of the genetic material of the intracellular organism may be
compromised leading to its killing (Molloy et al., 1994).
The reduced infectivity of C. ruminantium in cultures maintained in medium
containing SNAP was attributed mainly to the effects of NO upon the organism prior to
infection, since the incubation of EB's with SNAP prior to infection reduced the
infectivity in a dose dependant manner, but there was no apparent additional reduction of
growth by maintenance of the cultures in SNAP. After first appearance of infected
endothelial cells on day 2, there was similar increase of infection from day 2 to day 4
(Figure 3a) in treated and untreated cultures. The ratio of the organism per field in the
control and the cultures incubated with SNAP (Figure 4a) was not significantly different
from the ratio obtained when EBs were treated with the same levels of SNAP prior to
infection (Figure 3a). Since the EBs were allowed to infect cell cultures in the presence
of SNAP, the dose-dependent reduction in SNAP-maintained cultures can be attributed
to the inactivation during infection of the cultures with no significant increase in effect of
the SNAP during the 7 day period of experiment. Release of fresh EBs into culture
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media, from day 6, is expected from the approximately 6 day cycle of C. ruminantium
infection in vitro, and may explain the increased viability of EBs on day 7 (Fig 4a).
Thus, SNAP treatment reduced initial infection rates in the cells (Figure 3a), but the level
of infection increased in much the same rate irrespective of initial SNAP concentration in
culture medium. Taken together, these findings indicated that the induction of iNOS by
IFN-y may contribute to the anti-Cowdria activity manifested in interferon treated
cultures of C. ruminantium - infected BPEC. The NO level induced by infection of
BPEC without any treatment was approximately 10 |lM on day 7, with similar levels
being recorded in 100 U/ml IFN-y-treated cultures after 48 hours. This level of NO is
intermediate between the 5 pM and 13 pM NO concentration, produced by 25 and 50
pM SNAP concentrations respectively. Since the latter two treatments significantly
reduced infection level, it can be concluded that the level of NO released in culture by
infection alone or by EFN-y induction may have an effect on the infectivity of EBs being
released and thereby indicate a role of NO in the protective responses to heartwater
infection. This study reports for the first time that NO is capable of reducing both
viability and infectivity of C. ruminantium in BPEC in vitro, indicating that NO released
by endothelial cells or by other cells such as monocytes may have a role in reducing the
infectivity of extracellular EBs and thereby reducing spread of infection. If release of NO
during endothelial cell infection occurs in vivo, this can be expected to reduce viability of
the agent for other endothelial cells and potentially for the arthropod vector. The anti-
Cowdria effect of BorlFN-y may involve NO as well as other pathways involving
additional factors as the NO generated by cell exposed to interferon was not as high as
that generated by 100 pM of SNAP yet the reduction in viability was higher in the
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cultures treated by the former. The study shows that C. ruminantium organisms are
killed by events involving activities on IFN-y and NO in vitro. The findings reported here
are comparable with findings of a study carried out on IFN-y and TNF-a stimulated
mouse endothelial cells where it was demonstrated that endothelial cells were capable of
killing Rickettsia conorii through a mechanism involving NO synthesis (Walker et al.,
1997).
Several biological roles of NO have been described by different authors. NO
dependent non specific immunity is now accepted both as a general phenomenon
involving the reticulo-endothelial systems (Moncada et al., 1993) and as a primary
defence mechanism against tumour cells (Woodman, et al., 1991) and several microbial
pathogens and a potent agent in non-specific defence mechanisms by upregulating release
of inflammatory mediators (Liew et al., 1991a; 1991b). NO production by macrophages
and monocytes during response to infection has been correlated with resistance to a wide
variety of pathogens in vivo including Mycobacterium bovis (Walker et al., 1997),
Listeria monocytogenes (Boockver et al., 1994), Schistosoma mansoni (Oswald et al.,
1994) Theileria parva (Visser et al., 1995), Plasmodium berghei (Sequin et al., 1994)
and Histoplasma capsulatum (Lane et al., 1994). In contrast, NO mediation of
immunosupression has been suggested in cattle infected with the rickettsia Anaplasma
marginale where treatment with an NO inhibitor, aminoguanidine (AG), resulted in
lower parasitic levels (Gale et al., 1997). This was thought to be due to
immunosuppressive effects of NO, as its neutralisation was beneficial to the host, and the
inhibition of NOS by AG was postulated to increase immune effectiveness. The inhibition
of peripheral T-cell proliferation by NO in mice has also been reported (Bras et al.,
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1997). C. ruminantium resides in endothelial cells, an association which leads to
increased vascular permeability. The underlying cause of this permeability remains
obscure but mediators rather than structural changes have been more implicated in the
pathogenesis of the disease. Excessive NO production by endothelial cells in vivo which
are in continuous contact with the blood stream may therefore not only constitute an
important role in phenomena such as changes in vascular wall integrity leading to
increased vascular permeability. Under other circumstances, NO produced by activated
endothelial cells has been found to act as a toxic effector molecule inhibiting various
metabolic functions in cells leading to death of the Schistomula of Schistosoma mansoni
as well as to altered physiology of endothelial cells and increased vascular permeability
(Oswald et al., 1994). NO has also been shown to precipitate the loss of intracellular iron
resulting in inhibition of certain of the vital enzymes involved in mitochondrial respiration
(Busse et al., 1995). This finding suggests that NO may contribute to the mitochondrial
changes observed in the alveolar endothelial cells infected with C. ruminantium
(Prozesky and Du Plessis, 1985a; 1985b).
Conlusion
This study has shown that endogenously produced NO or NO from exogenous
source kills C. ruminantium in a dose - dependent fashion. Although lack of knowledge
limits discussion of the potential role of NO in C. ruminantium pathogenesis and
immunity, these findings point to a role for NO in resistance to C. ruminantium
infections and in the pathology of the disease. Toxic mediators have been suggested to
be responsible for some unexplained pathology of the disease including increased
vascular permeability leading to oedema and also vascular collapse seen in terminal cases
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of the disease, consistent with effects of NO production upon the vascular system. In a
recent study (unpublished data) we noted that infection of previously exposed African
breeds of sheep resulted in higher levels of nitrite in plasma during the clinical response.
The induction of NO synthesis by IFN-y may be an important determinant of the
outcome of C. rwninantium infection. This is supported by the following sequence of
events; rickettsaemia occurs 3-6 days prior to the onset of fever and pathology, but
terminal collapse, reduced blood pressure and peak pulmonary oedema occur only a few
days after the first immune responses are detectable and when rickettsaemia has declined
but endothelial cell infection is highest (unpublished data). On the basis of our results and
those cited previously, it is becoming clear that NO maybe an important component in
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The principle target cell of C. ruminantium is the vascular endothelium but the
organism is also found to infect other cells including neutrophils and macrophages. The
sequence of events in the response of cells or tissues to C. ruminantium infection from the
initial stimulus by the aetiological agent to the ultimate expression of the disease are poorly
understood. Increased vascular permeability leading to the escape of a protein rich exudate
into the interstitium is the hallmark of acute inflammation in heartwater disease (Clark, 1962).
It has been shown that C. ruminantium causes little damage to parasitised cells (Cowdry
1926, Prozesky and Duplessis 1985b and 1985c). Ultrastructural studies in lungs of sheep,
goats and mice infected with the organism have also revealed that the damage to capillary
endothelial cells of the alveoli was mild and could not account for the increased vascular
permeability, the main pathological finding of the disease (Prozesky and Duplessis 1985b and
1985c). The extent to which pathogenesis is a function of the pathogen, C. ruminantium, and
the extent to which it is a consequence of the immune responses of the host, is unclear.
Cell-mediated immune responses have been reported as playing key roles in the
protective mechanisms against C. ruminantium infection, a phenomenon involving T cells and
production of inhibitory cytokines (Du Plessis, 1970, 1982; Du Plessis et al., 1991; Mahan et
al., 1994). IFN-y has been demonstrated to have an inhibitory influence on C. ruminantium
growth in vitro (Totte et al., 1993; Mutunga et al., 1998; Mahan et al., 1996). It was also
demonstrated that animals that recovered from C. ruminantium infection contained higher
blood levels of IFN-a compared to those that succumbed to infection and that the inhibitory
influence of EFN-a was demonstrated on Cowdria growth in in vitro studies when added to
infected endothelial cultures (Totte et al., 1994).
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This study was designed to examine the extent to which IFN-y, IFN-a and P
contribute to the immune responses and the pathogenesis of C. ruminantium disease by using
mice deficient in IFN-y or IFN-oc/p receptors.
5.2. Materials and Methods
5.2.1. Experimental animals
Three groups of specially bred strains of mice, IFN-y receptor knockout mice (IFN-yRo/o)
(G 129), IFN-ot/p receptor knockout mice (EFN-a/pRo/o) (A 129) and wild type control
strain of the same genetic background (WT 129) were used in this study. The IFN-yRo/o and
IFN-a/pRo/o mice were homozygous for the lack of genes encoding receptors for IFN-y or
IFN-a/P respectively (see section 2.3.1.2.). The groups used were as follows:
1 15 IFN-y receptor knock out mice (G 129) in which deletion of the a-chain of IFN type II
(y) receptor had occurred (Huang et al., 1993 );
2 15 IFN-a/P receptor knock out mice (A 129) in which deletion of IFN type I (a and P)
receptor signalling sub unit had occurred (Muller et. al., 1994)
3 15 wild type control strain of the same genetic background (WT 129)
(For individual mice numbers see appendices 3.1). The source and management of these mice
before and after infection were as described in sections 2.3.1.2 and 2.3.2. Fifteen mice were
used for each group.
5.2.2. Infectious agent
The Welgevonden isolate of C. ruminantium, propagated in bovine endothelial cells in tissue
culture, as described in section 2.1.4., was used to infect the mice. Each animal was infected
with 1 xlO3 elementary bodies (EBs) diluted in culture medium after determining viability
count by staining the EBs with fluorescein diacetate as described in section 2.1.5. The EBs in
culture medium were chilled on ice until all the mice had been infected.
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5.2.3. Clinical disease monitoring
The disease was monitored daily by visual examination of the mice as well as recording rectal
temperatures as described in section 2.3.2. The mean incubation period in days, based on
onset of hypothermia, was determined in the 15 infected mice in each group, while the course
of the disease, mortality and morbidity rates were determined in 13 mice (as 2 mice were
sacrificed after onset of hypothermia as outlined in the next section). The results were then
analysed and compared between groups.
5.2.4. Pathological investigations
Two hypothermic (infected) mice and 1 uninfected mouse were sacrificed on day 7 from each
group and lung and brain tissues collected for histopathology and transmission electron
microscopy. Brain impression smears were also prepared from these sacrificed mice and
stained in giemsa. Pathological investigations, both macroscopically and microscopically, were
carried out for the sacrificed mice and the dead mice and any significant changes noted. These
included measuring the amount of thoracic oedema fluid using a 2 ml syringe (see section
2.3.3) and the results analysed and compared between the groups. Lung and brain sections
were prepared from the sacrificed mice for histopathology and electron microscopy as
described in sections 2.3.3.1 and 2.3.3.2 and examined. The histopathological investigation
carried out included assessment of inflammatory cell infiltration in the tissues, the distribution
and extent of oedema and presence of the rickettsial infectious organisms in the tissues.
Assessment of rickettsial burden in lung and brain sections was estimated by counting
infectious foci in giemsa stained histopathological sections, viewed under a light microscope
using an eyepiece with grids (at a magnification of xlOOO), as described in section 2.3.3.1.
Twenty fields per slide were randomly selected and examined for the presence of the
rickettsial organisms and the results expressed as mean +/- standard deviation. The results




Students T-test or Mann-Whitney tests and chi-square were used for data analysis and the
results expressed at 0.05 level of significance
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5.3. Results.
5.3.1. Incubation period, morbidity and mortality rates of infected mice.
The incubation period was taken to be the time from infection to the onset of hypothermia, a
characteristic development in mice infected with C. rwninantium (Prozesky and Du Plessis,
1985b). The first clinical manifestations of disease included depression, lack of appetite,
prostration and closed eyes and these coincided with the onset of hypothermia. Once
hypothermia occurred, the mice died within 1-3 days with the mean course of the disease
being 1.85 days for both the IFN-yRo/o and IFN-a/pRo/o groups and 2.15 for the control
group (Figure 5.1). Significant differences (t-test, p=0.045) were shown between the
incubation period of IFN-yRo/o mice and the wild type (controls) group but not between
LFN-oc/pRo/o and IFN-yRo/o (Table 5.1). Significant differences were also seen in the
cumulative mortality rates in the IFN receptor deficient mice as compared to the control, with
the IFN-^yRo/o mice (x 2 =6.89, p<0.05 for day 8,) and to a lesser extent IFN-a/pRo/o
mice (x 2 =5.99, p<0.05 for day 8), p<0.05) showing higher mortality rates earlier in the
disease as compared to the control (Table 5.1, Figure 5.1 and Appendix 3.2).
5.3.2. Pathology
5.3.2.1. Gross pathology
All the sacrificed and dead mice had extensive thoracic oedema, characterised by straw-
coloured fluid in the thoracic cavity. The lung and brain tissues were slightly congested in
some cases. Lung oedema was found to be more extensive in the IFN-yRo/o mice than in the
IFN-ot/pRo/o and the control mice, with the IFN-yRo/o mice showing a mean of 1.4 ml of
lung oedema fluid as compared to 1.1 in the IFN-oc/(3Ro/o group and 1.0 ml in the control
group, although the differences were not significant (t-test, p=0.34) (Table 5.1).
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Table 5.1
Clinical and pathological observations in interferon gamma and alpha/beta receptor deficient
mice (IFN-yRo/o and IFN-a/pRo/o respectively) and the control mice (WT) infected with C.
ruminantium.
IFN-yRo/o IFN-a/pRo/o WT
Mean infectious dose (ml) (n=15) 0.1 0.1 0.1
Mean incubation Per.(days) (n=15) 6.1+/-0.3 6.5+/-0.5 7.4+/-0.5
Mean course (days) (n=13) 1.85+/-0.4 1.85+/-0.9 2.5+/-0.9
Morbidity rate at day 7(%) (n=13) 87.5 87.5 37.5
Thoracic oedema fluid (ml) (n=13) 1.4 1.1 1.0
Mean No. of organisms (BS) (n=2) 15+/-3 9+/-4 2+/-3
Mean No. of organisms (LS) (n=2) 91 +/- 33 38+/-12 11+/-6
KEY: TO LEGEND:
1. Mean Incubation per. - Incubation period
2. Mean No. Of organisms (BS) - Mean number of organisms in giemsa stained brain
impression smears counted in twenty fields randomly selected at a magnification of X1000.
3. Mean No. Of organisms (LS) - Mean number of organisms in giemsa stained lung
histopathological sections, counted in twenty fields randomly selected at a magnification of
X1000.
4. n=The number of mice used in calculating each factor.
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Fig. 5.1.
Daily number of surviving mice, depicting cumulative mortalitites,
in C. ruminantium -infected mice deficient in IFN-y or IFN-a/p
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5.3.2.3. Histopathological findings
Fixed histological sections stained in giemsa and haematoxylin and eosin were examined.
The infectious agent was seen in giemsa-stained histopathological lung tissue sections (Figure
5.2) brain impression smears (Figure 5.3 and 5.4) and in cytospin smears of peritoneal lavage
fluid (Figure 5.5). Assessment of rickettsial burden in lung and brain sections revealed
presence of higher numbers of colonies in the IFN-yRo/o and to a lesser extent IFN—oc/pRo/o
mice. These colonies were seen singly or in clusters in the cytoplasm of endothelial cells and
in phagocytic cells (macrophages) and also extracellularly. Infection rates in the lung and brain
tissues of IFN-yRo/o and IFN-a/pRo/o mice were significantly higher than that of the
control, and the infection level in the IFN—yRo/o was significantly higher than that in IFN-
a/p (x 2 =6.75, p<0.05) (Table 5.1). The mean number of colonies per field in the lung tissue
of IFN-yRo/o was 3 fold as compared to that in the IFN-a/pRo/o and 9 fold as compared
to the control group. In the brain smears, the mean number of colonies per field in the IFN-
yRo/o was double that seen in the IFN-a/pRo/o and 8 times higher than that seen in the
control group (Table 5.1). The ratio of infection in brain and lung was approximately similar
between the groups of mice (9:3:1 in lung sections and 8:4:1 in brain sections for IFN-yRo/o,
IFN-ot/pRo/o and control groups respectively. Cytospin smears made from peritoneal fluid of
the IFN-yRo/o mice revealed massive numbers of C. ruminantiwn colonies seemingly in
macrophages, as well as infiltration by macrophages (Fig 5.5). In the IFN-yRo/o there was
interstitial pneumonia characterised by extensive infiltration of the lung parenchyma by a
mixed population of phagocytic cells with mononuclear cells being more prevalent than
neutrophils (Figure 5.6) resulting in thicker alveolar walls as compared to the control group
(Figure 5.7 and 5.8.). Pink-staining mass denoting oedema was seen to be more extensive in
the IFN-^yRo/o group as compared to the control (Figure 5.6., 5.7 and 5.8).
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Figure 5.2. Giemsa-stained lung histopathologic^ section of IFN-y Ro/o mouse showing a
colony of C. ruminantium organisms (arrow) (X3000)
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Figure 5.3. Giemsa-stained brain impression smear of an infected IFN-yRo/o mouse showing
C. ruminantium organisms in the cytoplasm of an endothelial cell of a blood capillary
(X3000).
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Figure 5.4. Giemsa-stained brain impression smear of an infected IFN-oc/pRo/o mouse
showing C. ruminantium organisms in the cytoplasm of an endothelial cell of a brain blood
capillary (X 1500).
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Figure 5.5. Giemsa-stained cytospin smear of peritoneal fluid harvested from IFN-y Ro/o
mice sacrificed on day 7 showing extensive numbers of C. ruminantium elementary bodies
(arrows) and infiltration by phagocytic cells, predominantly mononuclear cells (X3000).
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Figure 5.6. Giemsa -stained lung histopathological section of EFN-y Ro/o mouse. Note the
presence of oedema (pink-staining mass) (curved arrow), infection (triangle arrow head) and
infiltration by predominantly mononuclear cells (X3000).
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Figure 5.7. Hematoxylin and eosin stained lung histopathological section of IFN-y Ro/o
mouse showing thickened alveolar wall (triangle arrow head) with extensive inflammatory cell
infiltration and oedema fluid (arrow) (X300).
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Figure 5.8. Hematoxylin and eosin stained lung histopathological section of control mouse
showing less thickened alveolar wall (arrow head) as compared to Figure 5.7. (X300)
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Similar histopathological changes were observed in the IFN-a/pRo/o as in EFN-y Ro/o group,
but to a lesser extent. The amount of oedema and interstitial pneumonia (infiltration by
inflammatory cells) were lower than in the IFN-yRo/o group and there was marked infectious
foci in the lung sections and brain impression smears as compared to the control (Figure 5.9).
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Figure 5.9. Giemsa -stained lung histopathological section of IFN-a/p Ro/o mouse. Note the
presence of oedema(arrow), infection (arrow head) and phagocytic cell infiltration (X3000).
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5.3.2.4. Electron microscopical studies
Ultrastructural studies of lung sections showed infected endothelial cells and macrophages in
mice in each group. The main differences noted in the IFN-yRo/o mice and the control group
were the forms of the organisms seen. Bizarre looking forms were seen macrophages in the
IFN-7R0/0 mice (Figures 5.10, 5.11 and 5.12) and also in endothelial cells (Figure 5.11 and
5.12). These forms were in encapsulated vacuoles and were highly pleomorphic with
different shapes ranging from rods, rings, oval, horse-shoe shapes. The organisms were
observed to be electron-dense, surrounded by a double membrane and separated by a protein-
rich matrix. In the control mice, reticulate forms of the infective agent were seen in lung
sections in endothelial cells, and there was evidence of cells dividing by binary fission (Figure
5.13). Haemorrhages and oedema fluid were observed in the lung parenchyma of infected
mice (Figure 5.14). Higher numbers of mitochondria in the brain section of IFN-yRo/o mice
were seen as compared to the control (Figure 5.15). Lung sections of the IFN-a/pRo/o
showed presence of the electron-dense forms of C. ruminantium as well as reticulated
(dividing) forms in endothelia cells and macrophages (Figure 5.16). Evidence of increased
capillary permeability shown by haemorrhages and oedema fluid were also demonstrated in
the IFN—a/f)Ro/o mice (Figure 5.16 and 5.17) and in the control group (Figure 5.18).
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Figure 5.10. Lung section of an infected IFN-yRo/o showing bizarre forms in an
encapsulated vacuole in a macrophage. Note the pleiomorphic nature of the organisms
manifested by the different forms including rods, rings, oval and horse shoe shapes. The
organisms are electron dense, a reflection of late stages of multiplication, with an unexplained
lucent area in the middle of some of the organisms. The organisms are surrounded by a double
membrane (arrow) and divided by a protein-rich area. Also in the micrograph are intact
numerous mitochondria (M) (XI 1,500).(Micrograph No. 1412-IFN-yRo/o)
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Figure 5.11. Electron micrograph of a lung section of an infected IFN-yRo/o mouse. Note
the two encapsulated colonies of organisms. In one the capsulated vacuole is bulging into the
lung parenchyma with the cell nucleus pushed to one side although the vacuole wall is still
continuos with the cell membrane and seems to be in the process of detaching (A). A second
encapsulated vacuole seems to have fully detached from the cell (B). Note the presence of
bizarre forms of the organisms which are electron dense and in different shapes. Also to be




Figure 5.12. Higher magnification of Figure 5.11 showing the bizarre forms of C.
ruminantium which are separated by a protein -rich matrix. The organisms are electron-dense
and surrounded by two membranes reflecting a late developmental stage. 'Doughnut' shapes
are probably due to long-axis sectioning of concave elongated Cowdria bodies(X24,750).
(Micrograph No. 1574-EFN-^y Ro/o)
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Figure 5.13. Lung of a control mouse infected with C. ruminantium. Micrograph A; note
two colonies adjacent to each other in the cytoplasm of endothelial cell (a and b). The cell
nucleus has been pushed to one side by the bulging cytoplasm, and this seems to have caused
narrowing of the capillary. Micrograph B (higher magnification of A); note the reticulate
forms (dividing forms) each surrounded by a double membrane and note one organism is





Figure 5.14. Lung section of a C. ruminantium infected IFN-yRo/o mouse showing extensive
haemorrhages (arrow) in the lung parenchyma (X4,125). (Micrograph No. 1578-LFN-yRo/o)
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Figure 5.15. Brain of IFN-^y Ro/o infected mouse showing numerous intact mitochondria
(arrow). (XI8,750). (Micrograph No.l513-IFN^y Ro/o)
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Figure 5.16. Lung of IFN-a/(3Ro/o infected mouse. A: Note an infected cell with the shape
of the cell being altered by the C. ruminantium colonies in the cytoplasm and the nucleus
being pushed to one side. Two forms of the infectious agent which seem to be separately
encapsulated, can be seen, with larger reticulated forms in the upper one (triangle arrow head)
and electro-dense forms in the lower ones (curved arrow). B: Presence of the dividing forms
of C. ruminantium (reticulated forms) can be seen in the infected cell (straight arrow). Note




Figure 5.17. Lung of an infected IFN-a/pRo/o mouse showing increased permeability with
seepage of oedema fluid (o) and red blood cells (r) into the alveoli spaces. Note the
macrophage (m) in alveolar space (X9,000) (Micrograph No. 1571-IFN—a/pRo/o Lung).
170
 
Figure 5.18. Lung of infected control mouse showing disruption of the vascular wall
integrity resulting in seepage of red blood cells (r) into lung parenchyma. Note also the





This study demonstrated that mice lacking in receptors for type I (IFN—a/P) and type
II (EFN-7) interferons had reduced protection from C. ruminantium infection. This was
shown by significant differences in the clinical and pathological manifestations between the
receptor deficient mice and the controls. Infection of the IFN-yRo/o and to a lesser extent,
IFN—a/pRo/o mice resulted in an acute explosive disease characterised by shorter incubation
period, shorter course of disease, increased thoracic oedema fluid and higher morbidity and
mortality rates as a function of time as compared to the controls (Table 5.1 and Figure 5.1).
The IFN—yRo/o mice manifested lower resistance to the disease than the IFN—a/pRo/o in that
they had shorter mean incubation period, higher levels of thoracic oedema fluid and higher
mortality rates. IFN-yRo/o and IFN-oc/pRo/o mice showed significantly higher infection rates
in lung and brain tissue as compared to mice in the control group. The ease of finding C.
ruminantium infection in the brain was striking as this is considered a rare finding (Prozesky
and Du Plessis, 1985b). In addition, the marked exudation and infection of peritoneal
macrophages by C. ruminantium in the IFN—yRo/o mice was considered as an unusual feature
of infection in mice, but was exploited by Du Plessis (Du Plessis and Malan, 1987) to develop
the 'Kumm' antigen using the Kumm strain for use in indirect fluorescent test for serological
diagnosis of heartwater. It is tempting to speculate that the Kumm strain, which leads to high
levels of infection in peritoneal macrophages and is infective to mice by the intra-peritoneal
route, which is not the case for other isolates, is relatively resistant to IFN-^y, allowing higher
infection rates in peritoneal macrophages. Furthermore, strain variation to IFN-y
susceptibility has been reported for isolates of Rickettsia prowazekii (Turco and Winkler,
1994).
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The mice showing higher infection rates revealed a more extensive pathology in lung
histopathological sections with the IFN-yRo/o mice showing evidence of increased alveolar
oedema (pink-staining mass) and inflammatory cell infiltration than in the control group. The
IFN-yRo/o and IFN—a/pRo/o groups also revealed a more thickened alveolar wall which was
attributed to a more extensive inflammatory reaction characterised by increased infiltration of
the interstitia by predominantly mononuclear cells and also due to distension by oedema fluid
(interstitial oedema). However, although the infection rate was up to 8 fold higher in the
receptor deficient mice as compared to the control, the oedema fluid was increased but not
significantly so. It may therefore be the case that higher infection rate resulted in the earlier
occurrence of oedema which resulted in fatal outcome with earlier mortalities in these mice.
Ultrastructural studies in lung and brain sections revealed differences in morphology of
the infectious agent in the IFN-yRo/o group, where electron-dense bizarre looking forms of C.
riiminantiiim were seen in cytoplasm of endothelial cells and macrophages as compared to the
IFN-a/pRo/o and control groups. These forms were highly pleiomorphic ranging from
commas, rings, rods and oval shapes, as compared to the consistent observation of reticulate
forms seen in the IFN-a/pRo/o and control group. The reasons behind these morphological
differences were not conclusively known but one possible explanation for these differences
may be determined by the developmental stage of the organism in the disease at the time of
death, implying that the infection in the IFN-yRo/o mice may have been predominantly at a
later developmental stage (elementary body), while in the control group, the organisms were
predominantly at an early developmental stage (reticulate forms) with some seemingly
undergoing binary fission. A mixture of these forms of C. ruminantium were seen in the IFN-
oc/pRo/o group further supporting this hypothesis and explaining why the clinical disease and
pathology in this group was also intermediate between the two groups. Although these mice
173
were sacrificed on the same day (day 7) the stages seen on electron microscopy suggest
infection may have reached a different developmental stage. This implies that compromised
host immune defence mechanisms may result in more rapid developmental cycle with the result
that late stage forms predominated in IFN-yRo/o mice whereas dividing reticulate forms
predominated in the control mice which had not developed hypothermia on the same day. C.
ruminantium has a developmental cycle of approximately 5-6 days (Jongejan, 1990) and this
implies that the developmental cycle in the IFN-yRo/o mice was more advanced due to less
control by the host immune defence mechanisms and may have been in its 'second wave', at
the time the sections were made (7 days post-infection), whereby, fresh-released EBs were re¬
infecting new cells, while in the control there was some mechanism exhibiting a check on the
rate of the development of the disease and re-infection rate.
This study agrees with other findings on the role of cell mediated immunity and
interferons in disease resistance. Interferons are cytokines that play a complex and central role
in the resistance of mammalian hosts to pathogens (Boehm et al., 1997). The inhibition of
Cowdria growth by IFN-y has been reported in both in vitro and in vivo studies (Totte et al.,
1993 and 1994, Mahan et al., 1996 and Mutunga et al., 1998). Similar findings have been
reported for other infections including other rickettsia diseases. IFN-y and TNF-a depleted
mice infected with a sublethal infectious dose of Rickettsia conorii resulted in fatalities in the
cytokine-depleted mice but not the controls, with impairment of nitric oxide (NO) being
implicated as the main cause of this overwhelming disease (Feng et al., 1994). Walker et al.,
(1996) reported similar findings in which depletion of IFN-y and TNF-a receptors was found
to convert a sublethal infection of Rickettsial conorii into a fatal disease with overwhelming
rickettsia growth and decreased nitric oxide synthesis. Liew et al., (1990), reported in vitro
killing of Leishmania major by IFN-y was through the NO pathway and also showed that
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injecting the infected mice with the NO inhibitor, L-NMMA, resulted in 104 fold increase in
the number of parasites in lesions. IFN-7 was also found to kill Schistosoma mansoni
parasites through induction of NO production (Oswald et al., 1994). It was also reported that
IFN-7 provided by malaria -specific CD8+ cells stimulates liver cells to produce NO for the
destruction of infected hepatocytes and the parasites within these cells (Klotz et al., 1995).
The absence of IFN^y receptor may result in reduced NO production, and NO may provide
one of the effector mechanisms of controlling cell to cell spread of infection since NO is
inhibitory to infection of EBs to endothelial cell in vitro (Mutunga et al., 1998).
Antiviral activities of IFN—a/p have also been reported by several reviewers including
Svensson et al., (1995) and Haria and Benfield (1995). Higher levels of IFN-a were found in
cattle that resisted C. ruminantium infection as compared to lower levels found in those that
died of the disease (Totte et al., 1994). A similar picture was also reported for in vitro studies
where IFN-a reduced the yield of C. ruminantium (Totte et al., 1994). This inhibitory effect
of IFN-a to C. ruminantium was found to be limited in that very high concentrations of IFN-
a (1000 U/ml) did not completely prevent growth of the Cowdria organisms (Totte et al.,
1994). This agrees with our findings in this study were IFN-oc/pRo/o mice suffered a more
acute disease than the control infections, but a milder one as compared to IFN-yRo/o mice.
Similar findings were also reported in studies carried out using IFN-a for the treatment of
hepatitis B or C in which the results were shown not to be optimal with only less than 20%
recovering and relapses occurring once treatment was discontinued (Haria and Benfield,
1995), thus, limited inhibitory effect of IFN-a was further suggested in their work.
Murine macrophages have been reported to be activated by either IFN-y or IFN-a/p
in combination with LPS to induce synthesis of TNF- a and iNOS (Zhou et al., 1995). IFN-y
has been reported to induce induction of IFN-a and EFN-p and its function and response to
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be regulated by other cytokines (Boehm et al., 1997). IFN-ot/p have been said to be produced
early during viral infections and that they have antiviral activity including induction of a Th-1
type immune response (Zhou et al., 1995). Th-1 immune response is important in intracellular
infections including C. ruminantium infection, and therefore lack of receptors for this cytokine
would understandably result in a more severe infection as compared to control animals. IFN-
oc/p may not completely eradicate the infectious agent but offers a check in the multiplication
of the disease, affording the animal longer survival rate. It has been reported that IFN-a/{3
(type I) and IFN-y (type II) act through similar but distinct pathways to prime macrophages
for the induction of TNF-a and iNOS (Zhou et al., 1995). Both IFN-y and IFN-a/f} induce
synthesis and expression of MHC class I antigen but only IFN-y induces MHC class II
antigen expression in murine macrophages (Zhou et al., 1995). Although both IFN-^y and
IFN-oc/p have antiviral activities, they act to a different extent. It has been shown that these
cytokines act through several transcription factors at the gene level, one of which is
interferon regulatory factor 1 (IRF-1) (Zhou et al., 1995). IRF-1 was shown to be
prerequisite for the induction of the iNOS gene by either IFN-y or IFN-a/p (Kamijo et al.,
1994). Thus it has been generally concluded that type I (IFN-a/P) and type II (IFN-y) induce
in part the same genes, although to a different extent owing to subtle but distinct differences
in gene regulation (Shuai, 1994). This may explain the differences in disease severity in the
two receptor deficient groups.
Mitochondrial degenerative changes were noted in brain sections in some mice from
the control and IFN-ot/pRo/u groups but there was not much evidence of these changes in the
IFN-y Ro/o group. One hypothesis for this difference may implicate involvement of NO. IFN—
y activates phagocytic cells including endothelial cells to produce NO which has been reported
to suppress mitochondrial respiration by inhibiting electron transport through the respiratory
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chain and to decrease mitochondrial membrane potential (Gross et al., 1996). It is probable
that induction in mice macrophages of iNOS to produce NO did not occur in the LFN-yRo/o
mice, since NO synthesis is upregulated by IFN-y (Migliorini et al., 1991, Hanson, B. 1991,
Oswald et al., 1994, Gale et al., 1997), and that it was with the absence of increased NO and
oxidative enzymes that resulted in sparing the mitochondrial degeneration.
Conclusion
It is apparent from this study that C. ruminantium is inhibited or killed in vivo by
events involving the activities of IFN-y and possibly IFN-a/p. The mechanisms of action are
not fully known but the overall picture showed by this study is that, although 'normal' mice
undergo a lethal infection with low dose of C. ruminantium organisms, there is some control
of the infection as compared to the IFN-y and IFN-a/pRo/o mice, showing that lack of
interferons/receptors can result in an explosive disease that has lost control. The killing of
various parasites by IFN-y has been documented. The absence of EFN-y receptors is of
greater effect than loss of IFN-a/p receptor activity. Infection of mice deficient in the
receptors for these cytokines resulted in early death, severe pathology and massive rickettsial
infection rates in tissues due to a failure of the host defences to destroy intracellular
rickettsiae. Absence of IFN-y and IFN-<x/p receptors implies reduction in macrophage and
inflammatory cell activation leading to a more severe disease as a result of reduced
destruction of the intracellular infectious agent, and perhaps in consequence to release of
other macrophage products that may be deleterious to survival. This may also mean there is
less NO generation and therefore less anti-Cowdria activity. Previous studies have
demonstrated the inhibitory effect of interferon gamma (IFN-y) on C. ruminantium in vitro
(Mahan et al., 1996; Totte et al., 1994; Mutunga et al., 1998). An infection-limiting response
mechanism seems to exist in normal mice infected with C. ruminantium. Lack of IFN-y and
IFN-oc/p receptors can therefore result in reduced destruction of pathogens by the host
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immune mechanisms leading to a more severe pathology due to higher numbers of infectious
agent.
Since some control of infection occurred in the control group of mice, factors which
control the level of IFN—y and to a lesser extend, IFN-oc/p responses may be of great
importance to the outcome of infection. These may include genetic differences between mice
but also the upregulation of macrophage activation and upregulation of IFN-y production by
other cytokines such as interleukin 12 (IL-12). The studies in the following chapter (chapter 6)
were designed based on this hypothesis. Involvement of IL-12 in the immune response of C.
ruminantiwn was studied in the work reported in the next chapter (Chapter 6).
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CHAPTER 6
CYTOKINE STUDIES DURING EXPERIMENTAL COWDRIA
RUMINANTIUM INFECTION OF BALB'C MICE; INVOLVEMENT
OF IL-12 IN PROTECTIVE RESPONSES
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6.1. Introduction
Heartwater is caused by an obligate intracellular rickettsial organism, Cowdria
ruminantium which multiplies in endothelial cells and also phagocytic cells including
neutrophils (Cowdry, 1925; Logan et al., 1987). The clinical manifestations and
severity of the disease are mainly associated with severe respiratory, cardiac and
nervous embarrassment mainly due to increased capillary permeability leading to
oedema (Clark, 1962; Prozesky and Duplessis, 1985b; 1985c). The pathogenesis and
immunologic mechanisms of C. ruminantium infection remain obscure and this is a
major drawback at a time when developing a vaccine for the disease is of paramount
importance due to the massive losses of improved livestock breeds to the disease
experienced in the tropics. Cells in the immune system act mainly under the influence
of signals from other cells and these activities are regulated by cytokines (Playfair,
1995). Previous studies have highlighted the role played by cell-mediated immune
response in C. ruminantium infection, which is mediated in part through the
production of inhibitory cytokines including inteferons (Totte et al; 1993; Mahan et
al., 1994; 1996). Cytokines have been found to have widespread and overlapping
functions, including influence on the production of reactive nitrogen intermediates like
nitric oxide. In order to understand the pathogenesis and non-specific and adaptive
immune responses in C. ruminantium infections, it is important to investigate the
cytokine kinetics induced as a response to the infection. An infection-limiting response
mechanism involving IFN-y activities occurs in normal mice infected with C.
ruminantium (Chapter 5) and a possible influence upon the production of this
cytokine response is interleukin 12 (IL-12).
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Interleukin 12 (IL-12) is a pro-inflammatory cytokine produced by phagocytic
cells, B cells and other antigen-presenting cells in response to bacteria, bacterial
products and intracellular parasites (D'Andrea et al., 1992; Trinchieri, 1993; 1995).
IL-12 has been recognised as a central cytokine in early non-specific innate resistance
by inducing production of IFN-y from NK and T cells, which contributes to
phagocytic cell activation and inflammation (Kobayashi et al., 1989). IL-12 is known
for its role as a promoter of Th 1 cell generation, which are considered central to
eradication of intracellular pathogens and acting in antagonism to IL-4, the major
promoter of Th 2 responses (Flesch and Kaufman, 1990).
The first experiment described was designed to investigate the cytokine and
nitric oxide profiles during C. ruminantium infection with special reference to IFN-
y, IL-12p70, IL-4 and IL-10, in an attempt to clarify the host-parasite interactions in
the disease. The studies in the second experiment were prompted by the extensive
biological effects mediated by IL-12, to examine the role of this cytokine with, and in
relation to other cytokines, in C. ruminantium infection. This was done by treatment
of Balb'c mice with mouse recombinant IL-12 (MrIL-12) given at different doses and
different times during the infection. The effects of the cytokine administration upon
the clinical disease, pathological and immunological processes of C. ruminantium
infection were investigated.
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6.2. Experiment 1: Cytokine studies in Balb'c mice infected
with C. ruminantium
6.2.1. Materials and Methods
6.2.1.1. Experimental design
Seventy male 8-10 week old Balb'c mice were used in this study. The source and
management of the mice before and after infection was as described in section 2.3.1.1.
Six mice (identified as numbers 1-0 to 6-0 -see appendix 4) were sacrificed on day 0,
prior to infection, and the spleens removed aseptically and stored in sterile PBS before
being weighed and homogenised in CHAPS as described in section 2.3.4. The
remaining 64 mice were divided into groups identified as A to M (Table 6.1) and
individual mice in each group were given numbers 1 to 6 (see appendix 4). Forty two
of the mice were infected with the Welgevonden isolate of C. ruminantium each
receiving a dose of lxlO3 EBs diluted in 200 |il culture medium. The concentration of
EBs was determined by fluorescein diacetate staining as described in section 2.1.5.
The remaining 22 mice were mock infected with the same volume of culture medium.
Six infected and 4 mock infected mice were randomly selected and sacrificed every
two days and the spleens removed, weighed and homogenised in CHAPS and stored
at -20°C (see appendix 4). The spleen weights were compared between the Cowdria-
infected and the uninfected controls. The spleen homogenates were used to assay for
EL-12p70, IFN-y, IL-10, IL-4 and nitrite levels and these were compared between
infected and mock infected (uninfected) controls and also compared between different
days during the disease.
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Table 6.1.














INFECTED = Groups infected with C. ruminantium
UNINFECTED = groups mock infected with culture medium (uninfected controls)
6.2.1.2. Clinical disease monitoring
The mice were monitored daily for clinical disease, and by recording rectal
temperatures as described in section 2.3.2. The incubation period was considered to
be the period of time prior to the onset of hypothermia.
6.2.1.3. Cytokine and nitrite assays:
The levels of IFN-y, IL-12 p70, IL-4, and IL-10 in the spleen homogenates of all the
56 sacrificed mice were assayed using commercial ELISA kits as described in
materials and methods in sections 2.7.1.1, 2.7.1.3, 2.7.1.4 and 2.7.1.5. Nitrite levels
were assayed in spleen homogenates using the Griess assay method as described in
section 2.2.1.
6.2.2. Results
6.2.2.1. Clinical and pathological findings
The infected mice, with the exception of those sacrificed before disease onset,
developed marked hypothermia, with temperatures dropping to below 32°C from day
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7 post-infection, followed by development of respiratory distress and general malaise
of the affected animals. The mean incubation period was 7.4 days and the mean
course of disease was 2.1 days with a range of 1-3 days. Significant differences were
noted in the spleen weights between the infected and uninfected controls (Anova,
p=0.0002) from day 4 to day 10, with the highest mean spleen weight being recorded
on day 6, which was very significantly greater than day 0 spleen weight (t test,
p=0.001) (Figure 6.1.a and Appendix 4.1). This weight increase on day 6 was not
maintained and had reduced on day 8 (Figure 6.1.a). Only one mouse had showed
pleural effusion prior to onset of hypothermia (day 6) but all the mice sacrificed after
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6.2.2.2. Cytokine levels in mice infected with C. ruminantium
6.2.2.2.1. Interleukin 12 p70 (IL-12p70)
There was increase in mean IL-12 p70 levels on days 2, 4, and 8 in infected mice as
compared to uninfected control mice but the increase was only significant on day 2
post-infection (t test for paired samples: p=0.004) (Figure 6.2). Higher mean levels,
although not statistically significant as compared to uninfected controls, were
sustained from day 2 through to day 4 but a decrease was noted on day 6 and 10 post¬
infection at which time the levels were almost the same as those of uninfected control
(Figure 6.2 and Appendix 4.4).
6.2.2.2.2. Interferon gamma (IFN-y)
A significant, dramatic increase in mean IFN-y levels was recorded on day 6 post¬
infection in infected animals as compared to uninfected controls (t test; p=0.02). The
high levels were not sustained and had decreased by day 8 but were still significantly
higher than the levels recorded in the control group. This increase in IFN-y levels on
day 6 was about 8 fold higher (an increase of about 800 pg/ml) than that recorded for
uninfected controls and about 4 fold higher than that recorded for infected animals on
days 8 and 10 (about 100 and 200 pg/ml respectively) (Figure 6.3 and Appendix 4.3).
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Fig. 6.2.
Mean Interleukin 12 p70 (IL-12p70) levels in Balb'c mice













Mean Interferon gamma (IFN^y) levels in Balb'c mice


















6.2.2.2.3. Interleukin 10 (IL-10)
There were no significant differences in the mean IL-10 levels between infected and
uninfected controls in the course of infection (t test; p>0.05). A slight increase was
recorded on day 10 but this was not statistically significant (t test; p=0.22) (Figure 6.4
and Appendix 4.6). Individual variations were marked in the terminal stages (day 10).
6.2.2.2.4. Interleukin 4 (IL-4)
Mean IL-4 levels were noted to decrease significantly on days 6 and 8 after infection
with C. ruminantium as compared to uninfected control (t test; p=0.03 for day 6 and
p=0.02 for day 8). A terminal increase was noted on day 10 in individual mice but the
means were not statistically significant from that of the uninfected group (Figure 6.5
and Appendix 4.5).
6.2.2.3. Nitrite levels
Significant increase in mean nitrite levels were recorded during the later terminal
stages of C. ruminantium (day 10) as compared to uninfected control (t test, p=0.02).
Nitrite levels were recorded to range from 7-14 p.M for all the days assayed with the
highest nitrite levels being recorded on day 10 post-infection in the sacrificed mice
(Figure 6.6a and Appendix 4.7). Spleens harvested from mice which died of the
disease on day 9 showed significantly higher levels of nitrite as compared to those
sacrificed on days 8 (t test; p=0.02) but not those sacrificed on day 10 (p=0.07)
(Figure 6.6b and Appendix 4.7).
188
Fig. 6.4.
Mean Interleukin 10 (IL-10) levels in Balb'c mice infected





Mean Interleukin 4 (IL-4) levels in Balb'c mice infected with
























A. Mean Nitrite levels in Balb'c mice infected with C.
ruminantium and uninfected controls
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B. A comparison between nitrite levels in terminally ill, dead
and less ill mice: Mean Nitrite levels in C. ruminantium
infected mice sacrificed on day 8 and 10 as compared to
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6.3. Experiment 2: IL-12 inoculations in Balb'c mice
6.3.1. Material and Methods
63.1.1. Experimental design
This involved inoculations of MrIL-12 in Balb'c mice with different doses and at
different times during the disease. A total of 94 mice were used in this study; sixty six
mice were inoculated with MrIL-12 while 38 were not treated. This work was carried
out in two trials. The mice MrIL-12 inoculation plan was as given in Table 6.2 and
Table 6.3 and individual mice in each group were identified as shown on appendix 5.
MrEL-12 was kept in ice during inoculation and mice from different groups were
inoculated close together in time, to minimise loss of viability due to differences in
times of inoculation. In the first trial, 30 mice were used (Table 6.2) and clinical and
pathological investigations and immunoglobulin isotyping of anti-Cowdria antibodies
were carried out. In the second trial 64 mice were used and treated as shown in Table
6.3 In this second trial clinical and pathological investigations, cytokine and nitrite
assays were performed.
Table 6.2; First trial;
Group IL-12 Treatment in relation to infection
IA 10 mice Treated from day 0 with lOOng IL-12 S.C. every
2 days
IIA 10 mice Treated with lOOng IL-12 S.C. every other day
from onset of hypothermia
III 10 mice No treatment with IL-12 (control)
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Table 6.3: 2nd Trial
Group IL-12 Treatment in relation to infection
IB 18 mice Treated with 500 ng MrIL-12 S.C. 24 h prior to
infection and a 2nd inoculation of the same dose 7 days later.
ELB 18 mice Treated with 500 ng Mr IL-12 S.C. 24 h prior to infection
only.
EI 18 mice Treated with 0.1 ml PBS 24 h prior to infection .
IV 10 mice Uninfected controls; 5 mice were inoculated with 500 ng
MrIL-12 S.C. 24 h before infection of the test animals;
5 mice were left as uninfected and untreated controls.
Individual mice were identified in each group as shown on appendix 5.
63.1.2. Clinical disease monitoring
This was as described for the first experiment whereby rectal temperatures were
recorded daily and the following assessed and compared between the groups; days to
hypothermia (incubation period), period from onset of hypothermia to death (course
of disease) morbidity and mortality rates.
63.1.3. Immunoglobulin levels
Blood was collected for sera from 10 mice per group on days 0, and post-infection on
days 8, 16 and 24 in animals surviving the infection. The sera was used in enzyme-
linked immunosorbent assay for different isotypes of IgG i.e. IgGl, IgG2a, IgG2b and
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IgG3 as described in section 2.4.3. The levels were compared between the groups of
mice.
6.3.1.4. Pathological studies
Four mice from each group were sacrificed on day 8 post-infection. The spleens were
harvested, weighed and homogenised as described in section 2.3.4. and the amount of
thoracic oedema fluid (pleural effusions) was measured using a calibrated syringe.
This was also conducted for all the other subsequent dead mice. From the sacrificed
mice, spleens were collected aseptically into sterile PBS and homogenised as
described for the first experiment above, section 6.2.1.1. Lung and brain tissues were
also collected from the sacrificed mice and fixed in 4% buffered formalin for
histopathology. The tissues were prepared and stained as described in section 2.3.3.1.
6.3.1.5. Cytokine and nitrite assays:
Spleens were collected from mice in groups inoculated with 500 ng/ml MrIL-12
(groups IB and IIB ) and the control group on days 8, 10, 11 and 13 post-infection
and levels of IFN-y assayed using a capture ELISA assay. The levels of IFN—y, IL-12
p70, IL-4, IL-10 and nitrite levels in the spleen homogenates were assayed as
previously described in this chapter.
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6.3.2. Results
6.3.2.1. Incubation period, course of disease, morbidity and mortality rates
Differences in incubation period, morbidity and mortality rates were noted between
the four groups of C. ruminantium infected-mice which had also been inoculated
with MrEL-12 as compared to the control groups. Groups of mice inoculated with
MrIL-12 before or at time of infection (IA, IB and IIB) resulted in increased
incubation period, prolonged course of disease and lower morbidity and mortality
rates as a function of time, as compared to the group inoculated after disease onset
(HA) and the control groups (III and IV) (Table 6.4 and Appendix 5.1). The highest
protection was recorded in the group inoculated with lOOng MrIL-12 from start of
infection with booster doses every 2 days post-infection (group IA). This group
manifested the longest mean incubation period (10 days) and lowest morbidity and
mortality rates, of 80% and 50% respectively. Morbidity and mortality rates were
both significantly lower in this group as compared to the group inoculated after
disease onset (nA) and the control group (Table 6.4). Twenty percent of the mice in
group LA did not show any evidence of or clinical signs of disease whereas none of
the mice in groups IIA and III were resistant to or survived the disease.
Administration of 500 ng of MrIL-12 twenty four hours before infection, with or
without a booster dose 5 days post-infection (groups IB and IIB respectively) also
resulted in increased survival (27 and 18 % respectively) (Table 6.4). A booster
inoculation of MrEL-12 given 5 days post-infection (group IB) increased protection of
the mice in comparison to the single inoculation, with the mice showing longer mean
incubation period, and lower morbidity and mortality rates as compared to group IIB
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which was inoculated only once before infection (Table 6.4). Administration of 100
ng of MrIL-12 after disease onset (IIA), however, did not seem to alter the clinical
picture of the disease from that of the untreated controls with no significant
differences (t test and Chi-square; p>0.05) in mean incubation period, mortality and
morbidity rates between treated and the untreated controls. There were slight
differences in the course of the disease from onset of hypothermia to death between
the different groups. The mice inoculated with 500ng MrIL-12 before infection (IB
and IIB) recorded the longest course of disease, with a mean of 2 days as compared
to the control group which had a mean of 1.4 (Table 6.4) although the differences
were not significant. 45% of C. ruminantium infected mice in group LA survived the
disease while 27% and 18% of mice in groups IB and IIB respectively also survived
the disease while none survived in the control group (Table 6.4). Although the
survival rate was not very high in groups IB and IIB, the mice inoculated with IL-12
survived the disease longer than those not inoculated (with mean day of death post¬
infection being day 11 for IB, day 10 for IIB compared to day 8 for control group)
(Table 6.4).
Each of the survivors subsequently resisted challenge with 10,000 EBs per mouse
indicating an active immune response had occurred, despite the absence of clinical
signs in 20% of mice in group IA and IB in primary infection. The challenge inoculum
of 10,000 EBs results in 100% mortality in Balb'c mice (Paxton, 1997;. unpublished
data).
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Table 6.4. Summary of the clinical manifestations in mice treated
with MrIL-12 and infected with C. ruminantium
Group LP. +/-SD C.D. +/-SD Morb.R. Killed Mort. R. Survival R.
IA 10 1.2 1.5 0.5 8 (80%) 2 4 (50%) 4 (50%)
HA 7.3 0.9 1.3 1.2 10 (100%) 2 7 (90%) 1 (10%)
IIIA 7.2 1.0 1.3 0.5 10 (100%) 2 8 (100%) 0 (0%)
IB 9.2 1.2 2 0 15 (83.3%) 4 6 (42.8%) 4 (28.6%)
IIB 8.3 1.3 2 0.6 16 (88.8%) 4 12 (85.7%) 4(18%)
IIIB 7.0 0.5 1.4 0.5 18 (100%) 4 18 (100%) 0 (0%)
KEY: IA - group inoculated with 100 ng IL-12 from start of infection every 2
days
HA - group inoculated with 100 ng of IL-12 after disease onset
IIIA - Infected control group
IB - group inoculated with 500 ng of IL-12 twice 24 h pre-infection and 5
days post-infection
IIB - group inoculated with 500 ng of IL-12 24 h before infection
IIIB - infected control group
I.P.- Incubation period in days
C.D.- Course of the disease in days
Morb. R. - Morbidity rate
Mort. R.-Mortality rate
Killed - Number of mice sacrificed
Survival R. - Mice which survived the disease with or without clinical disease
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63.2.2. Gross pathological findings
The main gross pathological finding in each of the mice which succumbed to the
disease was the presence of pleural effusions. Some slight variations were recorded in
the amount of fluid between the groups, and, although the amount of oedema fluid
was slightly lower in mice inoculated with IL-12 before or at start of infection, the
differences were not statistically significant (p>0.05) (Figure 6.7. and Appendix 5.1).
Significant increase differences in the spleen weights (p<0.05) were noted in the
groups pre-treated with IL-12 and the control group. The mean spleen weights were
180, 167 and 100 mg for the group inoculated with two doses of 500 ng of IL-12
(IB), for the group which received one dose of 500 ng IL-12 (IIB) and the control
group respectively (Figure 6.7).
6.3.2.3. Histopathology
In some lung sections of mice inoculated with IL-12 a more pronounced inflammatory
reaction characterised by infiltration of lung interstitia by predominantly mononuclear
cells was seen as compared to the control (Figure 6.8 - 6.11). There was increased
number of apoptotic cells in the lung and brain sections of mice inoculated IL-12 prior
to or at time of infection as compared to the control group, with group IB, which
received a double inoculation, showing more apoptotic cells than group IIB (Figure
6.12 and 6.13). Apart from increased weight and size of spleens in mice inoculated
with IL-12 (IB and IIB), there were no other gross lesions noted on the spleen, and
only slight cellular changes in histopathological sections were discernible.
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Fig. 6.7.
Mean Spleen weights and Thoracic odema fluid in C.
ruminantium infected Balb'c mice inoculated with 500ng
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Fig. 6.8.
Giemsa-stained lung histopathological section of a mouse sacrificed on day 8 post¬
infection. This had been inoculated with 500ng MrIL-12 24 hours prior to infection
with a booster dose at 5 days post-infection. Note the infected cell (arrow) and
infiltration by phagocytic cells (arrow head) (X 1000).
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Fig. 6.9.
Giemsa-stained lung histopathological section of a mouse sacrificed on day 8 post¬
infection. This had been inoculated with 500ng MrIL-12 24 hours prior to infection




Giemsa-stained lung histopathological section of a control mouse sacrificed on day 8
post-infection showing infected cell (arrow) and oedema (o). Note the presence of




Hematoxylin and eosin stained lung histopathological section of a C. ruminantium
infected mouse sacrificed on day 8 post-infection. This mouse had been inoculated
with 500ng MrIL-12 24 hours prior to infection. The micrograph shows
inflammatory cell infiltration of predominantly mononuclear cells (XI500).
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Fig. 6.12.
Giemsa-stained lung histopathological section of a mouse sacrificed on day 8 post¬
infection. This mouse had been inoculated with 500ng MrIL-12 24 hours prior to
infection. The micrograph shows presence of apoptotic cells (arrow), inflammatory




Hematoxylin and eosin stained brain histopathological section of a mouse sacrificed
on day 8 post-infection. This mouse had been inoculated with 500ng MrIL-12 24
hours prior to infection. The micrograph shows presence of apoptotic cells (arrows)
(xl500).
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6.3.2.4. Infection rate in lung histopathological sections and brain smears
The mean number of C. ruminantium colonies per field in sections from mice
sacrificed on day 8 were analysed in giemsa stained lung sections by counting colonies
in twenty fields per slide. Quantification of infectious agent in showed the mice
inoculated with MrIL-12 prior to or at time of infection to have significandy lower
infection rates as compared to the control (x 2=6.24, p<0.05) (Table 6.5). The lowest
mean infection rate of 2 colonies per field was recorded in the group IA inoculated
with 100 ng of IL-12 every two days as compared to 5 colonies in group IB
inoculated with 500 ng twice, 14 in IIB inoculated with 500 ng once, 17 colonies in
IIA, the group given 100 ng after disease onset and 18 colonies in the control group
(Table 6.5). Non-hypothermic mice sacrificed from group IB, which had received
double MrIL-12 inoculation, had very low infection rates with a mean of less than 1
colony per field as compared to the hypothermic mice which had higher infection rates
of up to 30 colonies per field (Table 6.5).
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Table 6.5. Summary of infection rates in Lung tissue of mice
sacrificed on day 8 post-infection.







IB - group inoculated with 500 ng of IL-12 twice 24 h pre-infection and 5
days post-infection
IIB - group inoculated with 500 ng of IL-12 24 h before infection
Hi-infected control group
Mean Number of colonies +/- standard deviation (SD) counted in giemsa
stained lung sections in twenty fields at a magnification of XI000. Four mice
for each group were used.
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6.3.2.5. Isotype levels of anti-Cowdria immunoglobulins in mice treated with
MrIL-12
Sera was collected on days 0, 8 and 16 post-infection from survivors and compared
with sera obtained from tetracycline-treated controls for anti-Cowdria IgG levels by
indirect ELISA. Anti-Cowdria IgGl, IgG2a, IgG2b and IgG3 levels were determined
for the different groups of mice. On day 8 post-infection, IgG levels were recorded
for all the infected groups of mice as compared to the uninfected control with very
slight differences in levels of different isotypes in all the groups. On day 16 post¬
infection, however, there were significant differences in IgGl and IgG2a in these
groups with a ratio of 1:2 in group IA and IB and 2:1 in group IIA and IIB whereas
the ratio was 1:1 for pooled serum from an infection and treatment group (I/T) used
as control, since all mice in group III had died (sera obtained from Kibor, 1997)
(Figure 6.14a and b).
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Fig. 6.14.
A.Mean Immunoglobulin levels in C. ruminantium
infected Balb'c mice treated with MrlL-12 at 100ng (IA and
IIA) or pre-treated with 500ng with or without a booster
dose (IB and IIB), and infected and uninfected controls
(III and IV ) on day 8
Group of mice
□ lgG1 □ lgG2a PlgG2b OlgG3
B.Mean Immunoglobulin levels in C. ruminantium
infected Balb'c mice treated with MrlL-12 at 100ng (IA
and IIA) or pre-treated with 500ng with or without a
booster dose (IB and IIB), and infected and treated (l/T)
and uninfected controls (IV ) on day 16
Group of mice
PlgG1 PlgG2a PlgG2b PlgG3
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63.2.5. Cytokine Levels in C. ruminantium infected mice treated with MrlL-
12
6.3.2.5.1. IL-12p70 levels
Total IL-12 and IL-12 p70 levels were determined by an ELISA assay for day 9 post¬
infection. Significantly elevated total IL-12 levels were found in mice in groups IB
and IIB which had been inoculated with MrIL-12. However, no detectable IL-12 p70
were found in group IB and very low levels were detected in group IIB, while there
were significantly higher levels in the control group (III) (Figure 6.15 and Appendix
5.2).
6.3.2.5.2. IFN-y levels
Significantly higher mean levels of IFN-y were recorded in mice inoculated with IL-
12 twice (IB) as compared to those inoculated once and the untreated controls
(P<0.05) (Figure 6.16 and Appendix 5.2). All the animals in this group had IFN-y
levels ranging from 100 -200 pg/ml and a mean of 140 pg/ml. The highest IFN-y
levels in this group were recorded from mice which were sacrificed before onset of
hypothermia as compared to hypothermic mice. The mean levels of IFN-y in the
group given one inoculation of 500 ng IL-12 before infection (IIB) were low as
compared to those recorded in group IB with all the animals recording values less
than 100 pg/ml. IFN-y levels in the control group were also low but more varied than
in the other groups, with the lowest IFN-y levels being recorded in the mice which
succumbed early to the disease (with a mean of less than 50 pg/ml) but high in those
that survived the disease longer (with a mean of 80 pg/ml). IFN-y levels in this group
(IIB) and the control group (III) were not significantly different. The most striking
differences between these was the trend in which IFN-y increased or decreased.
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Although the mean spleen IFN-y concentration was significantly higher for group IB
mice over the period of 7-13 days than in groups IIB and III, the levels were highest
on day 7 and 8 post-infection but remained uniformly high up to day 13 (>120 pg/ml).
In group IIB mean IFN-y levels were highest on day 7, but these levels were about
half the mean recorded in group IB, and decreased significandy from day 8 to day 13
when very low mean levels of less than 20 pg/ml were recorded. In contrast, a steady
increase of mean levels of IFN-y were recorded in the control group, with the lowest
levels being recorded on day 7 and the highest on day 13. The levels of IFN—y and
apoptotic cell death were found to be highly correlated (r= 0.8) (Table 6.3).
6.3.2.5.3. IL-10 levels
Lower mean spleen levels of IL-10 were recorded over the 6 days in mice in group
IB, the group inoculated with IL-12 twice, 24 hours before infection and 5 days post¬
infection, as compared to the control mice. The highest mean spleen levels for group
IB (lOOpg/ml) were recorded on day 11 post-infection and the lowest (0 pg/ml) on
day 13. In group IIB mice, which had been inoculated with IL-12 once 24 h before
infection, the levels were significandy higher than group IB and the control group
(group III) on day 7 after which the levels dropped to about 100 pg /ml. Mean spleen
IL-10 levels were lower in group III at day 7 than for the other 2 groups but were
significandy higher on day 13 (about 200 pg/ml) as compared to 0 pg/ml in group IB
and about 100 pg / ml in group IIB. The trend of IL-10 in group IB was the reverse
of that of group III with the trend of group II being intermediate between that of
group IB and III (Figure 6.17 and Appendix 5.2).
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Fig. 6.15.
Mean Spleen IL-12 (total (T) and p70) on days 8 and 9
post-infection in Balb'c mice pre-treated with 500 ng
MrlL-12 twice ( IB) or once ( MB) and a control, all
infected with C. ruminantium (n=4 mice per group on
day 8 and 3 mice on day 9)
□ IB OIIB Dill
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Fig. 6.16.
Mean spleen IFN^y level in three groups of mice infected
with C. ruminantium. Group IB and IIB were inoculated
with 500ng IL-12 twice and once respectively and group





















Mean spleen IL-10 level in three groups of mice infected
with C. ruminantium. Group IB and IIB were inoculated
with 500ng IL-12 twice and once respectively and group
III was the infected control
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6.3.2.5.4. IL-4 Levels
The levels of IL-4 were much lower than those recorded for IFN-y and IL-10 and
they remained almost constant through out the course of the disease with very little
differences between the groups (p>0.05). The highest level was in group IIB and the
lowest was in group IB and both were recorded on day 8 post-infection (Figure 6.18
and Appendix 5.2). There was a negative relationship of IL-4 levels with IFN-y for
group IB, with the correlation coefficient (r) being -0.4 while the correlation
coefficient (r) between IL-4 and IFN-y levels in group IIB was +0.08.
6.3.2.6. Nitrite levels
Nitrite levels indicative of nitric oxide levels were assayed in the homogenised spleens
on days 8, 10, 11 and 13 where applicable. Nitrite levels were found to be
significantly higher on day 7 in group IB, which had been inoculated with 500ng
MrIL-12 twice as compared to mice in group IIB and the control group, and these
levels were sustained through out the course of disease. In group IIB, the highest
levels were recorded in the later stages of the disease (day 11) but these were not
sustained and had decreased by day 13. Nitrite levels in the control group (III) were
also shown to increase later in the disease (day 11) but again dropped in mice in the










Mean Spleen IL-4 levels in three groups of mice
infected with C. ruminantium. Group IB and IIB
were inoculated with 500ng IL-12 twice and once




Mean Spleen Nitrite levels in three groups of mice
infected with C. ruminantium. Group IB and IIB were
inoculated with 500ng IL-12 twice and once








In the past much progress has been made in understanding the cellular and
molecular mechanisms involved in the regulation of IL-12 and IFN-y and their role in
pathology and immune responses in disease. A few studies have been conducted on
the involvement of IFN-y in C. ruminantium infection but, to the best of our
knowledge, no studies have been reported on IL-12 involvement in the disease. IL-12
is produced after infection and acts as a pro-inflammatory cytokine eliciting
production of IFN-y by T-cells and NK cells. IFN-y activates phagocytic cells, hence
cell-mediated immune response (Trinchieri, 1993; 1995). The endothelium is the main
target cell of C. ruminantium. The disease infects and multiplies in the cytoplasm of
endothelial cells. The mechanism of immunity to this intracellular parasite has been
documented to be primarily cell-mediated, dependent upon T-lymphocytes (Du
Plessis, 1982; Du Plessis et al., 1991; 1992; Mahan et al., 1994; 1996; Totte et al.,
1993; 1994).
In this study, the first experiment showed that C. ruminantium infection of
Balb'c mice resulted in an acute disease characterised by onset of hypothermia on day
7, followed by death within 1-3 days. The study also showed that there was increased
pleural effusions leading to thoracic oedema, the main gross pathological finding in
this study. An interesting pathological finding in this study was the transient increase
in weight of the spleen, with the highest weight increase being recorded on day 6
post-infection. This increase in spleen weight on day 6 coincided with the dramatic
but transient increase in IFN-y levels, and both spleen weight and spleen IFN-y levels
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decreased on day 8 post-infection, but were still higher than levels recorded in
uninfected controls.
The mechanisms which resulted in increased weight of the spleen and IFN-y
on day 6 require to be established. It is possible, given the 6 day cycle of C.
ruminantium, that release of C. ruminantium organisms into the circulation which
occurs 5 to 6 days after infection, may have resulted in filtration of the organisms by
the spleen. This may have resulted in induction of proliferation of spleen cells which
produce interferons leading to the noted increase in the IFN-y levels. Alternatively,
the infection of antigen presenting cells (APC) in spleen and elsewhere, by the
increased numbers of released infectious agent, might result in proliferation in spleen
cells, peaking on day 6 and resulting in the noted weight increase, and the loss of cells
into circulation, or possibly by apoptotic cell death, to explain the reduction in weight
by day 8. It is also possible that the loss of spleen weight and of IFN-y production is
associated with exit of Th 1 CD4+ T cells.
High IL-12p70 levels were noted on days 2 to 4 prior to IFN-y increase. IL-
12 primes cells for production of IFN-y and is known as a strong inducer of IFN-y
production by NK and T cells (Trinchieri, 1995). IL-4 and IL-10 inhibits cytokine
production by Th 1 cells by inhibiting T cell and NK cell functions associated with
cell-mediated immunity to intracellular infections while IFN-y secreted by Th 1 cells
inhibits cytokine production by Th 2 cells (IL-10/IL-4) (Trinchieri, 1993; 1995). This
suggests that increase in IL-12 on day 2 and 4 in this study may have induced
differentiation of IFN-y producing cells leading to increased production of IFN-y
levels and also increased spleen weight recorded on day 6. Since IL-12 levels were
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not sustained beyond day 4, the reduction in IFN-y between day 6 and 8 may be the
consequence, and coincided with the acute onset of the clinical disease with a fatal
outcome. It was during this supposedly Th 1 response that IL-4 levels were noted to
be reduced in infected mice as compared to uninfected controls, with peak IFN-y
levels coinciding with the lowest IL-4 levels. It is possible that there was induction of
a Th-1 response during this period which lead to suppression of Th-2 response but for
some reasons this response was not sustained, resulting in lack of sustained high levels
of IFN-y and also reduction of spleen weight.
Increased nitrite levels, indicative of nitric oxide were recorded late in the
disease during terminal stages. The spleen homogenates from the dead mice (day 9)
showed the highest levels in nitrite levels as compared to mice sacrificed on day 8 and
10. Previous in vitro studies demonstrated that C. ruminantium infection of
endothelial cells induced increased production of nitric oxide (Mutunga et al., 1998)
and this may explain the high levels recorded in this study, at a time when the
infection level in endothelial cells is likely to be at its highest. Elevated IFN-y levels
on days 8 and 10 (about 3 fold higher than the basal level) could also have induced
nitric oxide production.
The first experiment of this study showed that C. ruminantium infection of
immunocompetent Balb'c mice resulted in induction of a transient IFN-y production,
hence Th 1 immune response, at a time when the disease was already established and
this did not influence the course of the disease. The second experiment further
supported the findings in the first experiment where early induction of a Th 1 immune
response was shown to be more beneficial to the infected mice than a late one. In this
study effects of treatment with MrIL-12 in Balb'c mice infected with C. ruminantium
217
were examined and showed, for the first time, that IL-12 given at the start or before
an infection increased the survival rate in mice infected with C. ruminantium as
compared to the controls. The inoculated mice showed elevated resistance to C.
rwninantium as evidenced by increased incubation period, reduced tissue infection
rate as seen in the lung and brain sections and reduced morbidity and mortality rates
as a function of time. The resistance was further increased by inoculating the mice
with booster doses as shown by groups IA, (given booster doses of 100 ng every two
days), and IB (given one booster dose of 500 ng five days post-infection). Inoculating
mice with 100 ng of MrIL-12 frequently from start of infection seemed to induce the
highest protection with longer mean incubation period and lower mortality rate (IA)
as compared to the control group. Mice inoculated with a single dose of 500 ng of
MrIL-12 prior to infection showed increased resistance to the disease, where as those
given a booster inoculation 5 days post-infection showed a higher survival rate than
those inoculated only once (IB and IIB). The protection, however, was not absolute,
as evidenced by variations in resistance noted in mice given MIL-12 every 2 days (IA)
in which 20% showed evidence of no clinical signs but recovered with solid immunity
to a high dose challenge, and 25 % recovered after clinical disease while 50% died of
the disease but these had a more prolonged incubation period and reduced infection
rates in lung and brain.
Both antibody responses in sera and cytokine assays in spleen homogenates
indicated that inoculating mice with MrIL-12 early or before infection induced a Th 1
immune response, a vital protective mechanism in infections by intracellular parasites
including C. ruminantium. Increased levels of IgG2a as compared to IgGl, IgG2b and
IgG3 were observed in group LA inoculated with MrIL-12 at infection as compared to
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group HA and the control group and this increase in IgG2a corresponded to the
survival rate of the mice in this group. IFN-y levels were also found to be significantly
elevated (p<0.05) in the groups inoculated with 500ng MrIL-12, corresponding to
survival rate in these groups (IB and IIB) with the highest IFN-y levels being recorded
in the group given two inoculations of IL-12 (IB). These groups showed an early
elevation of IFN-y as compared to the controls, where higher levels of IFN-y were
recorded late in the disease. As expected, high levels of total IL-12 were also
recorded in the groups inoculated with MrIL-12 but the low levels of IL-12 p70
recorded in these groups as compared to the control group were surprising and could
require further investigation. IL-10 levels recorded were almost a reverse mirror
image of IFN-y levels , while IL-4 levels were not significandy different between the
groups. In this study, we can therefore postulate that IFN-y and IL-10 levels were
regulating each other with the highest levels of IFN-y and lowest levels of IL-10
being recorded in IB while the lowest IFN-y levels and highest IL-10 were recorded
in the control group.
Nitrite levels indicative of nitric oxide (NO) were found to be significantly
elevated in mice inoculated with 500 ng MrIL-12 twenty four hours prior to infection
(IB and IIB) as compared to the control group. The group inoculated with IL-12
twice (IB) had higher levels of nitrite concentration than the group given only one
inoculation. The most striking feature was the time nitrite levels were highest in each
group; the groups inoculated with IL-12 i.e. those manifesting higher protection,
showed high nitrite levels earlier in the disease as compared to the control group,
suggesting that nitric oxide production early in the infection may be related to
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protection of the mice. This agrees with the findings in chapter 4 in which pre-
treatment of C. rwninantium (EBs) with NO resulted in reduced viability and
infectivity of the organism to endothelial cells. The high NO levels recorded especially
in EL-12 inoculated mice corresponded to high IFN-y levels in these groups, pointing
to increased induction of inducible nitric oxide synthase (iNOS) by activated
macrophages and endothelial cells.
Histopathological sections of mice showed evidence of increased apoptosis in
lung sections of mice inoculated with IL-12 as compared to the untreated controls but
their significance was not established. There was high correlation between IFN-y
levels and number of apoptotic cells (r=0.8). Thus, high IFN-y, NO levels and
presence of apoptosis were, possibly related as shown previously in an in vitro study
model in which BorlFN-y induced NO production and induced increased apoptotic
cell death of the infected cells resulting in reduced viability of C. rwninantium EBs
(Mutunga et al., 1998). In this study, as with the reported in vitro one, the increase in
NO coincided with decreased rickettsiae in lung tissue and endothelial cells
respectively. The high levels of NO recorded, which also corresponded to increased
IFN-y levels and therefore increased protection of the mice to C. ruminantium,
implies that the production of NO was through the iNOS. This also agrees with
results of the reported in vitro study where C. ruminantium infection of endothelial
cells induced production of NO with IFN-y enhancing this production and L-
NMMA, the iNOS inhibitor, blocking this production (Mutunga et al., 1998).
High NO levels in IL-12 inoculated mice may also explain the increased
leukocyte infiltration in lungs of mice. In infection of mice with Rickettsia conorii,
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reduction in the quantity of rickettsia in the endothelial cells was reported to be
associated with perivascular infiltration of T-helper and T-cytotoxic lymphocytes
(Walker et al., 1997). Therefore, increased leukocyte infiltration in the lungs and
spleen of mice inoculated with IL-12, which also corresponded to decreased infection
rate was possibly due to induction of innate non-specific cell immune responses which
may involve increased NO levels, also known to result in increased leukocyte
infiltration (Drapier et al.; 1988). NO has also been said to modulate leukocyte
adhesion to endothelial cells , an important component of the inflammatory response
(Harlan, 1985). This could also have influenced the significant increase in spleen
weights and the increased infiltration by inflammatory cells in the treated mice as
compared to untreated controls seen in this study. The increased levels of IFN-y, IL-
12, nitrite indicative of NO, and IgG2a in the mice showing resistance to the disease
were pointing towards a Th 1 immune response. In this study it seems, as in other
murine systems, that induction by IL-12 of IFN-y by Th 1 cells induced IgG2a and
IgG3 production by B cells ( Finkelman et al., 1988; Snapper et al., 1992). From
these results, it is suggested that production of IFN-y in high enough levels early in
the disease, before development of the primary immune system, reduced the infection
development rate in these groups. This resulted in increased survival of the infected
mice as seen by prolonged incubation period, lower morbidity and mortality rates as a
function of time. On the other hand the control animals had reduced survival rate and
also increased IgGl as compared to IgG2a showing a response associated with a Th 2
type immune response, which may explain the high mortality rate (100%) recorded for
this group. Increased IL-12 p70 recorded in the infected mice of the first experiment
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and the non MrIL-12-treated control group in the second experiment may be related
to the high IFN-y levels also recorded late in these groups (day 10 and 13) and the
response may have come too late to make a noticeable difference to the course and
severity of the disease, and already discussed above, may result in increased
permeability worsening the pathology.
It was also noted that, although there was increased survival in mice
inoculated with IL-12 before or at the start of infection, in the few which died there
was severe inflammatory response with increased inflammatory cell infiltration in the
lungs culminating in interstitial pneumonia with mononuclear cells being more
predominant. The infectious parasites were not in higher numbers in the IL-12
inoculated mice, thus the presence of large numbers of parasites does not appear to be
necessary to mediate the pathologic effects observed in these mice. Similar results
were reported in IL-10 depleted mice in which early deaths in mice infected with T.
gondii were found not to be associated with a corresponding increase in parasite
burden due to its major role in regulating IFN-y and IL-12 (Neyer et al., 1997,
Candolfi et al., 1995). Similar results were reported for Plasmodium chabaudi when
IL-10 knock out mice died earlier due to a lethal inflammatory response rather than
due to a fulminating parasitaemia (Linke et al, 1995). This implies that an immune
response to infection can be protective or pathogenic, according to the timing and
control of the IL-12 / IFN-y system. It appears then that in the IL-12 treated mice
which died, death was not due to an overwhelming infection but due to some
extensive inflammatory reaction. A mechanism exists in vivo to limit production of IL-
12 or the ability of T and NK cells to respond to it; IL-10 is the best studied inhibitor
of IL-12 production (D'Andrea et al; 1993). Several reports have indicated that IL-12
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itself can induce T cells to produce IL-10 suggesting a model in which IL-12 may
limit its own production by induction of its negative regulator IL-10 (Gerosa et al.,
1996). Interaction between these cytokines is complex and has important effects on
the quality of the immune response. IL-12 has been reported to prime cells for
production of IFN^y and also paradoxically for IL-10 production (Neyer et al; 1997).
Thus, the increased levels of IL-10 recorded in group IB on day 7 may have been
induced by high levels of IL-12. It maybe that the role of IL-10 is therefore a
physiological one to mediate deactivation of the innate immune response quickly, to
prevent non-specific tissue damage at a time when specific T-cell responses are being
generated to eradicate the infection. IL-10 inhibition of macrophage has been said to
be selective, rapidly down-regulating pro-inflammatory cytokine synthesis without
necessarily inhibiting critical macrophage effector functions needed for bactericidal
activity e.g. nitric oxide production (Strassman, 1994) or antigen presentation (Moore
et al., 1993). This maybe the explanation then in those mice inoculated with EL-12
which revealed extensive inflammatory reaction which corresponded also with lower
IL-10 levels. Thus, the physiologic role of IL-10 is favoured, being to shut off innate
immune cell activation by inhibiting IL-12 after specific T-cell immunity has been
stimulated. This mechanism has been reported to ensure minimal tissue damage while
the infection is specifically cleared (Tripp and Unanue, 1996).
Activation of macrophages represents one of the first events in the innate
resistance to intracellular infection. Early non-antigen specific responses of innate
resistance are very effective in eliminating pathogens or at least in significantly
reducing their ability to multiply (Trinchieri, 1995). Both non-specific innate immune
response by macrophages and NK cells, and specific adaptive immune response that
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generate specific antigen -specific T-cells are probably important in this disease, as
seen in field cases and in planned experiments. The macrophage via its ability to
produce EL-12 plays a major role in bridging the innate and specific cellular immune
responses in some studied diseases (Trinchieri, 1995).
IL-12 produced during the early inflammatory phases of an infection and IL-
12 induced IFN-y, create an environment in which antigen-specific CD4+ and CD8+
T cells are induced to differentiate into Th 1 cells, producing even higher levels of
IFN-y (Monterio and Trinchieri, 1996; Orange and Biron, 1996). In some viral
infections IL-12 has been found to be responsible for early production of IFN-y
mostly by NK cells, where as the late and most efficient production of IFN—y by T
cells appears to be IL-12 -independent (Monterio and Trinchieri, 1996; Orange and
Biron, 1996). This may explain why administration of IL-12 after disease onset did
not alter the course of the disease from that of the control group.
The study showed the importance on timing of cytokine availability during the
disease, as inoculation of MrIL-12 after disease onset did not seem to offer any
protection and manifested a clinical picture similar to that of the control group
indicating that IL-12 in this case did not influence the final outcome of the disease.
Furthermore, the pathological manifestations of some of the mice in this group given
MrIL-12 late in the disease, such as thoracic oedema fluid, were more severe than
even those of the control group pointing to a possibility that oedema formation was
induced by activities of EL-12 in this group at this late stage of the disease. Increased
endothelial cell permeability is the hall-mark of C. ruminantium disease. Interactions
between cytokines and acute inflammatory mediators have been reported to play a key
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role in endothelial cell permeability, and this increase in endothelial cell permeability
is believed to be the main determinant of immune complex deposition in blood vessel
wall (Beyond et al., 1993). IFN-y was reported to highly alter the endothelial cell
shape leading to increased permeability but IL-4 was found to have no effect (Beyond
et al., 1993; Stolen et al., 1986). The oedema formation may be associated with IL-12
via its induction of IFN-y and eventually induction of nitric oxide, a powerful
vasodilator which can influence vascular permeability (Furchgott, 1984). In this light,
IFN-y (and IL-12) may also be implicated in elevating the pathology of the disease by
leading to increased endothelial cell permeability. The dramatic elevation of IFN-y on
day 6, seen just prior to disease onset in the first experiment, supports this theory.
This would indicate that IL-12 activation occurred with the oedema being linked to
pro-inflammatory events mediated in part by IL-12.
Conclusion
The importance of the sequence of events at the early stages of infection, as
concerns generation of endogenous host mediators including cytokines is hereby
underlined as it can determine the outcome of disease. The results of the first
experiment in this study demonstrated changes in the weight of spleen, IL-12, IFN-y,
EL-4 and nitrite levels during C. ruminantium infection in Balb'c mice and has paved
way for more research in the interactions of the cytokines and other mediators in C.
ruminantium infection. The results in the second experiment demonstrated that IL-
12 early in the disease has some immunomodulatory effects on C. ruminantium
infection in mice by favouring a Th 1 immune response. From the results of this study
and the established facts of the functions of IL-12 in literature, we postulate that
treatment of mice with IL-12 early in the disease (before or at time of infection) is
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beneficial as the specific immune responses are not yet established and this leads into
induction of innate non-specific immune response. Treatment with EL-12 late after
the disease is established, however, may result in an unwanted increased inflammatory
response due to this innate non-specific immune responses. It is suggested here that
the protection was through induction of IFN-y production which then activated
macrophages and consequently induced early control of the organisms growth and
dissemination. In these mice, a mechanism involving increased IFN-y, nitric oxide
production, suppression of IL-10 and IL-4, and increased IgG2a, together indicative
of a Th 1 immune response, came into play.
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CHAPTER 7
GENERAL DISCUSSION AND CONCLUSIONS
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The aim of this study was to investigate the pathogenesis and immune
responses induced by the host-parasite interactions in C. ruminantium infections. The
effect of cytokines and nitric oxide levels on the disease, and vice versa, were
investigated using both in vivo and in vitro models.
The pathogenesis of C. ruminantium, and especially what culminates in death,
remains unclear. Increased vascular permeability resulting in effusions into body
systems is the pathological hall mark of the disease. A better knowledge of host-
parasite interactions in C. ruminantium infection is important in providing a better
understanding of the pathogenesis and immune responses of the disease and also for
development of effective control measures for the disease. C. ruminantium infects and
multiplies in endothelial cells and the implication of this host cell-parasite association
may be important in understanding the host-parasite interactions as a whole. Also, a
knowledge of the immunological mechanisms evoked or inhibited shortly after
infection might provide clues regarding the host of responses which determine the
course of the disease and that need to be induced or suppressed for effective
treatment and control of the disease.
The important role of IFN-y, and possibly nitric oxide (NO), in the control of
C. ruminantium infection was a consistent finding in all the chapters of this study. The
time factor, when these mediators were made available during the disease, was found
to be of paramount importance in the control of infection in mice. Induction of IFN-/y
production just before or after clinical disease onset in both ovine and murine
experimental infections was shown not to influence the final outcome of disease. This
was shown in sheep infected with the Welgevonden isolate of C. ruminantium which
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suffered a fatal outcome of the disease despite IFN-y increase recorded after onset of
clinical disease (day 10). Red Maasai sheep, which had prior exposure to C.
ruminantium antigens, showed higher resistance to the disease and also recorded
earlier and higher levels of IFN-y and NO levels as compared to naive infections.
Treatment of C. ruminantium infected BPEC with BorlFN-y resulted in
increased production of NO and reduced viability of EBs coupled with induction of
apoptotic cell death especially in infected cells. This effect was blocked by the nitric
oxide synthase inhibitor, L-NMMA, indicating the induction was through the
inducible nitric oxide synthase (iNOS) pathway. Pre-treatment of C. ruminantium
EBs with the NO donor molecule, SNAP, resulted in reduction in viability and
infectivity of the organism to endothelial cells in in vitro studies.
In Balb'c mice, very high levels of IFN—y in spleen homogenates on day 6
post-infection were recorded but these were not sustained and the mice had a fatal
outcome of the disease. Treatment of mice with MrIL-12 before or at time of
infection was shown to result in increased production of IFN-y and NO as compared
to untreated control, and increased protection as shown by reduced mortality and
prolonged course of disease. This increase in IFN-y and NO in IL-12 treated mice
coincided with lower levels of IL-4 and IL-10 as compared to the controls, and also
higher levels of IgG2a as compared to IgGl recorded in the control group.
Inoculating mice with IL-12 after disease onset did not influence the disease outcome,
in comparison to IL-12 inoculations performed before or at the time of infection.
Further evidence of the protective role mediated by interferons was shown in
the C. ruminantium infections of IFN-y and IFN-a/p receptor deficient mice. The
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disease was more severe with shorter incubation periods, early deaths and increased
infection rates in lung and brain sections as compared to the control groups. Thus, this
study also showed that some degree of protection was possibly mediated by the late
IFN-^y induction in 'normal' animals, resulting in delayed disease onset and death, as
infections of IFN-^y and IFN-a/P deficient mice resulted in a more acute and severe
disease than in the controls.
Cell-mediated immune response is important in protection against C.
ruminantium infections (Du Plessis et al., 1982, 1991 and 1992a; Mahan et al., 1994
and 1996; Totte et al., 1993 and 1994), as is also documented for other intracellular
parasites. Du Plessis et al., (1992) showed that transfer of immune spleen cells
conferred immunity to DBA mice against challenge with the Kumm strain of C.
ruminantium. Immune spleen cells depleted of CD8+ cells (Lyt-2+ T cells) could not
confer any immunity to challenge with C. ruminantium, whereas depletion of CD4+ T
cells (L3T4) had no effect on this protection. A later study on the flowcytometric
analysis of the peripheral T cell populations in mice immunised by infection and
treatment confirmed the above findings, that immunity in heartwater is largely
mediated through CD8+ T cells (Du Plessis et al., 1992a). IL-12 induces proliferation
of CD4+, CD8+ and NK cells, and induces production of IFN-y by T cells and NK
cells (Nicola, 1994; Trinchieri, 1993). IL-12-induced protection in this study was
thought to be mainly due to increased IFN-y production and, in line with the findings
of Du Plessis et al., (1992a), clearence of the infectious agent by CD8+ cells may have
been involved in this. One is therefore tempted to speculate that reduction in C.
ruminantium infection in the IL-12 treated mice was due to a combined effect of IFN-
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y, produced by T cells and NK cells, as well as clearance of the parasite is by CD8+ T
cells, but this requires investigating.
IFN-y has been reported to play a major role in clearance of rickettsial parasite
(Turco and Winkler, 1984; Hanson, 1991). Totte et al., (1993 and 1996) reported
inhibitory effect of IFN-y to Cowdria growth in endothelial cells in vitro.
Concanavalin A-stimulated bovine lymphocytes supernatants also inhibited Cowdria
growth, and this inhibition was abolished in the presence of anti-IFN-y but not anti-
TNF-a, further confirming the inhibitory effect of EFN-y (Mahan et al., 1994 and
1996). Evidence that IFN-oc/p can inhibit rickettsial replication in the host cells has
also been reported (Turco and Winkler, 1990; Hanson, 1991), including C.
ruminantium infections (Totte et al., 1993 and 1994). The latter showed that IFN-
a was able to reduce the yield of Cowdria organisms but its effects were 10,000 times
less efficient than those of IFN-y, leading them to conclude that IFN-a slows down
the course of the disease, allowing the host to mount a protective immune response
(Totte et al., 1994). This is in agreement with the results of Chapter 5 where mice
deficient in IFN-y receptors suffered a more severe disease, characterised by shorter
incubation periods and early deaths, than those lacking IFN-a/p receptors.
The overall picture of the results discussed here emphasise the importance of
an early induction of a Th 1 immune response (and suppression of a Th 2 immune
response) for the control of C. ruminantium infections. The time factor for the
availability of the mediators was found to be of utmost importance in controlling
infection. The cytokine micro-environment during the initial phase of an immune
response appears to play an important role in determining the outcome of the disease,
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as cytokine manipulations have been used to modulate immune responses to a variety
of infections, converting susceptible into resistant hosts (Trinchieri et al., 1993 and
Wynn and Sher, 199?). The induction of a pathogen-specific CD4+ T helper cell
response characterised by production of Th 1 or Th 2 type cytokines determines the
resistance or susceptibility of the host to the infecting organism (Wynn and Sher,
1996). Infection of immuno-competent animals with C. ruminantium induced some
protection by producing increased levels of EFN-y and NO with higher levels being
produced by resistant animals including those inoculated with EL-12 at or before
infection. Administration of IL-12 either just before infection or very shortly after
exposure to a variety of infectious organisms has proven to be highly effective at
eliminating or decreasing infection intensity. IL-12 has been reported to promote the
differentiation of CD4+ T cells into Th 1 cells (Stevenson et al., 1995). Animals
infected with Leishmania major (Spok et al., 1993), Toxoplasma gondii (Hunter et
al., 1995), Listeria monocytogenes (Wagner et al., 1995) Cryptococcus neoformans
(demons et al., 1995), Plasmodium yoelii (Sedegah et al., 1994) Mycobacterium
tuberculosis (Cooper et al., 1995) and Histoplasma capsulatum (Zhou et al., 1995)
have all benefited from treatment with IL-12 if administered during the initial
exposure to the pathogen. IL-12 has been reported to have less of an effect if
administered once infections are established (Wang et al., 1994) as was the case in
our study, hence the effects of IL-12 must be prominent at the time of antigen
priming. As EL-12 promotes Th 1 responses and suppresses Th 2 cell development,
this cytokine might be useful as a potential adjuvant for vaccines designed to promote
cell-mediated immune responses in C. ruminantium.
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From the results of mice inoculations with IL-12, it was hypothesised that an
early IFN-y response was beneficial in resolving C. ruminantium infections. IL-12
inoculations early in the disease may have led to induction of T-cell subsets which
promote Th 1 immune response leading to production of IFN-y and NO, and possibly
CD8+ T cells, and therefore increased killing of C. ruminantium organisms preventing
dissemination of the infectious agent , hence lower infection rates. The different
responses elicited by lethal and non-lethal malaria parasites were found to be due to
early IFN—y responses shown in infections with non-lethal parasites (De Souza et al.,
1997). This was further supported by the resistance to C. ruminantium infection
encountered in Red Maasai sheep in which there was higher IFN—y levels earlier in the
disease as compared the more susceptible Dorper sheep. In the IFN-y and IFN-a/p
deficient mice, early deaths were possibly due to unchecked and faster multiplication
rate of the infectious agent as evidenced by the bizarre, and probably, late forms of C.
ruminantium, in sections of these mice, resulting in overwhelming infectious burden
and earlier onset of clinical signs.
An activity of IFN-y in controlling infection in this study was suggested to
partly involve NO production. The killing of organisms by IFN-y activated
macrophages has been reported to involve both reactive nitrogen intermediates (RNI)
and reactive oxygen intermediates (ROI), but that the extent of the contributions of
ROI and RNI may differ from one pathogen to another and from one host to another
(Adams et al., 1991, Barbior et al., 1975, Miyagi et al., 1997). One mechanism used
by body defence mechanisms to kill parasites is by release of toxic molecules including
oxygen radicals and nitric oxide, (James, 1991). Work has been done to establish the
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role for NO in mammalian cell-mediated immunity. Nitric oxide has been postulated
to exert anti-microbial effects on pathogenic intracellular micro-organisms (Boockvar
et. al 1994, Walker et al., 1997, Liew et al., 1990). IFN-y and RNI were reported to
be central to the immune response against Mycobacterium tuberculosis in mice and
that this control was not achieved if production of RNI was delayed (Flynn et al.,
1995). Green et al (1993) showed that increased secretion of NO accompanying
Mycobacterium bovis BCG administration in mice correlated with non-specific
resistance, to challenge with the heterologous micro-organisms. Nitric oxide produced
during C. ruminantium infection seems to be beneficial to the host and is probably
part of the animals defence mechanism to the disease, as NO anti-Cowdria activity
was demonstrated in in vitro studies described in chapter 4. The in vivo significance
of elevated NO is unclear. Experiments were planned to investigate the infection
kinetics and pathology in mice in which the iNOS gene had been disrupted, but
sufficient numbers of mice were not available because of breeding problems in the
colony. Since NO levels tend to be elevated following LFN-y release, it is not clear if
some degree of protection arises from its production in vivo, since mice treated with
EL-12 had elevated production of IFN-y and NO, and up to 50% protection as
compared to 100% mortality rate in the control group.
The increased resistance seen in Red Maasai sheep cannot be fully explained
from these studies. The higher and earlier levels of IFN-y were thought to be
contributory to this resistance, resulting in retarded multiplication rate of the
organism, and therefore reduced dissemination of the infectious agent. A method to
quantify the level of infection in plasma during the course of the disease may clarify
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this; an attempt to use PCR for quantification of infection was tried but the results
were not conclusive. Protection or severity of C. ruminantium infection and
antibody levels were found not to be correlated (Du Plessis, 1984). It has been
generally said that antibodies do not play a major role in immunity to C. ruminantium
infection, as seen in studies where transfer of immune serum or gammaglobulins failed
to confer any protection to animals (Alexander, 1931; Du Plessis, 1971 and 1982).
But Byrom et al., (1993) showed that hyperimmune serum from mice and cattle had
a strong neutralising effect on C. ruminantium infection in vitro but not in vivo.
Genetic resistance to C. ruminantium was suggested by Matheron et al., (1987),
who postulated that populations in heartwater endemic areas developed resistance
through natural selection of resistant lines, and even hypothesised that this could be
sex-linked genetically. The mechanisms of non-specific resistance to C. ruminantium
infection of young animals of all breeds is unknown. This resistance of the young has
been said to bear no relationship with the immunity of the dam, and that it should not
be confused with passive immunity transmitted through colostrum (Neitz and
Alexander, 1941). However, some studies have suggested that the resistance of the
young is correlated to the prior exposure of the dam (Deeem et al., 1996a), and
lately, there has been suggestions that vertical transmission of C. ruminantium is
possible, further supporting this school of thought (Deem et al., 1996b). The
differences in resistance between adults and the young were also suggested to be
possibly due to differences in the replication rate of C. ruminantium (Du Plessis and
Malan 1987). Du Plessis and Malan (1987) found a strong positive relationship
between levels of conglutinin in sera of ruminants and resistance to heartwater and
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also reported that resistance of wild life to C. ruminantium was highly correlated to
conglutinin levels.
Increased levels in enzymes involved in antioxidation in sheep infected with C.
rwninantium were thought to be due to a homeostatic response to counteract
increased levels of oxidising radicals produced as part of the body defence
mechanism. A possible link between these antioxidising enzymes, NO and IFN-7 may
exist but this requires further investigation. On the basis of the results of this study, it
is clear that the induction of NO production may be an important component of cell
mediated immune response to intracellular infections. Future studies are necessary to
investigate the specific role of NO and the target cells of this molecule in the body.
This study showed that the course taken by C. ruminantium infection in both in
vivo and in vitro models is dependent on the cytokine / mediators milieu bathing the
tissues prior to or during infection. Infection in mice was characterised by a transient
high IFN- y response at about day 6 which was not sustained. It is likely that this
response controls C. ruminantium to some extent because mice deficient in IFN- y
receptors died earlier in the disease with higher infection levels as compared to the
control. Sustained release of IFN- y occurred in mice treated with MrIL-12 and
provided protection in a significant proportion. The failure to sustain DFN- y in mice
may be related to a lack of sustainable IL-12 production.
The importance of a Th 1 type immune response was, therefore, underlined and
the possible roles for IL-12 and IFN- y with involvement of nitric oxide in the killing of
the infectious agent suggested. The study showed for the first time the possible roles of
nitric oxide in the killing immune response and pathology of the disease and the
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importance of availability of IL-12 at time of infection in the development of protective
immune response in mice.
Suggested future work:
The study has highlighted some important factors in the pathogenesis and
immune response of the disease, which may be taken into consideration when
developing better treatment and control regimes for the disease.
It would also be of interest in future studies to investigate if C. ruminantium
infection by other isolates elicit similar responses; for instance, less virulent strains may
be early inducers of IFN-y and possibly NO.
The kinetics of disease in the young which exhibit some resistance to the disease
would also help in clarifying the markers of resistance/susceptibility and may be
incorporated in when developing new control measures of the disease. Investigation of
breed-related resistance reported in indigenous African breeds needs investigating
using animals without prior exposure to C. ruminantium.
The role played by NO in the control of the disease needs to be investigated
further. Use of animal models with disruption of the iNOS gene would help to clarify
this.
Also the effect of NO levels seen terminally may be contributory to pathology,
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A. Results of The Red Maasai and Dorper sheep:
1.1.Temperature Records of The Red Maasai
Sheep IN 0.
Day 1 2 3 4 5 6 Mean SD
2 38.5 39.1 38.4 39.2 38.7 38.6 38.75 0.32710
0 38.7 38.9 39.2 39.1 38.8 38.8 38.916 0.1940
2 38.5 38.4 38.4 38 38.4 39 38.45 0.3209
4 38.6 38.2 39 38.2 38.2 39 38.533 0.393
6 39 39 39.2 39 39 39 39.033 0.0816
8 38.2 38.9 38.1 38.2 38 39 38.4 0.4335
10 38.2 38.7 39.6 39.4 38.5 38.1 38.75 0.6220
12 39.2 39.1 39 39 39.2 39 39.083 0.0983
14 39 39 39 38.2 39 39.8 39 0.5059
16 39.3 39.5 39.5 39.1 38.5 39.6 39.25 0.4086
19 39.3 39 40.6 39 38.9 40.6 39.566 0.8115
22 39.9 39 41 39 38.9 41 39.8 0.9979
26 39.1 39.5 40 39.7 39.575 0.3774
28 39.5 39.7 40.4 39.7 39.825 0.3947
30 40 39.9 39.9 39.7 39.875 0.1258
1.2. Temperature Records of The Dorper
Sheep No.
Day 12 15 17 18 19 20 Mean SD
0 38.9 38.9 38.7 39 39.1 39.1 38.95
0.151658
2 39 39 38.8 39 38.9 38.9 38.93333 0.08165
4 38.2 38.6 38.9 38.7 39 39 38.73333 0.307679
6 39 39.3 39.4 39.1 39.2 39.2 39.2 0.141421
8 39 39 38.3 38.9 38.2 39 38.73333 0.377712
10 38.8 39 39 39 39 38.5 38.88333 0.204124
12 39.4 39.2 39.4 39.4 39.4 39.7 39.41667 0.160208
14 41.5 41.4 39.7 39.5 39.5 39.9 40.25 0.941807
16 41.4 41.2 39.4 39.5 39.4 39.6 40.08333 0.947453
19 40.6 41.5 39.8 41 40.4 40.8 40.68333 0.574166
22 41.2 41.7 39.9 41 40.4 40 40.7 0.715542
26 39.2 40 40 40.3
39.875 0.471699
28 39.7
41.3 40.4 40 40.35 0.695222
30 40
40.4 40.5 40.2 40.275 0.221736
1.3. Antibody and Immunoglobulin (IgG) Levels in Red
Maasai and Dorper sheep
1.3.1. lgG1 and lgG2 in Red Maasai and Dorper sheep




0 8 14 19 22 30
1 0.521 0.4 0.453 0.463 0.48 0.781
2 0.23 0.203 0.181 0.168 0.147 0.122
3 0.03 0.15 0.23 0.213 0.2 0.122
4 0.287 0.251 0.224 0.173 0.167 0.154
5 0.587 0.586 0.572 0.55 0.645 0.0635
6 0.049 0.053 0.053 0.055 0.07 0.09
12 0.052 0.05 0.07 0.04 0.055 0.1
15 0.049 0.051 0.051 0.054 0.061 0.111
17 0.058 0.049 0.053 0.055 0.058 0.085
19 0.05 0.052 0.05 0.052 0.055 0.121
20 0.048 0.049 0.051 0.054 0.061 0.111




0 8 14 19 22 30
1 0.075 0.095 0.085 0.088 0.089 0.056
2 0.133 0.128 0.112 0.104 0.099 0.072
3 0.056 0.063 0.061 0.075 0.095 0.085
4 0.08 0.084 0.067 0.066 0.056 0.052
5 0.06 0.066 0.064 0.056 0.063 0.061
6 0.056 0.063 0.061 0.048 0.057 0.078
12 0.048 0.057 0.078 0.051 0.057 0.067
15 0.051 0.057 0.067 0.065 0.034 0.05
17 0.048 0.055 0.048 0.051 0.057 0.067
19 0.048 0.048 0.048 0.048 0.057 0.078
20 0.048 0.056 0.047 0.049 0.059 0.091
1.3.2. Antibody evels (Indirect ELISA results)
Sheep
No.
-2 0 4 8 12 16 19 22
1 1.087 1.315 1.205 1.057 .528 .890 .730 1.084
2 .932 1.120 1.003 .465 .227 .682 .730 .690
3 .930 1.020 .955 .985 .900 .679 .804 1.012
4 .951 1.107 1.018 .832 .797 .692 .769 .885
5 1.069 1.109 1.107 .865 .778 .9225 .825 1.040
6 .925 1.427 1.264 .894 .789 .925 1.053 1.106
12 .046 .106 .202 .164 .160 .575 .840 .965
15 .046 .090 .092 .040 .045 .348 .737 .967
17 .055 .065 .072 .051 .031 .058 .054 .200
18 .048 .079 .084 .038 .039 .049 .045 .351
19 .042 .063 .080 .033 .057 .031 .050 .383
20 .063 .097 .093 .027 .079 .067 .076 .042
.5. Glutathione levels in Red Maasai and Dorpers
iPX in Red maasai
heep
2 3 4 5 6
1,765 54,005 63,595 36,845 37,850 48,433
3,180 93,880 84,790 51,990 51,600 11,608
4,560 91,333 85,750 61,560 52,170 40,350
6,540 89,170 70,181 56,180 56,600 49,100
0,100 89,760 65,340 54,150 62,170 50,170
8,300 70,140 69,170 61,340 55,310 50,500
6,504 66,170 65,170 62,100 41,600 66,321
3,500 62,340 64,300 61,300 57,160 64,170
1,580 62,580 58,380 83,530 77,220 76,970
1,700 61,511 57,340 82,530 70,120 66,620
>3,100 61,810 58,100 59,350 62,300 64,170
>0,711 62,510 56,300 62,110 61,170 65,310




15 17 18 19 20
90,849 119,620 108,260 121,890 108,770 103,970
68,640 140,914 71,670 151,210 114,820 120,760
68,100 141,311 85,700 150,200 107,860 117,720
70,230 130,411 84,100 147,361 115,800 114,760
71,450 126,270 87,500 148,761 113,700 90,600
72,400 110,100 73,130 124,311 100,106 84,440
70,150 90,305 75,750 90,700 97,170 88,560
74,360 91,200 69,120 76,540 94,600 74,130
74,190 74,940 67,630 50,220 75,200 78,480
64,300 71,360 67,510 45,370 60,710 74,110
61,460 68,170 67,750 47,210 59,410 70,310
65,510 66,670 62,400 44,500 60,200 66,510
60,120 62,540 61,720 41,560 55,310 62,560




Day 1 2 3 4 5 6
-2 42.37 32.45 36.1 16.91 31.37 19.28
0 28.79 26.29 31.67 15.02 23.34 33.46
2 26.47 34.95 29.75 16.16 28.16 21.55
4 28.79 34.18 32.35 18.42 25.52 22.4
8 26.57 37.36 24.57 24.61 34.49 38.5
10 21.17 24.8 23.24 23.53 13.23 45.41
12 18.24 24.28 38.51 13.42 21.26 16.25
14 16.63 25.25 28.49 16.63 23.15 20
16 38.9 35.62 32.35 42.46 47.07 36.58
19 37.45 52.08 53.14 57.24 54.48 57.05
21 31.87 44.19 70.24 46.13 71.35 69.5
22 46.88 27.92 72.82 55.58 71.53 63.32
27 34.56 37.16 60.1
30 51.22 33.02 54.73
Dorper
5
Sheep 12 15 17 18 19 20
Day -2 39.28 31.28 43.71 25.03 16.41 18.32
0 51.89 22.49 24.52 16.75 16.97 27.24
2 16.53 28.46 28.98 17.9 19.83 37.07
4 26.57 39.27 60.37 32.43 52.91 31.67
8 23.95 39.96 38.61 54.1 36.58 42.74
10 20.79 25.12 26.47 20.6 18.93 23.85
12 27.92 30.13 30.23 23.78 19.93 21.95
14 22.59 24.33 30.9 23.58 24.74 28.69
16 116.8 30.61 62.49 33.11 19.35 42.27
19 143.74 44.47 46.3 35.33 38.9 43.15
21 141.3 47.65 47.56 32.73 39.28 43.34
22 115.2 36.55 39.18 29.45 31.29 43.51
27 69.01 84.44 35.03 47.56
30 45.15 115.4 36.87 47.66




Sheep No 0 4 8 10 14 19 22 30
1 0.28 0.34 0.27 0.84 0.38 0.46 0.22 0.33
2 0.52 0.5 0.62 0.51 0.71 0.58 0.68 0.93
3 0.46 0.5 0.97 1.67 0.33 0.59 0.53
4 0.62 0.67 0.41 0.45 0.75 0.49 1.14 0.71
5 0.23 0.4 0.26 0.87 0.23 0.44 0.24 0.19
6 0.54 0.54 0.63 0.4 0.31 0.54 0.73
Mean 0.441667 0.491667 0.526667 0.79 0.451667 0.516667 0.59 0.54
Sd 0.154197 0.114615 0.01 0.05 0.221307 0.062823 0.1 0.2
Dorpers
Day
Sheep No 0 4 8 10 14 19 22 30
12 0.27 0.63 0.74 0.34 0.56 0.53 0.03
15 1 0.38 0.36 0.29 0.46 0.27 0.3
17 0.3 0.3 0.2 0.25 0.24 0.19 0.39 0.35
18 0.28 0.3 0.57 0.61 0.65 0.45 0.37 0.78
19 0.49 0.48 0.33 0.52 0.63 0.49 0.36 0.94
20 0.33 0.33 0.45 0.7 0.56 0.41 0.61
Mean (D) 0.445 0.403333 0.441667 0.451667 0.516667 0.39 0.343333 0.69
Sd 0.283602 0.130026 0.191355 0.184761 0.151085 0.132665 0.186726 0.305123
1.8. Interferon gamma Levels (OD values) in Red Maasai and Dorpers
infected with C. ruminantium
Sheep NO.
Day 3 6 12 15
-2 0.016 0.014 0 0
0 0.012 0.016 0 0
4 0.008 0.008 0.002 0
8 0.018 0.008 0 0
12 0.011 0.016 0.008 0.002
16 0.011 0.001 0.012 0.001
19 0.011 0.006 0.006 0.018
22 0.017 0.029 0.002 0.009





Sheep NO. 0 4 8 14 19 22 30
1 3224 5842 1345 5669 5234 5228 11221
2 21664 2923 12156 5858 4567 11889 13158
3 5732 1734 8946 1011 2353 7636
4 5842 3108 9002 9184 10876 11965 24426
5 4358 4497 8873 8834 7654 2586 2541
6 3036 595 1458 1652 4580 4164
Means 7309.333 3116.5 6963.333 5368 5877.333 7244.667 12836.5
Median 5045 3015.5 8909.5 5763.5 3466 6432 12836
Dorpers
Day
Sheep NO. 0 4 8 14 19 22 30
12 1128 3366 4231 3014 16076 22493
15 1359 3864 2554 1443 9623 9398
17 1233 2284 626 1265 15098 1243 15694
18 8142 9830 24782 8809 12890 9712 22886
19 278 4969 9908 4355 14657 4940 8731
20 2763 2376 3855 4512 18765 3827 9025
Means 2483.833 4448.167 7659.333 3899.667 12849.5 8602.167 14084
medians 1296 3615 4043 3684.5 7169 12359.5
1.10. Temperature, SOD, GPX, IL-8 and TNF-a levels of Sheep infected













0 61.6 10600 30 36 39.7
1 39.9
2 150 37.3 0 35 39.9
3 39.2
4 166.6 32.3 4339.9 0 34 39.6
5 39.7
6 174.9 40.3 23900 40 35 39.8
7 39.7
8 166.6 65.6 23500 110 36 40.1
9 41.2
10 133.2 56 21700 10 33 41.6
11 42.2













0 18 7338 20 32 39.9
1 39.9
2 166.6 24.2 0 30 39.9
3 39.8
4 174.9 17.7 2792.4 10 33 40
5 39.9
6 141.7 19.2 1728.5 20 31 40
7 41.3
8 158.3 52.5 11400 320 29 41.8
9 41.9
10 191.6 27.3 13600 110 24 42
11 41.7













0 57 14100 30 30 39.9
1 40.2
2 133.2 29.8 0 29 39.9
3 39.3
4 174.9 23.7 2867.9 0 30 39.7
5 39.7
6 174.9 29.2 14500 70 28 39.5
7 39.8
8 158.3 62.1 17100 90 27 41.2
9 41.3
10 133.2 45.4 17600 30 21 41.9
11 42.1














0 18 7338 120 32 39.9
1 39.9
2 166.6 24.2 40 30 39.9
3 39.8
4 174.9 17.7 2792.4 20 33 40
5 39.9
6 141.7 19.2 1728.5 120 31 40
7 41.3
8 158.3 52.5 11400 320 29 41.8
9 41.9
10 191.6 27.3 13600 160 24 42
11 41.7












0 8639.3 20 32 39.8
1 39.7
2 141.7 36.3 0 30 39.8
3 39.3
4 166.6 34.3 1896.36 20 33 39.7
5 39.7
6 166.6 33.8 5070.44 120 31 40.1
7 40.9
8 166.6 73.2 10600 140 29 41.4
9 42.2
10 150 37.8 12400 160 24 41.6
11 42
12 166.6 90.3 3148.8 100 29 41.4
Sheep 69
Day SOD GPX IL-8 TNF-a PCV Temp (oC)
U/ml U/ml pg/ml (pg/ml) %
0 51.8 7969.5 0 35 40.1
1 39.8
2 71.1 40.4 0 34 39.9
3 39
4 158.3 33.3 1620.6 20 36 39.4
5 39.7
6 158.3 51.9 1983.2 90 36 39.4
7 40.7
8 150 99.4 5947.3 430 34 41.2
9 41.4
10 133.3 58.5 9742.9 140 34 41.3
11 41.9
12 158.3 76.7 13100 80 30 42.2
Sheep 71
Day SOD GPX IL-8 TNF-a PCV Temp
U/ml U/ml pg/ml (pg/ml) % (oC)
0 61.6 10500 0 33 40.1
1 40.1
2 21.2 0 31 39.1
3 39.6
4 158.3 16.6 9406.4 17 36 39.9
5 39.8
6 141.7 19.2 3941 120 31 40.9
7 41.1
8 133.2 35.3 2025.4 120 30 42.1
9 42.5
10 71.1 27.25 5086.1 130 29 42.3
11 41.9












0 8639.3 0 6905.4 39.8
1 39.7
2 141.7 36.3 0 39.8
3 39.3
4 166.6 34.3 1896.36 20 1710.5 39.7
5 39.7
6 166.6 33.8 5070.44 202 4727.3 40.1
7 40.9
8 166.6 73.2 10600 300 11000 41.4
9 42.2
10 150 37.8 12400 100 12200 41.6
11 42












0 18 7338 0 32 39.9
1 39.9
2 166.6 24.2 0 30 39.9
3 39.8
4 174.9 17.7 2792.4 20 33 40
5 39.9
6 141.7 19.2 1728.5 202 31 40
7 41.3
8 158.3 52.5 11400 560 29 41.8
9 41.9
10 191.6 27.3 13600 300 24 42
11 41.7
12 158.3 49.5 6214.5 130 29 41.7




mean sd Mean sd Mean sd Mean sd
0 6 10 12
66 0.1125 0.003536 0.1085 0.002121 0.109 0.007778 0.1375 0.003182
67 0.106 0.008485 0.096 0.004243 0.0995 0.001768 0.1085 0.000354
68 0.1275 0.026163 0.105 0.001414 0.096 0 0.136 0.003536
69 0.107 0.022627 0.099 0.001414 0.097 0 0.099 0.002828
70 0.1015 0.014849 0.088 0 0.083 0 0.155 0.00495
71 0.121 0.001414 0.11 0.002828 0.098 0 0.1265 0.001061
72 0.115 0.11 0.1125 0.003536 0.107 0.11 0.1085 0.002121
73 0.112 0.1 0.106 0.008485 0.093 0.099 0.096 0.004243
74 0.146 0.109 0.1275 0.026163 0.104 0.106 0.105 0.001414
75 0.123 0.091 0.107 0.022627 0.1 0.098 0.099 0.001414
76 0.112 0.091 0.1015 0.014849 0.088 0.088 0.088 0
77 0.122 0.12 0.121 0.001414 0.108 0.112 0.11 0.002828




Sheep No. 0 2 4 8 10 12
67 22.95 23.25 26.55 23.75 33.4
68 18.05 19.15 19.05 29.4 26.05 27.4
70 27.1 23.05 32.15 49.35 33.8 24.95
73 28.95 24.35 31.1 21.7 40.15 44.1
75 22.26 22.45 29.21 22.05 31.35 32.15




66 29.4 23.9 33.8 21.05 17.55 44.85
69 20.1 29.75 33.1 23.7 20.4 40.9
71 32.9 31.9 26.95 30.45 26.45 62.8
72 33 22.35 35.4 29.75 23.55 42.9
74 25.85 28.97 29.31 22.27 24.98 49.86
76 31.85 24.97 34.31 30.75 18.75 45.25
Appendix 2


















0 0.15 0.17 0.42 0.01 0.42 0.01 0.42 0.29 0.42 0.03
1 0.15 0.03 0.75 0.03 2.65 0.18 1.68 0.06 1 0.01
2 0.84 0.18 3.7 0.18 4.77 0.13 4.2 0.53 1.35 0.25
3 1.25 0.2 3.13 0.28 2.94 0.04 3.34 0.41 3.75 0.28
4 1.88 0.18 2.53 0.18 3.57 0.13 1.5 0.18 3.35 0.4
5 1.7 0.2 2.57 0.18 3.08 0.13 2.25 0.18 2.93 0.12
6 1.9 0.13 2.97 0.08 6.73 0.13 5.75 0.06 4.63 0.24
7 1.96 0.2 3.68 0.17 6.67 0.13 3.97 0.06 5.82 0.15
8 0.95 0.13 2.7 0.08 2.7 0.06 2.7 0.18 3.19 0.13
9 1.18 0.18 2.56 0.07 3.34 0.09 1.68 0.06 2.57 0.29
10 1.3 0.06 3.87 0.05 5.36 0.26 2.7 0.06 3.43 0.18
11 1.61 0.29 4.19 0.05 8.96 0.53 4.6 0.06 3.12 0.18
12 1.71 0.18 4.19 0.08 9.41 0.06 4.45 0.06 3.71 0.07
13 2.02 0.18 6.1 0.53 11.45 0.59 4.6 0.13 4.51 0.15
14 2.06 0.18 9.99 0.65 16.58 0.11 8.19 0.02 6.71 0.19
15 1.03 0.13 6.52 0.35 5.66 0.18 5.58 0.05 5.43 0.34
16 1.62 0.18 6.46 0.13 4.83 0.18 3.97 0.02 3.92 0.18
17 1.68 0.13 6.26 0.08 6.74 0.13 5.8 0.13 5.65 0.06
18 2.26 0.13 8.37 0.11 5.62 0.34 5.4 0.53 1.87 0.29
19 2.2 0.13 6.35 0.07 6.87 0.22 6.27 0.06 4.35 0.24
20 1.73 0.09 7.91 0.16 11.07 0.39 8.1 0.06 6.25 0.19
21 1.93 0.2 8.5 0.23 12.07 0.23 8.56 0.13 6.55 0.06
2.2.Viability of C. ruminantium Elementary bodies in














0 73 6 2.98 3.8 6
25 54 4 3.12 3.9 4
50 35 12.5 3.36 4.6 12.5
75 28 8 3.8 5.25 8
100 19 2.5 4.9 9.8 2.5
2.3. Endothelial cell death in C. ruminantium infected










0 12 5 7 1.5
25 17 1.3 10 2
50 26 5.2 19 1
75 42 2.1 33 2
10C 75 6.2 50 9.3
.4. A. Viability and infectivity of C. ruminantium Elementary




0 87.5 100 67 67 75 82
25 67 50 60 50 75 67
50 60 42.8 60 25 40 40




0 71 80 71 78 70 77
25 50 57 50 62.5 50 42
50 25 33 25 25 25 25






0 112 115 110 112 2.5
25 68 73 76 72 4
50 30 26 34 30 4







0 195 200 230 208 18.9
25 140 132 122 131 9
50 96 100 110 102 7.2
100 50 55 60 55 5
J. Viability and infectivity of C. ruminantium Elementary bodies





Day 2 Day4 Day 7 Day7
SNAP
:onc.




0 112 208 82 75 14 4.3 1100 19 86
25 72 131 64 52 10 7 810 15 65
50 30 102 45 28 13 4 340 9 55
100 22 55 37 20 16 2.7 223 11 45







1 2 4 7 Nitrite
Cone.
0 112 200 1100 90 82 75 86 34
25 70 132 810 79 68 52 65 35
50 29 100 340 56 45 28 55 37
100 23 | 55 223 38 37 20 45 40.1
>pendix 3
1. Identification of Individual mice deficient in IFN-y
amma), IFN-a/p (alpha beta) receptors and the wild type
FT) (control) groups
gamma la alpha-beta la WT la
gamma 2a alpha-beta 2a WT 2a
gamma 3a alpha-beta 3 a WT 3a
gamma 4a alpha-beta 4a WT 4a
gamma 5a alpha-beta 5 a WT 5a
gamma lb alpha-beta lb WT lb
gamma 2b alpha-beta 2b WT 2b
gamma 3b alpha-beta 3b WT 3b
gamma 4b alpha-beta 4b WT 4b
gamma 5b alpha-beta 5b WT 5b
gamma lc alpha-beta lc WT lc
gamma 2c alpha-beta 2c WT 2c
gamma 3c alpha-beta 3c WT 3c
gamma 4c alpha-beta 4c WT 4c
gamma 5c alpha-beta 5 c WT 5c
3.2. Mortalities as a function of time in IFN-y and IFN-a/p receptor adeficient mice and
infected with C. ruminantium









1 10 2 0 0 dead 1 0 1 ifn-g 1 12 13
IFN-
a/bR%
3 6 3 1 0 not
dead
12 13 25 contro
I
0 13 13
Control 0 4 0 6 3 total 13 13 26 total 1 25 25
% dead Day 8 day 8














7.69 0 13 13 26 15 11 26




No. of surviving mice
Day 1 2 3 4 5 6 7 8 9 10 11
IFN-g
R%
13 13 13 13 13 13 12 2 2 0 0
IFN-
a/bR%
13 13 13 13 13 13 10 8 4 0 0
Control 13 13 13 13 13 13 13 9 3 C
ppendix 4.
4.1. Spleen weights in Balb'c mice infected with C.
ruminantium and the controls
Spleen wts
Day 0 2 4 6 8 10
Infected 120 120 120 240 160 200
120 110 120 180 160 210
100 150 130 140 160 110
80 120 170 210 120 160
130 120 140 200 110 110
90 110 130 180 150
Uninfected 100 140 110 100 90 100
80 110 100 80 110 100
130 120 110 90 130 110
90 90 90 140 90 100
2. Thoracic oedema in Balb'c mice infected with C.
rminantium
Day Oedema Amount (ml)
0 2 4 6 8 10
0 0 0 0.5 0.5 1
0 0 0 0 0 1
0 0 0 0 1 1.3
0 0 0 0.6 1.1 1.25
0 0 0 0 1.2 1.3
0 0 0 0.22 0.76 1.17
0 0 0 0.271293 0.449889 0.14
4.3.Interferon gamma levels in Balb'c mice infected with C. ruminantium
absorbance ifn-g
cone
Animal 1 2 MEAN x 2 dilution x511,99
A1-Day 2 0.161 0.176 0.1685 0.0465 0.093 47.61507
B2 0.146 0.148 0.147 0.025 0.05 25.5995
C3 0.152 0.147 0.1495 0.0275 0.055 28.15945
D4 0.135 0.146 0.1405 0.0185 0.037 18.94363
E5 0.135 0.159 0.147 0.025 0.05 25.5995
F1 0.136 0.122 0.129 0.007 0.014 7.16786
H1 0.129 0.149 0.139 0.017 0.034 17.40766
12 0.127 0.157 0.142 0.02 0.04 20.4796
J3 0.163 0.149 0.156 0.034 0.068 34.81532
K4 0.142 0.143 0.1425 0.0205 0.041 20.99159
A2-Day 4 0.178 0.174 0.176 0.054 0.108 55.29492
B3 0.174 0.159 0.1665 0.0445 0.089 45.56711
C3 0.173 0.183 0.178 0.056 0.112 57.34288
D5 0.178 0.183 0.1805 0.0585 0.117 59.90283
E1 0.175 0.165 0.17 0.048 0.096 49.15104
G1 0.707 0.241 0.474 0.352 0.704 360.441
H2 0.154 0.168 0.161 0.039 0.078 39.93522
13 0.247 0.166 0.2065 0.0845 0.169 86.52631
K5 0.167 0.177 0.172 0.05 0.1 51.199
J4 0.136 0.157 0.1465 0.0245 0.049 25.08751
A3-Day 6 0.945 0.848 0.8965 0.7745 1.549 793.0725
B4 1.082 1.216 1.149 1.027 2.054 1051.627
C5 0.144 0.168 0.156 0.034 0.068 34.81532
D1 1.063 1.125 1.094 0.972 1.944 995.3086
F2 1.342 1.401 1.3715 1.2495 2.499 1279.463
G2 1.365 1.455 1.41 1.288 2.576 1318.886
H3 0.183 0.17 0.1765 0.0545 0.109 55.80691
14 0.144 0.15 0.147 0.025 0.05 25.5995
L1 0.16 0.16 0.16 0.038 0.076 38.91124
M1 0.142 0.141 0.1415 0.0195 0.039 19.96761
B1-Day 8 0.218 0.217 0.2175 0.0955 0.191 97.79009
D3 0.207 0.207 0.207 0.085 0.17 87.0383
E2 0.246 0.254 0.25 0.128 0.256 131.0694
E3 0.229 0.244 0.2365 0.1145 0.229 117.2457
G3 0.264 0.279 0.2715 0.1495 0.299 153.085
G4 0.217 0.215 0.216 0.094 0.188 96.25412
L3 0.161 0.169 0.165 0.043 0.086 44.03114
L4 0.148 0.156 0.152 0.03 0.06 30.7194
M2 0.144 0.158 0.151 0.029 0.058 29.69542
M5 0.192 0.161 0.1765 0.0545 0.109 55.80691
A5-Day 9 0.253 0.243 0.248 0.126 0.252 129.0215
C2 0.286 0.262 0.274 0.152 0.304 155.645
E4 0.347 0.336 0.3415 0.2195 0.439 224.7636
F3 0.324 0.3 0.312 0.19 0.38 194.5562
F4 0.28 0.271 0.2755 0.1535 0.307 157.1809
G5 0.288 0.281 0.2845 0.1625 0.325 166.3968
A4-Day 10 0.313 0.285 0.299 0.177 0.354 181.2445
B5 0.375 0.371 0.373 0.251 0.502 257.019
C1 0.272 0.315 0.2935 0.1715 0.343 175.6126
D2 0.192 0.205 0.1985 0.0765 0.153 78.33447
)2 0.192 0.205 0.1985 0.0765 0.153 78.33447
:5 0.332 0.346 0.339 0.217 0.434 222.2037
5 0.149 0.151 0.15 0.028 0.056 28.67144
12 0.148 0.158 0.153 0.031 0.062 31.74338
13 0.142 0.158 0.15 0.028 0.056 28.67144
15 0.177 0.17 0.1735 0.0515 0.103 52.73497










1600 2.588 2.642 2.615 0.3915
800 1.651 1.635 1.643 0.1995
400 0.931 0.97 0.9505 0.0875
200 0.51 0.517 0.5135 0.052
100 0.323 0.32 0.3215 0
50 0.22 0.199 0.2095
25 0.194 0.154 0.174













Day 2 Day 4 Day 6 Day 8 Day 9 Day 10
k1 -Day 2 47.61507 55.29492 793.0725 97.79009 129.0215 181.2445
12 25.5995 45.56711 1051.627 87.0383 155.645 257.019
:3 28.15945 57.34288 34.81532 131.0694 224.7636 175.6126
)4 18.94363 59.90283 995.3086 117.2457 194.5562 78.33447
:5 25.5995 49.15104 1279.463 153.085 157.1809 222.2037
1 7.16786 360.441 1318.886 96.25412 166.3968
n 17.40766 39.93522 55.80691 44.03114 28.67144
i 20.4796 86.52631 25.5995 30.7194 31.74338
3 34.81532 51.199 38.91124 29.69542 28.67144
A 20.99159 25.08751 19.96761 55.80691 52.73497




OD-1 OD-2 ODX2 ODX2 IL-12 (X437) IL-12 MEAN SD
A1-D2 0.042 0.045 0.084 0.09 36.708 39.33 38.019 1.854034
B2 0.046 0.05 0.092 0.1 40.204 43.7 41.952 2.472045
C3 0.055 0.084 0.11 0.168 48.07 73.416 60.743 17.92233
D4 0.091 0.084 0.182 0.168 79.534 73.416 76.475 4.326079
E5 0.071 0.071 0.142 0.142 62.054 62.054 62.054 0
F1 0.079 0.081 0.158 0.162 69.046 70.794 69.92 1.236023
H1 0.091 0.08 0.182 0.16 79.534 69.92 74.727 6.798125
12 0.049 0.056 0.098 0.112 42.826 48.944 45.885 4.326079
A2-D4 0.053 0.051 0.106 0.102 46.322 44.574 45.448 1.236023
B3 0.055 0.059 0.11 0.118 48.07 51.566 49.818 2.472045
C3 0.077 0.069 0.154 0.138 67.298 60.306 63.802 4.944091
D5 0.06 0.058 0.12 0.116 52.44 50.692 51.566 1.236023
E1 0.069 0.057 0.138 0.114 60.306 49.818 55.062 7.416136
G1 0.102 0.095 0.204 0.19 89.148 83.03 86.089 4.326079
H2 0.053 0.044 0.106 0.088 46.322 38.456 42.389 5.562102
13 0.056 0.038 0.112 0.076 48.944 33.212 41.078 11.1242
A3-D6 0.059 0.067 0.118 0.134 51.566 58.558 55.062 4.944091
B4 0.062 0.045 0.124 0.09 54.188 39.33 46.759 10.50619
C5 0.054 0.059 0.108 0.118 47.196 51.566 49.381 3.090057
D1 0.041 0.048 0.082 0.096 35.834 41.952 38.893 4.326079
F2 0.055 0.039 0.11 0.078 48.07 34.086 41.078 9.888181
G2 0.06 0.055 0.12 0.11 52.44 48.07 50.255 3.090057
H3 0.093 0.063 0.186 0.126 81.282 55.062 68.172 18.54034
14 0.042 0.038 0.084 0.076 36.708 33.212 34.96 2.472045
B1-D8 0.045 0.085 0.09 0.17 39.33 74.29 56.81 24.72045
D3 0.087 0.089 0.174 0.178 76.038 77.786 76.912 1.236023
E2 0.043 0.051 0.086 0.102 37.582 44.574 41.078 4.944091
E3 0.056 0.054 0.112 0.108 48.944 47.196 48.07 1.236023
G3 0.078 0.082 0.156 0.164 68.172 71.668 69.92 2.472045
G4 0.068 0.065 0.136 0.13 59.432 56.81 58.121 1.854034
L3 0.061 0.065 0.122 0.13 53.314 56.81 55.062 2.472045
L4 0.044 0.055 0.088 0.11 38.456 48.07 43.263 6.798125
A4-D10 0.068 0.054 0.136 0.108 59.432 47.196 53.314 8.652159
B5 0.05 0.038 0.1 0.076 43.7 33.212 38.456 7.416136
C1 0.045 0.07 0.09 0.14 39.33 61.18 50.255 15.45028
D2 0.035 0.037 0.07 0.074 30.59 32.338 31.464 1.236023
F5 0.056 0.059 0.112 0.118 48.944 51.566 50.255 1.854034
15 0.038 0.046 0.076 0.092 33.212 40.204 36.708 4.944091
J2 0.054 0.049 0.108 0.098 47.196 42.826 45.011 3.090057
J3 0.059 0.064 0.118 0.128 51.566 55.936 53.751 3.090057
D-0 0.04 0.047 0.08 0.094 34.96 41.078 38.019 4.326079
Means Da\
0 2 SD 4 SD 6 SD 8 SD 10
4.326079 38.019 1.854034 45.448 1.236023 55.062 4.944091 56.81 24.72045 53.314
41.952 2.472045 49.818 2.472045 46.759 10.50619 76.912 1.236023 38.456
60.74C 17.92233 63.802 4.944091 49.381 3.090057 41.078 4.944091 50.255
76.479 4.326079 51.566 1.236023 38.893 4.326079 48.07 1.236023 31.464
62.05* 0 55.062 7.416136 41.078 9.888181 69.92 2.472045 50.255
69.92 1.236023 86.089 4.326079 50.255 3.090057 58.121 1.854034 36.708
74.722 6.798125 42.389 5.562102 68.172 18.54034 55.062 2.472045 45.011



































































































































































































































































































































































































































































































































































































































































































































































































































































4.6. Inteleukin 10 levels in Balb'c mice infected with C. ruminantium
Animal Anima OD1 OD2 Mean pg/mi
1 A1 -Day 2 0.07 0.062 0.066 134.6083
2 B2 0.077 0.071 0.074 150.9245
3 C3 0.049 0.035 0.042 85.65984
4 D4 0.099 0.062 0.0805 164.1814
5 E5 0.04 0.026 0.033 67.30416
6 F1 0.055 0.047 0.051 104.0155
7 H1 0.04 0.033 0.0365 74.44248
8 12 0.041 0.042 0.0415 84.64008
9 J3 0.086 0.052 0.069 140.7269
10 K4 0.025 0.02 0.0225 45.8892
11 A2-Day 4 0.035 0.046 0.0405 82.60056
12 B3 0.043 0.038 0.0405 82.60056
13 C3 0.062 0.072 0.067 136.6478
14 D5 0.024 0.024 0.024 48.94848
15 E1 0.045 0.028 0.0365 74.44248
16 G1 0.065 0.081 0.073 148.885
17 H2 0.066 0.065 0.0655 133.5886
18 13 0.03 0.065 0.0475 96.8772
19 K5 0.177 0.03 0.1035 211.0903
20 J4 0.042 0.055 0.0485 98.91672
21 A3-Day 6 0.032 0.045 0.0385 78.52152
22 B4 0.039 0.038 0.0385 78.52152
23 C5 0.067 0.063 0.065 132.5688
24 D1 0.046 0.044 0.045 91.7784
25 0.062 0.048 0.055 112.1736
26 G2 0.065 0.058 0.0615 125.4305
27 H3 0.038 0.039 0.0385 78.52152
28 14 0.032 0.032 0.032 65.26464
29 L1 0.063 0.062 0.0625 127.47
30 M1 0.023 0.025 0.024 48.94848
31 B1-Day 8 0.05 0.048 0.049 99.93648
32 D3 0.068 0.047 0.0575 117.2724
33 E2 0.034 0.027 0.0305 62.20536
34 E3 0.031 0.034 0.0325 66.2844
35 G3 0.027 0.011 0.019 38.75088
36 G4 0.03 0.015 0.0225 45.8892
37 L3 0.036 0.033 0.0345 70.36344
38 L4 0.023 0.017 0.02 40.7904
39 M2 0.028 0.032 0.03 61.1856
40 M5 0.063 0.053 0.058 118.2922
41 A5-Day 9 0.037 0.041 0.039 79.54128
42 C2 0.104 0.027 0.0655 133.5886
43 E4 0.078 0.025 0.0515 105.0353
44 F3 0.048 0.039 0.0435 88.71912
45 F4 0.042 0.044 0.043 87.69936
46 G5 0.029 0.059 0.044 89.73888
47 A4-Day 10 0.024 0.03 0.027 55.06704
48 B5 0.03 0.034 0.032 65.26464
49 C1 0.034 0.042 0.038 77.50176
50 D2 0.013 0.026 0.0195 39.77064
51 F5 0.162 0.153 0.1575 321.2244
52 15 0.034 0.019 0.0265 54.04728
53 J2 0.041 0.016 0.0285 58.12632
54 J3 0.042 0.026 0.034 69.34368
55 J5 0.042 0.035 0.0385 78.52152
56 1-0 0.081 0.053 0.067 136.6478
57 2-0 0.191 0.197 0.194 395.6669
58 3-0 0.051 0.038 0.0445 90.75864
Day 0 2 4 6 8
IL-10
cone
136.6478 134.6083 82.60056 78.52152 99.93648
Infected 395.6669 150.9245 82.60056 78.52152 117.2724
90.75864 85.65984 136.6478 132.5688 62.20536
164.1814 48.94848 91.7784 66.2844
67.30416 74.44248 112.1736 38.75088
104.0155 148.885 125.4305 45.8892
Uninfect
ed
74.44248 133.5886 78.52152 70.36344
84.64008 96.8772 65.26464 40.7904
140.7269 211.0903 127.47 61.1856






0 207.6911 164.4008 207.6911 164.4008
2 117.7823 38.21992 86.42466 39.74339
4 95.68748 38.69404 135.1182 53.3761
6 103.1657 23.60401 80.05116 33.84723
8 71.72312 30.80733 72.6579 32.83749




OD1 OD2 Mean pg/ml
1.281 1.418 1.3495 1080
0.424 0.568 0.496 540
0.131 0.126 0.1285 180
0.016 0.016 0.016 60
0.012 0.007 0.0095 30
4.7. Nitrite levels in Bab'c mice infected with C. ruminantium
Day
0
Day 2 Day 4 Day 6 Day 8 Day 9 Day 10
7.856 10.736 8.88 8.912 8.912 13.344 12.912
6.768 9.392 8.4 8.832 8.832 11.904 11.632
8.08 10.304 9.568 8.32 8.32 12.256 10.896
10.256 11.328 4.864 8.64 8.64 14.32 10.32
6.928 6.496 7.776 9.872 9.872 12.832 13.376
9.664 11.68 7.696 9.52 9.52 14.272
9.376 7.488 11.152 11.152 12.064 12.576
9.008 4.976 7.568 7.568 9.824 12.528
10.656 6.128 8.592 8.592 11.952 11.104
10.352 6.224 7.408 7.408 . 14.032 11.856
ppendix 5: IL-12 inoculation results
idividual Mice Numbers in different Groups (IA, IIA, IB, MB, III
ND IV)















1a 1a 1a 1a 1a 1a 1a
2a 2a 2a 2a 2a 2a 2a
3a 3a 3a 3a 3a 3a 3a
4a 4a 4a 4a 4a 4a 4a
5a 5a 5a 5a 5a 5a 5a
6a 6a 6a 1b 1b 1b 1b
7a 7a 7a 2b 2b 2b 2b
8a 8a 8a 3b 3b 3b 3b
9a 9a 9a 4b 4b 4b 4b
10a 10a 10a 5b 5b 5b 5b
1c 1c 1c 1c
2c 2c 2c 2c
3c 3c 3c 3c
4c 4c 4c 4c



















































































































KEY:IP=incubationperi d;CD=courseofd seasDOD=dayeath LOF=lungoedemafluid;SP.WT=spleeweight;Morb=morbidity; Mort=mortality
2. Cytokine (IFN-y , IL-10, IL-4 and Nitrite levels in C. ruminantium-
ifected Balb'c mice inoculated with IL-12
GROUP I
Mouse No. FN-g (pg/ml) IL-10 IL-4 N02 (uM)
IA1 96.8 98 32.9 8.63
IA4 163.8 70.2 36.2 8.99
IA5 170.4 93.7 36.1 10.93
IB1 169 33.9 8.9
IB3 148.2 33.7 5.8
IB4 150 33.5 32.5 3.12
IB5 178.7 93.7 25.3 5.86
IC1 137.6 0 38.1 5.99
IC4 87.3 64.4 37.6 9.15
MEAN 144.6444 64.78571 34.03333 7.485556
SD 32.50323 36.47078 3.844802 2.423495
median 150 70.2 33.9
Group 1
D7 (mean) 163.8 70.2 36.2 8.99
D8 159.5 63.6 30.6 5.96
D10 117.8 33.5 35.6 7.5
D11 133.6 95.8 34.5 8.6
D13 137.6 0 38.1 5.99
G1 Stats. Correlation FN/NO
-0.11492
GROUP II
Mouse No. I FN-g (pg/ml) IL-12p70 IL-10
2A1 68.8 106.8
2C3 12.5 13.86 79
2B3 57 81.9







MEAN 49.45 14.1 98.95556







GROUP III IL-12p70 IL-10
Mouse No. I FN-g 9 pg/mL) 76.1
3A2 23 33.7
3A3 35.5 43.9








MEAN 72.45111 16.2 86.34286
SD 51.83197 12.7 54.9913
Median 70.5 76.1
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Interferons gamma and alpha/beta are
involved in the pathological and immune
response mechanisms of Cowdria
ruminantium infection in mice.
M. Mutunga1 , K.J. Sumption1 & C.J. Clarke2
'CTVM; 2Dept. of Veterinary Pathology, Royal (Dick)
School of Vet Medicine, University of Edinburgh, Easter
Bush, Midlothian EH25 9RG
It has been suggested that T cells play an important role in the
immunity against Cowdria ruminantium infections, a
phenomenon mediated through the production of inhibitory
cytokines In a previous study we demonstrated the inhibitory
effect of interferon gamma (lFN-y) on C.ruminantium in
vitro Previous studies also demonstrated that animals
recovering from C.ruminantium infection contained higher
blood levels of interferon alpha (IFN-a) as compared to those
that succumbed to infection Armed with these findings, this
study was designed to investigate the role played by IFN-y,
IFN-a and interferon beta (IFN-p) in the pathogenesis and
immune responses of C ruminantium infection A murine
model comprised of three groups of specially bred mice,
IFN-y, IFN-a/p knock-out mice (mice without receptors for
IFN-y and IFN-a/p respectively) and a control group was
used Short incubation period and course of disease were
recorded in the IFN-y and IFN-a/p knock-out mice, with
more animals dying in the early stages of the disease The
pathological findings were a reflection of the clinical picture.
Grossly, the IFN-y and IFN-a/p knock-out mice manifested a
more extensive thoracic oedema than the control group, a
finding possibly linked to higher infection rate in the lungs of
the IFN-y and IFN-a/p knock-out mice as seen in
histopathological lung sections. Dot blot hybridization of
DNA extracts of lung tissue using digoxigenin-labelled
GroEl probe revealed further support for a higher rate of
infection in the IFN-y knock-out, and to a lesser extend, the
IFN-a/p knock-out groups as compared to the control group.
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Nitric oxide production in Cowdria ruminantium-infected
bovine endothelial cells in vitro', effect of interferon-' on
the nitric oxide production, the organism and ceil via¬
bility
M. Mutunga and K. J. Sumption University of Edmbvrfk.
Centre for Tropical Veterinary Medicine, Easter Bush, Edinbwjk,
EH25 9RG, UK
Cowdria ruminanttum, the aetiological agent oi hart-
water, infects and multiplies in the cytoplasm of endothe¬
lial cells (EC) (COWDRY, E. V., 1925: Uth-I2ih Reponj
the Veterinary Research Union in South Africa, 161-121
EC generates a powerful vasodilator, nitric oxide NO .
which plays a central role in oedema formauon, hype-
tension and blood pressure (MONCADA, S. et ai. I'M.
Hypertension, 12, 365-372). The objective of this study
was to investigate the role of the EC and related media¬
tors in the pathological mechanisms of heartwater.
There was a significant increase in NO levels in in¬
fected bovine EC cultures. Exposure of infected cultures
to bovine recombinant interferon-y (BorlFNy) resulted
in more rapid attainment of maximal levels of NO. Mor¬
phological evidence of EC apoptosis and decreased via¬
bility of the organism were recorded in infected cultures
exposed to BorlFNy. Addition of the NO synthesis in¬
hibitor L-monomethyl-L-arginine (L-NMMA) resulted in
suppression of NO production, indicating involvement
of the inducible nitric oxide synthase oarhwav
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Nitric Oxide And Cowdria ruminantium
Infection Of Bovine Pulmonary Endothelial
Cells In Vitro
M. Mutunga K.J. Sumption1 and P.M. Preston2
' Centre For Tropical Veterinary
Medicine,University of Edinburgh, Roslin,
Midlothian,Edinburgh EH25 9RG; 2 Division of
Biological Sciences, Institute of Cell, Animal and
Population Biology, University of Edinburgh,
King's Buildings, West Mains Road, Edinburgh.
EH9 3JT.
Cowdria ruminantium infection of bovine
pulmonary endothelial cells resulted in substantial
elevation of nitric oxide. Exposure of the infected
cultures to bovine recombinant interferon-gamma
resulted in more rapid nitric oxide production,
reduced viability of the infectious agent and
induction of endothelial cell apoptosis in a
dose-dependent fashion. Addition of the nitric oxide
synthesis inhibitor N-monomethyl-L-arginine
resulted in a significant inhibition of nitric oxide
production indicating that the increase in production
utilises the inducible nitric oxide synthase pathway.
Co-cultivation of infected endothelial cells with the
nitric oxide donor molecule S -nitroso-N-acetyl
DL-penicillamine decreased viability of the
infectious agent in a time and dose-dependent
fashion.
